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HUMAN T-LYMPHOCYTE COLONY FORMATION IN VITRO
Human blood mononuclear cells (MC) stimulated with phytohaemagglutinin (PHA)
were shown to form lymphocyte colonies in agar. Colony cells were shown to be mature
T lymphocytes by immunological typing.
Colony formation by blood MC and purified T cells in primary culture was enhanced
by monocyte (MoCM) and lymphocyte conditioned media (LyCM). Proliferation of colony
cells in secondary culture was wholly dependent on a factor present in LyCM (probably
interleukin 2).
Using a mathematical approach (Kinetic analysis) to analyse cell interactions,
it was shown that at least three interacting cells are involved in PHA induced, primary
T-cell colony formation. Further analysis showed that the requirement for cell inter¬
actions could be substituted for by the inclusion of MoCM and LyCM into cultures. These
findings are discussed in relationship to current concepts of interleukin mediated
regulation of T lymphocyte proliferation.
Studies of leukaemic T-cells, from patients with T-cell chronic lymphocytic
leukaemia (T-CLL) showed that colony formation by T-CLL cells was dependent on growth
factors in a similar manner to colony formation by normal T-lymphocytes. It was also
shown that T-CLL cells could not only respond to growth factors but were also able to
produce normal or increased amounts of interleukin 2.
Colony formation by blood MC from patients with Hodgkin's disease was shown to
be subnormal. Interleukin 2 production was also shown to be decreased. The reduction
in colony formation was shown to correlate with alterations in blood T-cell subsets
and in some cases to be secondary to impaired interleukin 2 production.
Finally, in a study of glucocorticoid-induced inhibition of T cell proliferation,
it was demonstrated that inhibition of colony formation by methylprednisolone was the
result of inhibition of growth factor production by accessory cells.
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GENERAL INTRODUCTION
The normal function of the immune system depends upon
controlled lymphocyte proliferation. Conventionally
proliferation has been investigated using simple, short term,
cultures of lymphoid cell suspensions stimulated with antigen
or mitogens (Nowell 1976). The use of such cultures to study
cell proliferation, however, has been recognised to have
several disadvantages (Metcalf 1977). A major problem results
from the heterogeneity of freshly isolated blood or tissue
cell suspensions which contain a mixture of T and B cell
subsets and non lymphoid cells such as monocytes. This makes
precise monitoring and identification of the proliferating
cell(s) and analysis of cellular interactions difficult
(Metcalf 1977). This study of human T cell colony formation
was initiated in order to develop a more satisfactory method
for the analysis of lymphocyte proliferation that would
overcome these limitations of suspension culture.
The advantages of colony forming assays over suspension
cultures are well recognised (Metcalf 1977): They allow
relatively easy characterisation of proliferating cells and
allow more accurate measurement of cell proliferation than
suspension cultures (Roper and Drewinko 1977, Maurer 1981).
Colony formation has also been shewn to be a powerful in vitro
technique for the identification of regulatory factors
controlling growth and differentiation of haemopoietic and
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lymphoid cells ( Metcalf 1977, Rosenszajn et al 1978, 1981). A
further advantage of colony forming assays is that they appear
to be more sensitive in detecting perturbations of lymphocyte
proliferation resulting from disease (Wilson and Dalton 1976)
or use of pharmacological agents (Roper and Drewinko 1977).
The aim of the present study was therefore to develop a
colony forming assay for human T lymphocytes that would allow
analysis of cell interactions leading to T cell proliferation
by normal T lymphocytes and which could be utilised
r
subsequently to investigate T lymphocyte proliferation in
patients with abnormalities of T cell function.
The results presented in the first chapter of this thesis
deal with the establishment of the colony forming assay and
the characterisation of the colony forming cell. In the second
chapter the cell interactions and growth factor requirements
for colony formation are analysed. In chapter 3 the
informtion gained frcm studies of normal T cell colony
formation is applied to the investigation of abnormalities in
T lymphocyte function in patients with Hodgkin's disease and T
cell chronic lymphocytic leukaemia. In chapter 4 analyses of




CULTURE REQUIREMENTS AND PHENOTYPIC CHARACTERISTICS OF
HUMAN T-CELL COLONIES IN VITRO.
SUMMARY
In this chapter preliminary investigations of PHA induced
T cell colony formation are described. Two methods allowing
colony formation were studied; a single step procedure in
which freshly isolated blood mononuclear cells were plated
directly into agar and a two step procedure in which
mononuclear cells were preincubated in suspension with PHA
before plating into agar. Comparison of these two methods
showed that single step cultures offered advantages over the
two step cultures including a higher plating efficiency and
ease of harvesting of colony cells for further studies.
Colony cells from these cultures were shown to be mature T-
lymphocytes by immunological typing.
INTRODUCTION
The first description of human T-cell colony formation
was provided by Rosenszajn et al in 1975. This group described
a two step culture method which required preincubation of
blood mononuclear cells (MC) with PHA in suspension for 12-24
hours, followed by plating of cells in a soft agar overlayer
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onto an agar base in which PHA was present. Similar two step
cultures were subsequently succesfully used to demonstrate
colony formation by other groups (Fibach et al 1976, Wilson
and Dalton 1976, Dao et al 1978). Initial attempts to grow T-
cell colonies by directly plating MC into agar were
unsuccessful (Rosenszajn et al 1975, Gerassi and Sachs 1976).
However modifications of the culture methods were later
described that allowed T-cell colony formation to occur. Tt>
obtain colony formation in single step cultures it was found
to be necessary either to plate cells at a relatively high
f
cell concentration (Riou et al 1976, Goube deLaforest et al
1979a), or to include autologous or sheep erythrocytes in the
cultures (Gerassi and Sachs 1978, Claesson et al 1977a). More
recently leucocyte feeder layers or conditioned media have
been used to support single step colony formation (Foa and
Catovsky 1979, Gelfand et al 1981). (TABLE 1A).
Colony cells harvested from PHA induced colonies have
been shewn to posess morphological features typical of
lymphocytes undergoing blastic transformation and to form
rosettes with sheep erythrocytes (E- rosettes). They do not
express surface Ig or exhibit cytochemical staining
characteristics of myelo-monocytic cells i.e. phenotypically
they are T-oells (Rosenszajn et al 1975, Riou et al 1976,
Claesson et al 1977a). Gelfand et al (1981) have shown that
colony cells express the T cell antigen 0KT3 and also expresfe
HLA-DR antigens characteristic of activated T-cells.
_ 4 _
TABLE l.A TECHNIQUES USED IN T-CELL COLONY FORMATION
Plating Plating
Culture technique concentration efficiency Reference
Two step cultures 6*10~5/ml
Two step cultures with 6*10"5/ml
autologous erythrocytes
0.05% Rosenszajn et al
1975
1.0-2.0% Gerassi and Sachs
1976, 1978
One step cultures with 10*10"5/ml
thin agar overlayer
0.4% Riou et al 1976
Two step cultures and l*10~4/ml
one step cultures with
sheep erythrocytes
5.0% Claesson et al
1.0% 1977a,b
One step cultures with 1*10"5/ml
leucocyte feeder layer
0.2% Foa and Catovsky
1979




5*10"5/ml 0.8% Gelfand et al
1981
The above data were abstracted from published work cited in
the references column
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Early studies of T-cell colony formation demonstrated
that the colony forming cell precursor is an E-rosetting small
lymphocyte, responsive to PHA in both liquid and agar culture,
(Claesson et al 1977a, Swart and Lowenberg 1980). Recently
studies of colony formation have shewn that T colony forming
cell precursors may include not only an E- rosette positive,
OKT3 positive T cell but also an E-rosette negative, OKT3
negative T cell precursor (Spitzer et al 1982).
The proportion of blood mononuclear cells that give rise
to colonies has been variably reported as between 0.05%
(Rosenszajn et al 1975) and 5.0% (Claesson et al 1977a) with
other groups reporting intermediate values. These differences
in plating efficiency are probably attributable to differences
in the culture methods (summarised in table l.A). Factors
affecting plating efficiency have been found to include:
1) The number of cells plated and the cell concentration
(Gerassi and Sachs 1976, Claesson et al 1977a, Goube de -
Laforest et al 1979a, Gelfand et al 1981).
2) The inclusion of red blood cells in cultures (Claesson
et al 1977a, Gerassi and Sachs 1978, Woods and Lowenthal
1981).
3) The inclusion of leucocyte feeder layers or
conditioned media in cultures (Claesson et al 1977b, Zeevi et
al 1977, Gerassi and Sachs 1978, Gelfand et al 1981).
4) Other modifications of the culture medium; e.g. source
of serum, concentration of certain amino acids, addition of
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defined serum proteins such as transferrin, nature of the
mitogen and mitogen concentration (Sachs 1978, Tice and Davey
1983).
In view of these reported variations in culture
conditions and plating efficiencies, it was therefore
necessary to establish, in preliminary studies, suitable
conditions for colony formation in our laboratory. The results
in this chapter describe the relative plating efficiencies of
one step and two step cultures, the effect of varying the cell
concentration, the effect of red blood cells in cultures, the
serum requirements and the optimal mitogen concentration. In
addition evidence is presented which confirms that the
colonies growing in agar were of T-lymphocyte derivation. The
effects of leucocyte feeder layers and conditioned media are




Blood was obtained by venepuncture and added to sterile
plastic universal containers, containing either heparin
(lOunits/ml final concentration) or E.D.T.A. (2% v/v final
concentration). Blood mononuclear cells (MC) were isolated by
centrifugation over Ficoll Hypaque (Habeshaw and Young 1975).
After centrifugation the plasma was removed, and kept if
required,and the MC removed from the plasma-Ficoll
interface.The MC were then washed twice in RPMI-1640 and
resuspended at the required cell concentration.
COLONY FORMATION
Colony formation by blood MC was assessed using both a
single step culture method,in which MC were plated directly
into agar after isolation , and a two step method, in which MC
were preincubated in suspension culture before plating in
agar.
Single step colony formation: This technique is a modified
version of a method described initially by Riou et al(1976).
Standard culture method:
Blood MC were suspended at cell concentrations between
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0.625- 10.0xl0®/ml in 0.3% agar (Bacto-agar, Difco
laboratories) in RPMI 1640 containing 15% autologous
plasma,unless otherwise stated.This cell suspension was
pipetted onto an landerlayer of 0.5% agar in RPMI 1640
containing 15% autologous plasma and PHA (phytohaemagglutinin
M, Difco laboratories). Unless otherwise specified PHA was
added to give a 1% v/v concentration in the agar underlayer
(i.e 20 microlitres of PHA-M diluted 1/10 were added to 200
microlitres of agar underlayer). Cultures were normally
carried in 17rrm diameter wells irr Linbro multiwell plates
(24x17mm diameter, flat bottomed wells, Flow laboratories); in
these experiments 40 microlitres of cells in 0.3% agar were
added to 200 microlitres of 0.5% agar underlayer. In some
experiments washed autologous red blood cells were added to
the underlayers at concentrations between 0.5-2.0%. Cultures
were incubated at 37°C in a fully humidified atmosphere of 5%
C02 in air.
toss cultures:
These "mass cultures" were used to obtain colony cells in
large numbers for cell phenotyping . MC were cultured in 90mm
diameter petri dishes :1.0ml of cell containing overlayer was
added to 6.0ml of underlayer. After 5- 7 days incubation,
colonies were harvested by gently pipetting 1.0ml of RPMI 1640
onto the cultures. This caused the colonies to detach from the
agar, and colonies could then be harvested by aspirating the
medium. Cytospin preparations were then made from colonies
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without further treatment. In order to obtain single cell
suspensions harvested colonies were in sane cases washed twice
in TC199 and disaggregated by refluxing through a fine pasteur
pipette. Cultures were incubated at 37°C in a fully humidified
atmosphere of 5% C02 in air.
Colonies, defined as aggregates of greater than 40 cells,
were counted after 6-7 days incubation, using x40
magnification light microscopy. Three fields were examined in
each 17rtm well and the number of colonies present within a
ruled eye-piece grid were counted. As each grid area was equal
to l/20th of the total well area the total number of
colonies/well could be estimated :
Total colonies/well= colonies in 3 fields x 20-r3
Colony size (i.e. the number of cells per colony) was
measured either by direct examination of cultures at xlOO
magnification or by examination of photomicrographs.
Two step colony formation :This technique is modified from
a method described by Rosenszajn et al (1975).
Five million freshly isolated blood MC were first
preincubated in 5.0ml RPMI 1640 containing 10% autologous
plasma, and l%v/v PHA, for 18hours. The cells were then
harvested by centrifugation, washed three times in RPMI 1640 ,
disaggregated by repeated passage through a fine pasteur
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pipette, and resuspended in 0.3% agar, containing 10% plasma
in RPMI 1640, at the required cell concentration. One ml of
this suspension was then pipetted onto an one ml of agar
underlayer, 0.5% agar in RPMI 1640 with 10% plasma and l%v/v
PHA, in a 35mm diameter petri dish. Cultures were incubated at
37°C in a fully humidified atmosphere of 5% C02 in air.
Colonies were counted after 5 days incubation by counting
all the colonies (aggregates of more than 40 cells) present in
the petri dish. r
CELL PHENOTYPING
MC and cells harvested from colonies were characterised
using light and electron microscopy, enzyme cytochemistry,
immunohistochemistry, inmunofluorescence, irnnunoperoxidase and
rosetting procedures.
Cytospin preparations were made frcm cell suspensions (MC
and colony cells) using a Shandon Mark II cytocentrifuge and
were stained with May-Grunwald-Giaxtsa for routine
morphological examination. Cytospin preparations were al so
stained for acid phosphatase, non specific esterase (alpha
naphthyl acetate esterase ) and chloroacetate esterase (Yam et
al 1971). For electron microscopy, cell suspensions (10
million cells) were pelleted in plastic conical centrifuge
tubes, the supernatant drained off, and the cells then
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resuspended in 5-10mls of 2.5% glutaraldehyde in cacodylate
buffer. Cells were then processed routinely for electron
microscopy.
Immunological studies
Cell suspensions and cytospin preparations were stained
with a panel of anti T and B-cell and anti monocyte antibodies
(0KT3, 0KT4, 0KT6, 0KT8, OKTll, OKMl-Ortho diagnostics, M02,
B1-Coulter, anti HLA-DR/DA6.231 aqd anti IgM/DA6.127 donated
by Dr K.Guy) to demonstrate cell surface and cytoplasmic
immunoglobulin and other cell antigens.
Iirmunof luorescent staining of cell suspensions with monoclonal
antibodies
Aliquots of 0.5-1.0x10 cells were pelleted in 12x7nm
glass tubes and the supernatants removed. Ten microlitres of
antibody at the appropriate concentration (diluted in
phosphate buffered saline, pH 7.2 containing 2% hurran serum
albumin [PBS- 2%HSA]) was then added to the tube and the cells
were resuspended, and incubated on ice for 30minutes. Cells
were then washed twice in ice cold PBS and the supernatants
drained off. Twenty microlitres of fluorescein conjugated goat
anti mouse immunoglobulin (FITC- GAMIg, Qrtho diagnostics ) at
a 1/40 dilution in PBS-2%HSA was added and the cells
resuspended and incubated on ice for a further 30 minutes. The
cells were then washed twice in PBS and resuspended in 0.1ml
of PBS.
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A drop of this cell suspension was placed on a slide,
covered by a cover slip and examined by irtrnunofluoresoence.
The percentage of fluorescent cells was determined by counting
at least 200 cells. Controls stained with only the second
layer antibody ( FITC-GAMIg) were also rau t i nely examined.
These controls usually showed less than 1% positive cells and
never showed more than 5% positive (i.e. non specifically
staining cells).
Demonstration of cell surface Immunoglobulin (SIg)
Cell suspensions were stained for SIg either by an
indirect imnunofluorescenoe procedure using rabbit anti human
IgM as first layer antibody and FITC- conjugated goat anti
rabbit antibody as the second layer antibody (Habeshaw and
Young 1975) or by direct immunofluorescence using fluorescein
(FITC) or rhodamine (TRITC) conjugated Fab2-sheep anti human
kappa or lambda chain antibodies ( Kallestad •)• In
both direct and indirect procedures cells were first incubated
at lxl0®/ml in TC199, at 37°C, for 45 minutes, then washed
once and resuspended at 10xl0®/ml in PBS. Aliquots of 1x10®
cells were then incubated with antibody at the appropriate
dilution (1/80 for rabbit anti human IgM and 1/40 for FITC and
TRITC- conjugates), for 30 minutes at 4°C and then washed twice
in PBS. In the indirect procedure the second layer antibody
(FITC-GAR) was then added at 1/40 dilution and incubated for
30 minutes at 4°C, following which the cells were again washed
twice in PBS.In order to determine the percentage of cells
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with SIg at least 200 cells were counted using the fluorescent
microscope.
Cytoplasmic Iitmunoglobulin (Cytlg)
Cytospin preparations were fixed in 90% ethanol for 90
seconds. Cytlg was detected using the same antibodies, at the
same concentrations, as were used for SIg. The cytospins were
treated with antibody for 30 minutes , at room temperature,
in a humidified box. They were then washed twice in PBS. For
indirect immunofluorescence, cytospins were then stained with
second layer antibody (GAR-FITC) for a further 20 minutes,
and then washed twice in PBS. Cytospins were mounted in
glycerol saline and examined by immunofluorescence.
Immunoperoxidase staining of cytospin preparations with
monoclonal antibodies.
The following procedure was used to stain cytospin
preparations of intact colonies by an indirect
inmunoperoxidase staining technique.
1.Cytospins fixed in acetone for 30 seconds.
2.Whshed in PBS(pH 7.4) for 5 minutes.
3.Treated with normal rabbit serum (NRS), 20%NRS in PBS,
for 10 minutes, and drained.
4.Treated with monoclonal antibody at the appropriate
dilution for 30 minutes. All antibodies, except DA6.231 and
anti kappa and lambda, were used at 1/20 dilution. DA6.231 was
used at 1/80, and anti kappa and anti lambda were used at
1/2000. Antibodies were all diluted in PBS- 20%NRS.
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5.Washed in PBS for 5 minutes, twice .
6.Washed in PBS- 20%NRS for 10 minutes, once.
7.Treated with peroxidase conjugated rabbit anti mouse
immunoglobulin (Dakopatts), (Peroxidase- RAMIg), at a 1/20
dilution for 30-minutes.
8.Washed in PBS for 5 minutes, twice.
9.Treated with Graham and Karnovsky's standard DAB
solution, containing .01M Imidazole. Staining was controlled
microscopically; with anti kappa and lambda staining times
were about 5 seconds; with othe1" antibodies staining times
were about 5 minutes.
10.Washed in tap water.
11.Counterstained with a 1% aqueous solution of toluidine
blue.
12.Dehydrated through alcohol, cleared in xylene, and mounted
using a synthetic resin.
Rosetting
Rosetting was used to demonstrate T- cells with sheep red
blood cell receptors (E-rosettes), B-cells with mouse red
blood cell receptor (MRBC- rosettes), and cells with FcIgG,
FcIgM, and Complement receptors by rosetting with IgG, IgM,
and Ccmplorient coated Ox red blood cells (QxEAG, OxEAM,
OxEAC). The methods used have been fully described (Habeshaw
and Young 1975, Stockdill et al 1983).
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RESULTS
Culture requirements and morphological observations of T-
cell colony formation by blood MC.
Freshly isolated blood MC formed colonies when plated
directly into agar, in single step cultures, only if PHA was
present in the culture underlayers. Colony formation was
maximal at a l%v/v concentration of PHA (FIG 1.1). In two step
cultures MC formed colonies only if PHA was present both in
the liquid preincubation phase and subsequently in the agar
underlayer. p
In one step cultures freshly plated blood MC were
dispersed as single cells in culture overlayers. Sequential
observations of cultures showed that small clusters of 4-8
cells were visible on the surface of the agar within two days
of the initiation of cultures; these progressively increased
in size until day 5 when colonies (greater than 40 cells)
were clearly visible on the agar surface. At day five, in
addition to colonies, smaller cell clusters (4- 40 cells) and
enlarged single cells could also be seen both on the agar
surface and occasionally deeper in the agar. (PLATES 1.1, 1.2).
The appearance of colonies , after day 5, usually remained
static for the next two to three days following which colonies
began to degenerate. Two step cultures plated after
preincubation with PHA consisted of both single cells and
small clumps of cells. In these cultures colonies developed
within the agar as irregular aggregates with only a small
number of well defined rounded superficial colonies that
predominated in the single step cultures
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PLATE 1.1 T-LYMPHOCYTE COLONIES


















PLATE 1.2 T-LYMPHOCYTE COLONIES


















5 1 1.5 2
Figure 1.1: The effect of PHA concentration on colony formation
in single step cultures.
la: standard culture method
lb: culture with 1% RBC in underlayer
Points are the mean values of quadruplicate cultures
of blood mononuclear cells, (2 x 10^ cells/well) from a
single donor. Similar results were obtained using mono¬
nuclear cells from other donors.
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In both one step and two step cultures colony formation
was greater when autologous plasma or human serum (pooled heat
inactivated normal human serum) were used rather than foetal
calf serum. No colonies grew in the absence of serum (TABLE
1.1).
TABLE 1.1
THE EFFECT OF DIFFERING SERUM SOURCES ON COLONY FORMATION
Number of colonies
One step cultures Two step
Standard underlayer RBC underlayer culture
15% Autologous Plasma 92+5 112±12 199±17
15% Pooled normal heat 99+11 101±13 169±16
inactivated human serum
15% Foetal calf serum 10±8 50+8 24±9
Figures are mean values+lS.D. of triplicate cultures. In
single step cultures three low power fields (x40) were
counted per well. 2x10^ cells were plated per well. In two
5
step cultures the whole dish was scored for colonies. 5x10
cells were plated per well. In two step cultures the same
serum was used in both preincubation and agar culture.
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The number of colonies that developed was related to the
cell concentration.In two step cultures colony formation
showed a linear relationship to cell concentration and
colonies grew at cell concentrations between 1x10^-3x10^
cells/well, with a plating efficiency of about 0.05% (TABLE
1.2) . In single step cultures a plating efficiency ten times
that of the two step method was obtained when 2x10® cells
were plated per well (FIG 1.2). However at lcwer cell
concentrations the plating efficiency decreased such that no
colonies were present when the cell concentration was less
than 0.5x10® cells per well (1.2x10® cells/ml in the agar
overlayer). The addition of 1% v/v autologous RBC to
underlayers increased the number of colonies and resulted in a
less marked fall in plating efficiency with lower cell
concentrations. However even in the presence of RBC few or no
colonies formed when less than 0.25xl0®cells (6xl0®cells/ml)
were plated (TABLE 1.3).The enhancing effect of RBC on colony
formation was most marked at low MC concentrations but showed
little variation with changes of RBC concentration in the
underlayer (between 0.5-2.0%)(TABLE 1.4).At RBC concentrations
greater than 2% colonies could only be counted after lysis of
the RBC using an acetic acid solution; this resulted in

































Figure 1.2: Plating efficiencies in one step and two step
cultures.
Points are individual values showing the total
number of colonies developing from 10^ blood mono¬
nuclear cells from 20 normal individuals.
5
In one step cultures 2 x 10 cells were cultured
in 17 mm diameter multiwell plates using standard
culture method or cultures supplemented with 1% v/v
autologous RBC. In two step cultures 0.5 - 1.0 x 10
blood mononuclear cells were cultured in 35 mm diameter
petri dishes.
TABLE 1.2
COLONY FORMATION BY BLOOD MC IN TWO STEP CULTURES: EFFECT OF
CELL CONCENTRATION ON COLONY FORMATION
No.eells/wel 1 (xl0^) Total colonies/well Plating efficiency(%)






Figures are mean values ±1S.D of three experiments using blood
JVC from 3 different donors.
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TABLE 1.3
COLONY FORMATION BY BLOOD MC IN SINGLE STEP CULTURES: EFFECT . ,
OF CELL CONCENTRATION ON STANDARD AND RBC SUPPLEMENTED
CULTURES

















ENHANCEMENT OF COLONY FORMATION (SINGLE STEP) BY AUTOLOGOUS
RBC
% enhancenent of colony formation
Underlayer Standard 0.5%RBC 1.0%RBC 2.0%RBC
2x10^ cells 0 (115±14) 10 29 27
1x10 5 0 (14±5) 107 171 150
0.5xl05 0 (6±4) 250 383 250
Figures are the mean of triplicate cultures. Figures in
parentheses are the number of colonies in three lew power
fields on standard underlayers without RBC. %enhancement=[(no.
colonies on RBC underlayer - no. colonies on standard
underlayer) / no.colonies on standard underlayer] x 100
In single step cultures, colony size, as well as colony
number , was also dependent on cell concentration. A
progressive decrease in colony size was seen with falling cell
concentration. At low cell concentrations although few or no
colonies were present, clusters (less than 40 cells) could be




















0.5 1 1.5 2
cells/well x 10^
Figure 1.3a: The effect of cell concentration on colony
number in one step cultures.
The number of colonies - S.D. (aggregates
>40 cells) and the total number of colonies and
clusters (aggregates 4-40 cells) developing at
different cell concentration are shown.
0.5 1 1.5 2
cells/well x 10^
Figure 1.3b: The effect of cell concentration on colony
size in one step cultures.
In the same experiment as shown above
(Fig. 1.3a), the mean number of cells - SEM present
in cell aggregates (colonies and clusters) develop¬
ing at different plating concentrations is shown.
Aggregate size was determined by counting the number
of cells in 50-100 colonies and clusters at each
cell concentration.
— O K
Phenotypic characteristics of colony cells
In two step cultures colonies formed deep in the agar and
were difficult to harvest in sufficient numbers for
functional or morphological characterisation. Nevertheless in
four experiments about 100 colonies were removed from the
agar using a fine pasteur pipette and micromanipulator. After
washing and disaggregating the cells it was possible to
demonstrate that 44±7% (37-54%) of these cells formed E-
rosettes. Insufficient cells werer obtained for further
studies.
In one step cultures colonies were easily harvested by
washing the culture wells with PBS; this led to the
detachment of around half the colonies from the agar surface.
Between 0.5 and 5x10® cells oould be harvested in this way
either frcm a single 90mm plate or frcm the 24 wells of a
multiwell plate.
Cytospin preparations of colonies showed large
lymphoblastoid cells, some in mitosis and a small number of
small lymphocytes (PLATE 1.3). Cytochemistry showed occasional
cells with focal acid phosphatase activity and less than 1%
cells with non specific esterase activity . No cells posessed
chloroacetate esterase activity. (TABLE 1.5).
- 26 -




E SIgM NSE. CE
Blood Mononuclear cells 67+15 17+11 14±6 9+4
( preculture ) (40-85) (5-35) (8.5-23) (3-13)
Colony cells 83+6 2.5±1 0.2 0
(74.5-91) (1.5-4.5) (0-0.5) (0)
Figures are the mean +1S.D. of six experiments. Figures in
parentheses give the range.
TABLE 1.6 IMMUNOLOGICAL TYPING OF COLONY CELL SUSPENSIONS
USING MONOCLONAL ANTIBODIES
% positive cells
E OKT3 OKT4 OKT8 OKT6 HLA-DR
Blood Mononuclear 57±13 59+10 48±13 23±8 - -
cells (43-68) (46-69) (33-64) (16-32)
Colony cells 96±3 97±2 65+16 39±9 0 53+22
(93-99) (93-98) (42-78) (34-52) (0) (22-72)
Thymocytes (1) 89 21 73 81 86 4
Figures are the mean values + 1S.D. of four experiments.
Values for a thymocyte suspension are included as a control.
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Electron microscopy showed cells with rounded or
convoluted nuclei, with dispersed chromatin and prominent
nucleoli. There was moderate surrounding cytoplasm that
contained polyribosomes and mitochondria but few lysosomes and
little rough endoplasmic reticulum was seen .
Colony cells therefore possesed morphological and
cytochemical characteristics of transformed lymphocytes, with
few or no cells shewing evidence of plasmacytic, myeloid or
monocytic differentiation.
Disaggregated colony cells were further characterised by
imnunofluorescence and rosetting techniques. Over 80% of
colony cells formed rosettes with sheep red blood cells (E-
rosettes) (PLATE 1.4). Colony cells did not form rosettes with
IgG, IgM, or complement coated ox erythrocytes, nor did they
form rosettes with mouse red blood cells. Imnunofluorescent
staining for surface IgM showed less than 5% positive cells
and less than 0.5% cells contained cytoplasmic IgM or kappa or
lambda light chains.
Suspensions of colony cells stained with anti T-oell
monoclonal antibodies showed over 90% 0KT3+ cells, with
0KT4+(T-helper) and OKT8+(T- suppressor/cytotoxic) cells
present in the same proportions as in blood MC. Colony cells
did not stain with 0KT6, nor did they show Tdt activity;
markers of immature thymic and prethymic T-cells. About half
of the colony cells stained with the polyvalent anti HLA-DR
antibody DA6.231. (TABLE 1.6).
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Immunohistochemical staining of cytospin preparations of
non disaggregated colonies gave similar results to
immunofluorescent staining of disaggregated cell suspensions.
Colonies contained over 90% 0KT3 and OKTll (anti sheep red
blood cell receptor) positive cells about half of which were
also HLA-DR positive. Variable numbers of cells within
individual colonies stained with OKT4 and OKT8, the
appearances suggesting that colonies contained a mixture of
0KT4 and OKT8 positive cells. Many of the colonies contained a
central OKMl, M02, la positive macrophage. Colonies did not
stain with the antibodies B1(anti-B cell) or DA6.127 (anti-
IgM) (PLATES 1.5-1.8).
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PLATE 1.3 T-LYMPHOCYTE COLONY
Cytospin preparation
May-Grunwald-Gisnsa (original magnification xJ^O)
PLATE 1.4 T-COLONY CELLS; E-ROSETTES
Cytospin preparation
May-Grunwald-Giemsa (original magnification xlfOQ)
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PLATE l_.b: T cell colony stained with OKTil
(original magnification x 250)
PLATE 1.6: T cell colony stained with M02
(biM:',inal magnification x 250)
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PLATE 1.8: T cell colony stained with
(original magnification x 250)
PLATE 1.7: T cell colony stained with 0KT4
(original magnification x 250)
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DISCUSSION
These studies confirm previous observations that human
blood MC can be induced to form T cell colonies in agar when
stimulated with PHA . Colony formation could be induced either
by plating cells directly into agar (single step cultures) or
by preincubating cells in suspension with PHA and then plating
into agar (two step cultures). The plating efficiencies
observed (0.05% for two step and 0.5% for single step) are
similar to those reported by previous workers using the same
techniques (Rosenszajn et al 1975, Riou et al 1976).The
increase in plating efficiency obtained by using human serum
(or plasma) rather than foetal calf serum and by
incorporating red blood cells into cultures is consistent with
previous observations (Gerassi and Sachs 1976, Claesson et al
1977a, Woods and Lowenthal 1981).
It has been suggested that the lew plating efficiency of
two step cultures may be attributable to colonies developing
from aggregates of cells rather than single cells (Claesson et
al 1977a). In the present study it was found to be difficult
to completely disaggregate cells following preincubation with
PHA and when cells were plated into agar small clusters of
cells were often present at the beginning of culture. This
problem of cell clumping was not encountered when freshly
isolated blood MC were plated directly into agar in the single
step cultures. However even in the single step culture system
colony formation was dependent on plating cells at a
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relatively high cell concentration in the thin agar overlayer,
suggesting that some degree of cell crowding and contact might
be necessary to allcw colony formation. Others have also
observed a similar requirement for a minimum number of cells
to be plated in order to obtain colony formation (Riou et al
1976, Claesson et al 1977a, Shen et al 1977, Gerassi and Sachs
1978, Goube deLaforest et al 1978,1979a).
These findings'suggest that colonies may not be clonal in
origin but originate frcm clusters of cells, particularly in
the twa step cultures. Studies by Singer et al (1981) using
lymphocytes from individuals heterozygous for G6PD, and
carrying GdA and GdB isoenzyme markers have shewn that
colonies grown frcm these individuals contain a mixture of the
tvo enzymes in over 90% of two step colonies and in 70% of one
step colonies. Mathematical analysis of these results
indicated that in two step cultures colonies on average
developed from 10 cell clusters and in single step cultures
frcm 2-3 cell clusters (Singer et al 1981). These findings
conflict with the observations of Gerassi and Sachs (1978)
who, using mixtures of lymphocytes frcm normal and G6PD
deficient donors, could only detect 20% mixed colonies; their
finding may however be the result of a failure of colonies to
develop from clusters containing allogeneic cells (Farcet et
al 1980). Rosenszajn et al (1975) claimed to observe colony
development from single cells in culture and even Singer et al
(1981) noted that, by morphological examination of two step
cultures, most colonies apparently originated from clusters of
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no more than 2- 4 eel Is. It therefore seems probable that
differences in the plating efficiency between one step and two
step cultures are not solely attributable to cell clumping and
although this plays seme part other factors may be involved:
e.g the higher plating efficiency of two step cultures may
result from a proliferation requironent for direct cell- cell
interactions or interactions dependent on adequate local
levels of growth factor production, both of which are more
likely to occur at the higher cell plating concentrations used
in the one step method. The fall in plating efficiency that
occurs with falling cell concentration in one step cultures is
consistent with this interpretation and is supported by
subsequent observations of cell interaction requirements in
colony formation (see Chapter 2).
In order to confirm that the colonies grown in these
studies were of T- cell type, colony cells were harvested from
agar for immunological and cytological characterisation. A
problen with two step cultures, was that the majority of
colonies formed deeply within the agar overlayer with only a
few small colonies on the agar surface; these correspond to
the type 1 (deep) and type 2 (superficial) colonies described
by other groups (Rosenszajn et al 1975, Fibacn et al 1976).
Because of this it was difficult to harvest colonies free of
agar and only small numbers of cells (<1x10^ ) oould be
obtained from the culture dishes. Colony cells frcm these
cultures showed 40-50% E- rosetting cells. This figure is
similar to that reported by others (Rosenszajn et al 1975,
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Flbach et al 1976, Claesson et al 1977a). The lew value of E-
rosettes has been attributed to agar adhering to cells or
persisting in the culture medium, rather than to colonies
containing a mixture of T and non T cells (Claesson et al .
1977a, Galbraith et al 1977).
In one step cultures colonies were readily harvested in
large numbers from culture dishes. Colony cells showed typical
cytological and cytochemical characteristics of T- lymphocytes
undergoing blast transformation. Over 90% of colony cells
showed immunologic characteristics of mature T- cells i.e they
formed rosettes with sheep red cells (E- rosettes) and reacted
with the T-cell specific antibodies OKT3 (pan T), OKT4
(helper- inducer subset) and OKT8 (suppressor cytotoxic
subset). Colony cells did not react with OKT6 (irmature T
cell, thymocyte) nor did they show Tdt activity characteristic
of immature T cells (Reinherz et al 1980a). In the present
study 40-60% of colony cells expressed HLA-DR antigens
characteristic of T cell activation. Gelfand et al (1981) have
reported similar results.
Immunofluorescent and iiririunohistochemical staining of
intact colonies (rather than disaggregated single cells) gave
similar results. Interestingly most colonies appeared to
contain a mixture of OKT4 and OKT8 positive cells and a
central HLA-DR+, 0KM1/M02+ cell i.e. a macrophage. These
findings are consistent with colonies developing from several
T- cells clustered around a macrophage rather than a single
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cell, although it ranains possible that colonies develop from
a precursor that differentiates into 0KT4+ and 0KT8+ cells
(Spitzer et al 1982, Claesson et al 1983). This is discussed
further in chapter 2.
In contrast to the results of others no Fc or C3
receptors could be demonstrated on colony cells (Claesson et
al 1977a, Dao et al 1978). This discrepancy is probably the
result of differences in the methodology used for detecting EA
(Fc) and EAC (C3) rosetting cells; these groups used antibody
and complement coated sheep erythrocytes, rather than ox red
cells as used here. Coated sheep red blood cells may however
bind non specifically to T cells (by E-receptor) even when
coated with antibody (Palutke et al 1977).
In the present study a small number of cells (<5%) with
surface Ig were found in colony cell suspensions. A similar
finding was reported by Goube de Laforest et al (1979 a). It
is probable that these cells include both cells with non
specifically bound antibody (e.g. antibody bound to T cells or
macrophages via Fc receptor) and individual blood B-cells
persisting in cultures without proliferation . Cytospin
preparations of intact colonies showed no colonies with
plasmacytoid features or expressing B-oell antigens (Bl and
cytoplasmic Ig) and the culture conditions are not those which
would be expected to support B- cell colony formation (Radnay
et al 1979, Bobak and Whisler 1980).
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These studies show that although both one and two step
culture methods can be used for PHA induced T-cell colony
formation, the one step method appears to offer several
advantages. These advantages included the convenience of a
single step procedure, a higher plating efficiency and a
simple method for harvesting colony cells for characterisation
and for possible future functional studies. For these reasons




CELL INTERACTIONS AND COLONY STIMULATING FACTORS IN COLONY
FORMATION
SUMMARY
In this chapter studies of cell interactions in colony
formation are described. These studies included investigation
of the role of monocyte and lymphocyte derived growth factors.
r
Monocyte (MoCM) and Lymphocyte conditioned media (LyCM) (with
interleukin 1 and interleukin 2 activity respectively) were
both found to enhance colony formation by blood mononuclear
cells and purified blood T cells in primary culture.
Maintenance of proliferation of colony cells in secondary
culture was however wholly dependent on a factor present in
LyCM (probably interleukin 2).
Using a mathematical approach (kinetic analysis) to
analyse cell interactions, it was determined that at least
three interacting cells are involved in PHA induced, primary T
cell colony formation by blood mononuclear cells. Further
analysis showed that the requirements for cell interactions in
primary colony formation could be reduced or eliminated by the
inclusion of MoCM and LyCM into cultures. These findings are
discussed in relationship to the findings of other authors and
to current concepts of interleukin mediated regulation of T
1ymphocyte pro1iferation.
INTRODUCTION
It can be postulated that binding of lectin to T-cells
• t
directly triggers their entry into and their passage through
the cell cycle, however experimental observations of both
colony formation and proliferation in liquid culture have
indicated that this is unlikely as proliferation is dependent
upon interactions between mitogen, accessory cells and cells
with a proliferative potential (Andersson et al 1979, Couthino
et al 1979, Rosenszajn et al 1981). Both macrophages and
lymphocytes have been implicated as accessory cells.
Claesson et al (1977a,b) demonstrated that there was a 60-
85% reduction in colony formation by blood MCs depleted of
adherent cells. Colony formation was restored to normal levels
by culturing MC either on an adherent cell feeder layer or by
adding conditioned medium from adherent cell cultures.
Similar findings were reported by Rosenszajn et al (1978) who
showed that depletion of macrophages from blood MC reduced
colony formation and that this could be restored by the
addition of macrophages to the cultures. Earlier studies by
Rosenszajn's group had failed to demonstrate any colony
stimulating activity in adherent cell culture supernatants
(Zeevi et al 1977) but later studies showed that medium
conditioned by exposure to adherent cells contained a high
molecular weight colony promoting factor (LCPF) whose activity
was demonstrable following dialysis and removal of a low
molecular weight inhibitory factor (LCIF) (Rosenszajn et al
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1978, 1980, 1981).
Evidence that other accessory cells, in addition to the • •
macrophage, might play a role in colony formation was provided
by studies of Goube deLaforest et al (1979a, 1979b) and Klein
et al (1982). In contrast to other groups they were unable to
show colony stimulating activity in mcnocyte culture
supernatants (Klein et al 1982), but they demonstrated that in
primary culture colony formation by purified T- cells, and to
a lesser extent unfractionated mononuclear blood cells, was
enhanced by conditioned medium from PHA stimulated lymphocytes
(Klein et al 1982). This PHA conditioned medium was essential
for colony formation in secondary cultures of T-oolony forming
cells harvested from primary colonies and replated in
secondary cultures (Goube deLaforest et al 1979a). From
mathematical analysis of the number of colonies produced at
different cell concentrations in primary cultures they deduced
that colony formation was dependent on interactions between at
least three cells (Goube deLaforest et al 1979b), and
suggested that colony formation by T- cells was dependent on
interactions between a colony forming cell and two accessory
cells; one accessory cell being a lymphocyte and the other a
monocyte (Klein et al 1982). This is consistent with numerous
observations by other groups that both monocytes (Claesson et
al 1977b, Rosenszajn et al 1978) and PHA stimulated
lymphocytes produce colony stimulating factors that enhance
colony formation in prinary cultures (Zeevi et al 1977,
Rosenszajn et al 1978, Gerassi and Sachs 1978). The failure of
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some groups (Klein et al 1982) to demonstrate colony
stimulating activity by monocytes may be attributable to the
contamination of monocyte stimulatory factors by inhibitory
factors, such as prostaglandins, also present in conditioned
medium (Bockman and Rothschild 1979).
Data on accessory cells and their products is suntnarised
in table 2.A.. Although this table lists the various colony
stimulating factors under the names given by the various
groups, these factors were not fully characterised at the time
of their first description and do not necessarily represent
separate entities. It is apparent however that these colony
stimulating factors fall into two main groups; a factor
produced by adherent cells (macrophages/monocytes) and a
factor produced by PHA stimulation of lymphocytes.
The three cell model for T-cell colony formation ,
described above, shews marked similarities to models for
interleukin regulated proliferation of lymphocytes , which
include a cell capable of clonal proliferation and two
accessory cells; one a lymphocyte producing interleukin 2 (IL-
2) and the other a monocyte producing interleukin 1 (IL-1)
(Smith et al 1980, Palacios 1982). The main biological and
biochemical characteristics of IL- 1 and IL-2 are summarised
in tables 2.B,2.C..
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TABLE 2A FACTORS MODULATING T-LYMPHOCYTE COLONY FORMATION










T cells+PHA 90-110K Zeevi et al 1977
blood MC+PHA protein Rosenszajn et al
1978, 1980, 1981
spleen adherent 10-30K
cells, peritoneal protein "
exudate cells
spleen and blood <1K "









blood adherent 12-15K Claesson et al
cells - 10OK protein 1977b
Colony promoting blood MC+PHA not known Goube delaForest
activity CPA et al 1979a,b
The factors listed in this table are named as described by the
authors. Several of these factors are probably biochemically
identical.(see text)
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murine macrophage cell line
P388D1










Human 15K protein (gel filtration) 15K protein





for references see text
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TABLE 2C BIOLOGICAL ACTIVITIES OF IL-1 AND IL-2
Activity IL-1 IL2
Direct mitogenic effect +(high concentration) -
on thymocytes
Enhancement of thymocyte and T-
lymphocyte mitogenic responses to + +
PHA and ConA
Enhancement of IL-2 production +
by T-cells
Maintenance of long term prolifer¬




for references see text
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IL-1 was first described by Gery et al (1971) as a factor
present in leucocyte culture supernatants that enhanced
proliferation of murine thymocytes. Subsequent studies have-
shown that IL-1 is produced by human and murine adherent
cells (Gery and Waksman 1972), murine peritoneal exudate cells
(Calderon and Unanue 1975) and human blood monocytes (Blyden
and Handschumacher 1977) as well as by murine (Mizel et al
1978) and human monocytic cell lines and myelcmonocytic
leukaemias (Lachman et al 1978). Hie production and release of
IL-1 from monocytes is stimulated by phagocytosis (Unanue et
al 1976), endotoxin (Gery et al 1972, Lachman et al 1977)
and also by products derived frcm activated T-eel Is (Mizel et
al 1978). IL-1 enhances the response of murine and human
thymocytes and T-oells to mitogens, but does not support long
term proliferation of T- cells in vitro (Oppenheim et al 1980,
Mizel 1982).
IL-2 has been defined as a lymphokine that can maintain
lcng term proliferation of normal T-cells in vitro (Morgan et
al 1976, Aarden et al 1979). IL-2 is produced by T-
lymphocytes, with a T-helper phenotype following stimulation
with mitogens, and also by stimulation with specific antigen
(Reinherz et al 1980b, Palacios 1982). Recently IL-2
production by murine and human T-cell lines has also been
demonstrated (Mochizuki et al 1980, Gillis and Vfatson 1980).
The production of IL-2 by normal T-lymphocytes is dependent on
the presence of both T- cells and macrophages or IL-1 (Larsson
and Couthino 1979, Couthino et al 1979, Larsson et al 1980,
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Smith 1980, Smith et al 1980).
IL-2 has been shewn to bind to a specific IL-2 receptor
that appears following activation of IL-2 responsive cells
(Robb 1982). Proliferation of IL-2 responsive cells can be
maintained, probably indefinitely, as long as IL-2 is added to
cultures (Ruscetti et al 1976, Gillis et al 1978a).
At present the relationship of the interleukins to the
factors that regulate T- cell col coy formation is uncertain.
Both in terms of production and biochemical characteristics
IL- 1 and IL- 2 show similarity to the described colony
stimulating factors (see tables 2AJ3,C ) • Lymphocyte colony
enhancing factor (LCEF) prepared frcm PHA stimulated cells has
a mol.wt 90- 110K (Rosenszajn et al 1980) that corresponds to
high molecular weight IL-2 activity described by Oppenheim et
al (1980). This high mol.wt activity may represent corrplexed
low mol.wt units as Gillis et al (1980) have shown that
following dialysis against 0.5M NaCl such high mol.wt
fractions in PHA MC conditioned media when rechromatographed
give a peak of IL-2 activity at 15K. Lymphocyte colony
promoting factor (Rosenszajn et al 1980) and the adherent cell
factor described by Claesson et al (1977b) are biochemically
similar to IL-1 which is a protein with a mol.wt of 15K
(Lachman et al 1977, Blyden and Handschumacher 1977).
Although the classically defined interleukins 1 and 2 may
enhance colony formation (Claesson et al 1977b, Mossalayi et
al 1982), there is evidence that colony formation may also be
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regulated by other less well defined factors (Spitzer et al
1982).
The aim of the studies described in this chapter was to
determine the cell interaction requirements for colony
formation and in particular the role of monocyte and
lymphocyte derived growth factors in regulating T-cell colony
formation. This was done by two techniques:
Firstly I investigated the effect of conditioned media
with IL-1 and IL- 2 activity on colony formation. The ability
of conditioned media to stimulate colony formation in primary
cultures containing either unfractionated mononuclear cells or
purified T-cells was compared and the ability of such media to
maintain proliferation of colony cells in secondary cultures
was measured.
Secondly I used a mathematical model, that allows kinetic
analysis of colony formation, to deduce the number of
interacting cells (Goube deLaforest et al 1979a) and to




PREPARATION OF CELL SUSPENSIONS
Blood MS were isolated as described in chapter 1.
Spleen MC were obtained from a patient who had undergone
splenectomy for congenital spherocytosis. Spleen MC were
isolated by scraping the cut surface of spleen with a scalpel
into heparinised (lOunits/ml) TCI99. This suspension was then
passed through a fine wire nosh and then layered onto Ficoll-
Hypaque. After centrifugation cells from the medium-Ficoll
interface were washed twice and resuspended at the required
cell concentration in RPMI1640. The viability of the spleen MC
was greater than 95%; 88% of these cells formed E-rosettes.
Spleen MC were used to prepare spleen lymphocyte- conditioned
medium (see below).
Thymocytes were obtained from thymuses removed frcm
children undergoing cardiac surgery . The cut surface of the
thymus was scraped into heparinised TC199 and the resulting
thynocyte suspension was then washed twice and resuspended in
RPMI 1640 at the required cell concentration.The viability of
the thymocyte suspensions used was greater than 90%.
Tonsil and lymph node cell suspensions were obtained frcm
surgical specimens, shewn to be histologically normal, using
.the same method as described for thymus.
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Preparation of T cell enriched and depleted MC
populations:- T cell enriched and depleted cell
populations were prepared by rosetting MC with neuraminidase
treated sheep red blood cells (n-SRBC), followed by
centrifugation over Ficoll- Hypaque . MC were incubated with n-
SRBC at a ratio of 1:40 in RPMI 1640 with 5%PCS for 5minutes
at 37°C., centrifuged for 5 minutes to pellet and then
incubated on ice for 45 minutes. The cell pellet was then
gently resuspended and layered onto Ficoll- Hypaque and
centrifuged for 20 minutes at 1200g.. Cells at the Ficoll
interface (T- depleted) were removed and washed twice . Cells
in the pellet were resuspended in medium at 4°C. and again
layered onto Fiooll and centrifuged. The supernatant was
removed and the cell pellet resuspended in a small volume of
medium. The red cells were lysed by adding hypotonic medium (1
volume distilled water: 9 volumes of RPMI 1640). The remaining
mononuclear cells were then washed twice and resuspended at
the required cell concentration., The T cell enriched fraction
contained more than 90% E positive cells and the T depleted
fraction less than 5% E positive cells.
Depletion of T cells and Monocytes from cell suspensions by
treatment with monoclonal antibodies and complement
Aliquots of 5x10b cells were pelleted in round bottomed glass
tubes (12x7nm) and the supernatants renoved. Twenty
microlitres of the appropriate antibody (OKT3, OKT4, OKT6,
OKT8 or OKMl) was then added to the tube (diluted 1/2 in PBS-
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2%HSA) and the tubes incubated at roan temperature for 45
minutes. Following this the cells were washed once in PBS-
2%HSA and resuspended in 0.1ml PBS-2%HSA, and 0.1ml of fresh
AB,Rh-positive human serum was added. Cells were then
incubated for "45 minutes at 37°C, washed twice in RPMI 1640
and resuspended at the required concentration.
COLONY FORMATION
Primary colony formation
Colony formation by freshly isolated MC was carried out using
a single step culture method as described in chapter 1 , but
with some modifications. In addition to the standard culture
method already described cultures were prepared in which
conditioned media were added to the underlayers. Conditioned
media used to supplement the cultures were prepared as
described below. Lymphocyte conditioned medium (LyCM) and
monocyte conditioned medium (MoCM) were usually incorporated
in underlayers at 25% v/v and 15% v/v concentrations , either
alone or in combination.
In seme experiments colony formation was assessed in the
presence of adherent cell underlayers. These were prepared by
adding freshly isolated MC to culture wells (0.1ml of cell
suspension at 10x10®eells/ml in RPMI 1640 with 20% human
serum) and incubating for 4 hours at 37°C. Following this the
wells were washed at least three times by aspirating the
supernatant and adding fresh medium, thus leaving a relatively
pure population of adherent cells attached to the well bottom.
After this the standard culture procedure was followed, the
culture underlayers being added to wells containing adherent
eelIs.
Secondary colony formation
Colony cells (T-CFC) were harvested from primary cultures as
described in chapter 1. After washing and disaggregation these
were used to measure colony formation in secondary cultures.
The culture procedure was identical to that described for
primary cultures with the exception that cultures were
prepared both with and without PHA in the underlayer. Human
serum (pooled heat inactivated human serum) was used in place
of autologous plasma.
Colonies were scored as described in chapter 1. Primary
cultures were scored after 6-7 days incubation and secondary
colonies after 5-6 days incubation. In some experiments
colony size was measured . This was done either by
photographing individual wells and counting the number of
cells in colonies in photographic prints or by directly
examining colonies at xlOO magnification using an inverted
microscope.
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PREPARATION OF CONDITIONED MEDIA
Preparation of conditioned medium with interleukin-1
activity (Monocyte conditioned medium - MoCM)
MoCM was prepared as described by Lachman et al (1978), using
human monocytic leukaemia cells obtained from a patient with
acute monocytic leukaemia . Leukaemic cells were isolated from
blood by centrifugation over Ficol1-Hypaque and stored in 20%
DMSO in foetal calf serum in liquid nitrogen. The leukaemic
cells showed morphology typical of Schilling type monocytic
leukaemia, and were greater than 90% non specific (alpha
naphthyl acetate) esterase positive , were chloroacetate
esterase negative. These cells reacted strongly with anti-
monocyte serum (Stuart et al 1976) and contained only 8% E-
rosette positive cells.
To prepare MoCM leukaemic cells were taken from storage
in liquid nitrogen, thawed, washed and resuspended in RPMI
1640 containing 5% human serum and 10-5M. 2-mercaptoethanol
(Sigma) at 0.5x10® /ml. This suspension was incubated for 24
hours at 37°C in 10% C02 in air, in Roux flasks. The
supernatants were collected after centrifugation at 800g for
20 minutes , aliquoted, and stored at -20°C until used.
Preparation of conditioned medium with interleukin-2
activity [Lymphocyte conditioned medium - LyCM]
LyCM was prepared by a method modified from Morgan et al
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(1976). Spleen MC were obtained as described above. These were
suspended at 1x106 cells/ml in RPMI 1640 containing 1% human
serum and 1% PHA. This suspension was incubated at 37°C in a
humidified 5% C02 in air atmosphere , in 25ml Falcon flasks ,
for 48 hours. The supernatants were collected after
centrifugation at 500g for 10 minutes , aliquoted and stored
at -20°C. Unless otherwise stated this spleen LyCM was used in
the experiments described in this chapter. Other batches of Ly¬
CM were prepared by incubating MC from blood, disaggregated
thymus or other sources under the same conditions. When these
were used instead of spleen LyCM this is stated in the text.
BIO-ASSAYS DEMONSTRATING INTERLEUKIN ACTIVITY
Interleukin-1 (IL-1 assay)
IL-1 activity in conditioned medium was detected by
demonstrating a direct mitogenic effect on thymocytes and by
demonstrating enhancement of PHA induced thymocyte mitogenesis
(Maizel et al 1981). Human thymocytes (either freshly isolated
or from storage in liquid nitrogen) were incubated at 1x10®
cells/ml in RPMI 1640 containing 10% human serum or foetal
calf serum, together with the test CM at concentrations
between 0-50%. All cultures were performed in triplicate both
with and without 0.5% PHA. Cultures were either carried out in
Linbro multiwell dishes (24x17mm diameter wells) or in Nunc
multiwell plates (96x5mm diameter wells). In both cases 0.2ml
of suspension (2xl0^cells) was added to the wells (Maizel et
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al 1981 ). Cultures were incubated for 72 hours , at 37°C , in
a humidified 5% C02 in air atmosphere. Proliferation was
assessed by tritiated thymidine (3H TdR) incorporation as
described below.
In order to demonstrate that MoCM enhanced IL-2
production experiments were also performed in which
lymphocytes (thymocytes, blood MC or purified T-cells) were
incubated with PHA with or without 15% MoCM, under the
conditions described above for the preparation of LyCM.
Supernatants from these cultures were tested for IL-2
production.
Interleukin-2 (IL-2 assay)
IL-2 activity was detected using techniques similar to those
described by Gillis et al (1978b). Target cells for testing IL-
2 activity were T colony cells (T-CFCs) harvested from primary
cultures after 6- 7days incubation. These cells respond poorly
or not at all to PHA but proliferate if Ly-CM is present .
They therefore behave in an identical manner to conventional
target cells used in IL-2 assays i.e. T cells maintained in
suspension culture with LyCM for two or more weeks (Inouye et
al 1980, see also results). T- CFCs were suspended at 1x10"^
cells/ml in RPMI 1640 containing 10% human serum and CM at
concentrations between 0-50%. Cultures were incubated for 96
hours under the same conditions as described above for
thymocytes in the IL-1 assay. Cell proliferation was assesed
by 3H TdR uptake.
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Measurement of 3H TdR incorporation
Tritiated thymidine (methyl 3H thymidine 40-60 Ci/MMol,
Radiochemical centre, Amersham) was added to cultures 4 hours
prior to termination to give a final concentration of
1.0 microCi/ml. At the end of the culture period ice cold PBS
was added to the wells and samples from the wells were
aspirated and pipetted either onto Whatman GF/C filters
mounted in a multiple sampling harvester (3025 sampling
manifold , Millipore) or aspirated automatically onto filters
using an automatic harvester (Multimash cell harvester,
Dynatech Laboratories Ltd.). The cells were washed with 0.85%
NaCl and then with 5% TCA. The filters were then dried and
placed in 4.5ml of scintillant (Ne260 micellar scintillator,
Nuclear Enterprises Ltd. or Scintillator 299, Packard), in
mini-vials. 3H-TdR incorporation into acid precipitable
material.was measured in a Tracor Analytic Delta 300, 6891
liquid scintillation system, with an efficiency for 3H of
approximately 50%.
KINETIC ANALYSIS OF COLONY FORMATION
This type of mathematical analysis has previously been
used to investigate cell interactions in mitogen induced
lymphocyte activation and proliferation in both liquid
cultures (Kondracki et al 1977, Tse et al 1980) and in agar
cultures (Goube deLaForest et al 1978, 1979b, Kondracki
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1979). The basic principle is to consider cells as kinetic
particles. If a cellular response, such as colony formation,
is dependent upon cell interactions between a number (n) of
different cell types, then the probability of cell interaction
(and the subsequently detected response) depends on the
concentration of each of the cell types present. This can be
represented mathematically by an equation similar to that for
the law of mass action (Tse et al 1980):
Response(R) oc [cell-1] x [<?ell-2] x [cell-n]
R = C x al [ X ] x a2 [ X ] x an[X]
Where R is the response, C is the constant of
proportionality,[X] is the total cell concentration and ai =
[ai]/[X], i=l to n.
Hence R = C (al x a2 x ....an) [X]n
By taking the logarithm of the equation:
log R = n log [X] + K
Where K = log C + (log al + log a2 + ...log an)
Hence a plot of log R against log [X] should give a
straight line, with a slope n, where n represents the number
of cells interacting to give the response R.(Tse et al 1980).
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In this study the response measured was colony formation
obtained by plating cells at different cell concentrations.
The following equation was used to calculate the requirement
for cell interactions:
log n = b log N + a (derived from logR=n log[X]+K)
where n = number of colonies, N = number of cells plated,
b = number of interacting cells. The value of b (slope of the
line logn/logN) was calculated by simple regression analysis.
By culturing MC on standard underlayers with PHA alone
and also on underlayers containing conditioned media, it is
possible to compare regression coefficients (b) under
different conditions and hence to determine whether CM can
substitute for cellular interactions.
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RESULTS
1. ENHANCEMENT OF T-CELL COLONY FORMATION BY MONOCYTE AND
LYMPHOCYTE CONDITIONED MEDIA
1A.PREPARATION AND BIOASSAY OF CONDITIONED MEDIA
This section describes the T cell stimulatory activity of
monocyte and lymphocyte conditioned media (MoCM, LyCM). IL-1
activity was detected by demonstrating enhancement of PHA
induced thymocyte mitogenesis and also by enhancement of IL-2
production by thymocytes and T lymphocytes. IL-2 activity was
detected by demonstrating the ability of conditioned media to
maintain the proliferation of cultured T cells after loss of
responsiveness to PHA and IL-1.
MoCM enhanced PHA induced thymocyte mitogenesis and also
showed a small but consistent direct mitogenic effect on
thymocytes (TABLE 2.1A). Optimal stimulation of thymocytes
occured when MoCM supplemented the culture medium at 12% v/v
concentration, with less marked stimulation at higher or lower
concentrations (TABLE 2.2). MoCM showed little or no
stimulatory activity when tested on cultured T-cells (TABLE
2.IB and see next paragraph), but did enhance the mitogenic
" *




T-CELL STIMULATORY ACTIVITY OF MoCM AND LyCM IN LIQUID CULTUR
2.1A)THYMOCYTES
Thymidine incorporation (c.p.m. x 103)
expt.1 expt.2 expt.3
medium 0.4 0.3 1.5




MoCM+PHA 5.7 6.1 31.7
LyCM (50%) 3.9 11.5 25. 8
LyCM+PHA 4.2 n. t n. t
LyCM+MoCM n. t 87. 3 85.7
2. IB)CULTURED T-iCELLS (T-CFCs)
Thymidine incorporation (c.p.m. x 103)
expt.1 expt.2 expt.3
medium 0.7 0.5 0.4
PHA (0.5%) 1.0 0.9 1.0
MoCM (15%) 1.4 0.5 0.7
MoCM+PHA 1. 3 0.6 0.5
LyCM (50%) 28. 7 28.1 36.4
LyCM+PHA 22.9 . 3 5.7 34.6
LyCM+MoCM n. t. 32.7 41.3
continued on following page
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TABLE 2.1 (continued)
T-CELL STIMULATORY ACTIVITY OF MoCM AND LyCM IN LXQUID CULTURI
2.1C) BLOOD MONONUCLEAR CELLS AND T-CELLS
Thymidine incorporation (c.p.m. x 103)
expt.l expt.2
MC T MC T
medium 0.5 1. 5 0.6 0.9
PHA(0.5%) 24.0 7. 3 36. 5 8.4
MoCM 0.4 2. 1 0.8 1.0
MoCM+PHA 29.9 28 .2 41.8 29.6
LyCM 24.0 18 . 5 31. 7 29. 8
LyCM+PHA 25.9 42 .8 33.8 35.3
Cultures were carried out and thymidine incorporation was
measured as described in materialsand methods.
Figures are the mean values of duplicate or
triplicate cultures in each experiment. n.t.= not tested
TABLE 2.2








MoCM 12% (no PHA) 1321+279
Figures are the mean values ± 1S.D. of quadruplicate cultures,
in a representative experiment. Similar results were obtained
with thymocytes in other experiments.
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In contrast to MoCM, LyCM not only enhanced thymocyte and
blood T- cell proliferation but also stimulated proliferation
of cultured T-cells (TABLE 2. IB). In the majority of these
experiments target cells for testing for IL-2 activity were T-
colony cells (T-CFCs) harvested from 6-7 day old primary
cultures. These cells showed responses to PHA and MoCM for a
short period after harvesting (48hrs), but by 96 hours these
responses were either markedly reduced or abolished, whereas
there remained a vigorous proliferative response to LyCM
(TABLE 2.3). Long term proliferation of T-CFCs (2-4 weeks
after harvesting) could be maintained by regular feeding,
every 3-4 days, with fresh LyCM. In this respect no
differences could be observed between cultured T-CFCs and
cultured T-cells produced by PHA activation in liquid culture
of blood MC with subsequent maintenance in LyCM (FIG 2.1). Nor
could any differences be observed between conventionally
cultured blood T-cells and T-CFCs either in their
proliferative responses to PHA and CM (TABLE 2.4) or in their
phenotype (TABLE 2.5), although conventionally cultured T-
cells were found to retain greater resposiveness to PHA than T-
CFCs (TABLE 2.6). The response of T-CFCs to LyCM was
dependent on the concentration of CM and increased to a
maximum at 25% concentration (with spleen LyCM). The response
of cultured T-*cells was not increased by the addition of PHA
to cultures (TABLE 2.7).
— V -
TABLE 2.3
EFFECT OF INCUBATION TIME ON PROLIFERATION OF T-CFCs
Thymidine incorporation (c.p.m.xlO^)
Incubation time: 48hours 72hours 96hours
medium 39.6±10.0 0.2±0.1 0.4+0.1
PHA 1% 128.7+6.8 0.9+0.1 0.4+0.2
MoCM 15% 90.6+13.0 0.7+0.5 0.4+0.1
MoCM+PHA 122.0+11.7 4.5+0.3 0.8+0.4
LyCM 50% 166.3+9.3 89.7+10.6 63.0+6.4
LyCM+PHA 137.5+15.9 94.5+19.9 54.4+9.4
Figures are the mean values ± 1S.D of triplicate cultures.
T colony cells (T-CFCs) were harvested from primary cultures
after 6 days and then incubated for 48, 72 or 96 hours in
suspension culture at 10^cells/ml in medium containing
RPMI 1640 with 10% human serum supplemented with PHA or
conditioned media, as shown in the table. Cells were pulsed with
3H-thymidine for the last four hours of culture, and cells
were then harvested and thymidine incorporation was
measured as described in materials and methods.
- 64 -
TABLE 2.4
COMPARISON OF PROLIFERATIVE RESPONSES TO CONDITIONED MEDIA "BY


















Figures are the mean value ± 1S.D of triplicate cultures. In
this experiment blood MC from a single individual were
cultured to provide colony cells - T-CFCs (from standard one
step cultures) and conventionally actiVated T-cells by
incubating blood MC in suspension with 1% PHA for three days.
T-CFCs and conventionally activated T-cells were sub¬
sequently cultured in LyCM, with regular feeding every three to
four days, (see FIG 2.1) Two weeks after the initiation of
cultures proliferative responses to CM were assayed as
described in materials and methods. Similar results have





COMPARISON OF PHENOTYPE OF T-CFCs AND CONVENTIONALLY
CULTURED T-CELLS
% positive cells
E-rosettes OKT3 OKT4 OKT8
T-CFCs 96.0 98.5 56.5 44.0
Cultured T-cells 92.0 93.0 53.0 43.0
T-CFCs (colony cells) and conventionally cultured T-cells were
obtained from two week cultures as described in table 2.4.
TABLE 2.6














Figures are the mean values + 1S.D. of 12 experiments using
freshly isolated T-CFCs and 4 experiments using conventionally
activated T-cells that had been maintained in culture with
LyCM for two to three weeks.
TABLE 2.7 RESPONSE OF T-CFCs TO LYCM
Thymidine incorporation (c.p.m.)
Concentration of LyCM(%) medium +PHA
0 1071±313 1402±480




Figures are the mean values ± 1S.D of triplicate cultures.
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days
FIGURE 2.1 LONG TERM CULTURE OF T-CFCs AND CONVENTIONALLY
ACTIVATED T-CELLS
T colony forming cells (T-CPCs * - — -X ) and T cells
activated by conventional culture in suspension with PHA
( •- -• ) were prepared as described in table 2.4.
Cells were initially suspended at 1 x 10^/ml in RPMI 1640
containing 10% human serum and 50% LyCM (growth medium).
Cells were cultured in 5ml volumes in 25ml Falcon tissue
culture flasks. Every three to four days cells were counted,
and resuspended in fresh growth medium at 1 x 10?cells/ml.
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FIGURE 2.2 SEPHADEX G-100 FILTRATION OF LYCM
Points represent the mean response of triplicate cultures.
IL-2 activity was assessed as described in methods by culturing
T-CPCs with test medium at 50% v/v concentration.
Colony stimulating activity was measured by culturing blood MC .
at 1 x 10^eells/well in standard one step primary colony forming
assays, with test medium at 50% v/v concentration and PHA 1% v/v
in the underlayer. No colony growth was obtained in the absence
of PHA.
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Partial purification of LyCM by Sephadex G-100 gel
filtration showed several peaks of activity. The maximum IL-2
activity was in fractions, corresponding to the reported
mol.wt of interleukin 2 of 15,000 daltons (FIG 2.2).
Partially purified IL-2 stimulated cultured T- cells, but was
not mitogenic for freshly isolated blood T-cells in the
absence of PHA (TABLE 2.8).
TABLE 2.8








Figures are the mean values of duplicate cultures. T-cells
were isolated from blood MC by rosetting with sheep
erythrocytes, as described in materials and methods. T-cells
consisted of 96% E-rosette positive cells. T-cells were
cultured at 1x10® /ml for three days and T-CFCs at 1x10®
cells/ml for four days.
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With medium renewal every three to four days both T- CFCs
and conventionally cultured blood T- cells could usually be
maintained for 3-4 weeks in rapid proliferation (with a
*
»
doubling time of about 24- 36 hours). After this most cultures
lost responsiveness to LyCM and could not be induced to
proliferate further (FIG 2.1). The maximum period over which T-
CFCs were maintained was 12 weeks in continuous culture before
loss of responsiveness to LyCM. Withdrawal of LyCM from
cultured T- CFCs resulted in rapid cell death, as evidenced by
a fall in cell count and morphological changes such as
r-
chromatin condensation and nuclear and cellular fragmentation.
These changes appeared within 24 hours of LyCM withdrawal. In
these cultures cell viability assessed by trypan blue
exclusion was not a reliable indicator of cell death and
remained high (>90%) for several days after withdrawal of
LyCM, even though suspensions stained with acridine orange or
by the Feulgen method showed nuclear pyknosis and
fragmentation (TABLE 2.9.).
TABLE 2.9
THE EFFECT OF WITHDRAWAL OF LyCM FROM CULTURED T-CFCs
cell count (xlO^/mlj %pyknotic cells %viability
(trypan blue)
+LyCM(50%) -LyCM +LyCM -LycM +LyCM -LyCM
Day of culture:
0 5.0 5.0 23 e. 23 96 96
1 7.8 6.6 15 27 100 100
2 16.5 6.3 11 34 100 99
3 25.2 6.1 27 59 100 99
Cultures adjustedI to 5x10 ~5/ml and resuspended in fresh medium
4 4.1 2.8 22 60. 5 100 100
5 6.5 1.5 23 86.0 100 97
6 9.0 1.6 14.5 63. 0 100 100
7 11.2 0.1 7 not counted 100 not counted
Figures are the mean values of duplicate cultures. Freshly
harvested T- CFCs were cultured in 17mm diameter multiwell
plates under the conditions described in the table.
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LyCM, prepared by PHA stimulation of blood, tonsil and
lymph node lymphocytes were also found to be effective in -
stimulating proliferation of cultured T-cells. The highest
activities were found in supernatants from unfractionated MC;
CM from T- enriched cells (prepared by E-rosetting) showed
slightly lower levels of activity than MC. The activity of
these CM was increased when they were prepared from cells to
which MoCM had been added. This enhancement was more marked
with T-enriched cells than unfractionated MC (TABLE 2.10A). An
unexpected finding was that T-depleted cell suspensions (<5%
E+) produced active supernatants, although the activity of
these was less than that found in CM from MC or T-enriched
cells. PHA stimulated thymocyte culture supernatants showed
only low levels of IL-2 activity. This was increased by
culturing thymocytes with MoCM although activity of thymocyte
CM was still much lower than that present in blood MC or
spleen MC culture supernatants (TABLE 2.10B). Supernatants
from cultured T-cells, stimulated with PHA and/or MoCM did not
contain any IL-2 activity (TABLE 2.IOC).
TABLE 2.10 PRODUCTION OF IL-2 BY MONONUCLEAR CELLS
2.10A) IL-2 PRODUCTION BY BLOOD, TONSIL AND LYMPH NODE.,
IL-2 activity
Thymidine incorporation (c.p.m.xlO^)
CM prepared from blood lymph node tonsil
unfractionated MC + PHA 35.0 84.3 92.7
+PHA + MoCM 42.1 115.1 103.2
T-enriched (E+) +PHA 30.2 41.1 67.2
+PHA + MoCM 62.2 59.0 93.6
T-depleted (E-) +PHA n.t 12.6 57.3
+PHA + MoCM n. t 35. 0 71.0
controls: medium' 0.7 0.5 2.2
PHA (0.5%) 1.0 0.5 4.1
PHA + MoCM (15%) 1.4 1. 4 1.5
spleen LyCM (50%) 89.9 135. 0 102. 3
Figures are the mean values of triplicate cultures. MC were
fractionated into T-enriched and depleted populations by
rosetting with sheep red blood cells. All T-enriched cells
contained >95% E+ cells and <1% NSE positive cells; T-depleted
suspensions contained <5% E+ cells and between 10-15% NSE
positive cells, (table 10 continued on next page)
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2.10B) IL-2 PRODUCTION BY THYMOCYTES
IL-2 activity
Thymidine incorporation (c.p.m.xlO^)
Conditioned medium from;thymus 123
thymocytes + PHA 1.6 1.6 1.6
+PHA + MoCM 4.5 7.4 3.6
e
controls: medium 0.5 0.5 0.5
PHA 0.5% 0.6 0.9 0.9
PHA + MoCM 15% 1.0 0.6 0.6
spleen LyCM 50% 39.9 28.2 28.2
C) IL-2 PRODUCTION BY T-COLONY FORMING CELLS
IL2 activity
Thymidine incorporation (c.p.m.xlO^)
Conditioned medium from; T-CFCs1234
T-CFCs + PHA o • 0.4 o • 00 0.7
+PHA + MoCM n. t. n. t. 0.9 0.6
controls : medium 0.3 0.3 0.8 0.8
' '
- - -
PHA 0.5% 0.7 0.7 1.2 1.0
PHA + MoCM 15% n. t. n. t. 1.2 0.7
LyCM 50% 12.8 12.8 16.4 11. 7
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These studies demonstrated that, by conventional
bioassay, MoCM exhibited IL-1 activity and LyCM exhibited IL-2
activity: MoCM showed a direct mitogenic effect on thymocytes,
enhanced PHA induced thymocyte and T-cell mitogenesis and
enhanced IL-2 production by thymocytes and blood T-cells. MoCM
did not possess demonstrable IL-2 activity : proliferation of
cultured T- cells was not supported. LyCM in contrast was able
to maintain relatively long term proliferation of cultured T-
cells that no longer respond to MoCM and PHA and therefore
showed IL-2 activity.
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IB. ENHANCEMENT OF T-COLONY FORMATION BY CONDITIONED MEDIA
Colony formation by blood MC
Addition of either MoCM or LyCM to culture underlayers
enhanced colony formation by blood MC, in a dose dependent
manner: optimum enhancement with MoCM was obtained with 12%
MoCM and with 25% spleen LyCM (TABLE 2.11).
TABLE 2.11
ENHANCEMENT OF COLONY FORMATION BY MOCM AND LYCM
Concentration (%) of CM Colonies
in underlayer MoCM LyCM
0 17 + 12
3 24±27 35 + 33
6 78+ 22 85+14
12 112+13 156+26
25 79 + 12 185+53
50 64 +20 151+32
Cells were cultured at 1 x 105 /well. Figures are the mean
value + 1S.D of triplicate cultures.
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Enhancement of colony formation was dependent on the
presence of PHA. With MoCM no colony formation occurred in the
absence of PHA. With LyCM some colony formation was observed
in cultures to which PHA had not been added, but many more
were formed in cultures containing both LyCM and PHA (TABLE
2.12). Unlike MoCM, LyCM contains some PHA, albeit at
concentrations suboptimal for colony production. This probably
accounts for colony growth in medium supplemented with LyCM
alone. In an experiment using partially purified IL- 2,
prepared by gel filtration, colony formation only occurred in
the presence of PHA (FIG 2.2).
The enhancing effect of both CM was most marked at low
cell concentrations (0.5-1.0x10^ cells/well). At higher cell
concentrations more variable effects were seen: some donors'
MC showed no increase or a small reduction in colony numbers
(FIG 2.3).
As well as increasing the number of colonies MoCM and
LyCM were also observed to increase colony size. This effect
on colony size was most marked at low cell concentrations when
LyCM was present in the cultures. With MoCM the effect on








PHA (0.5%) 7 9±9 195±6
PHA + MoCM (15%) 128+6 312±29
PHA + LyCM (25%) 108±16 247+14
PHA + MoCM + LyCM 169+4 305±29
no PHA
MoCM (15%) 0 0









Cells were cultured at 1.5 x 10^/well. Figures are the mean
value ± 1S.D of triplicate cultures. These three experiments




















































0.5- 0.75 1.0 1.5 2.0
number of cells x1()5 /well
FIGURE 2.3 ENHANCEMENT OF COLONY FORMATION BY MOCM AND
LYCM AT DIFFERENT CELL CONCENTRATIONS
Each point represents the % enhancement of colony formation seen
when blood MC were cultured on underlayers containing either
MoCM ( X ) , LyCM ( • ) or both MoCM and LyCM ( o ).
%enhancement=no. colonies with CM - no. colonies with PHAxl00










FIGURE 2.4 THE EFFECT OF MOCM AND LYCM ON COLONY SIZE
Each point represents the mean size of 50-100 cell aggregates
(colonies and clusters) developing in cultures either with PHA
alone ( • •• ), or in cultures supplemented with MoCM (15%v/v)
( ■*) orLyCM (25%v/v) (« © ) or both MoCM and LyCM
(0 tS ). Aggregate size on CM underlayers was significantly
greater than with PHA alone (P<.01 Mann WHitney U test), except
where shown (n.s.=not significant).
-81 -
Colony formation by blood T-cells purified by E-rosettinq
Mononuclear cells were fractionated into T-enriched and T-
depleted populations by rosetting with sheep red blood cells
(E-rosetting) (TABLE 2.13).
T-enriched cell populations (>96%E+) showed poor or no
colony formation on underlayers with PHA alone. However when
MoCM, or LyCM was included in culture underlayers colony
formation was comparable to that of unfractionated MC (TABLE
2.14). Further experiments showed that colony formation by
enriched T- cells could also be induced by culturing cells on
underlayers containing T- depleted blood MC (i.e. B-cells and
monocytes) or on adherent cell underlayers (i.e. monocytes)
(TABLES 2.14 and 2.15).
T-depleted cell suspensions (<5%E+) produced either no
colonies (2/4 experiments) or only a small number of colonies,




FRACTIONATION OF BLOOD MC BY ROSETTING WITH SHEEP RED BLOOD CELL
% positive cells
E+ N.S.E.+ SIg+
Experiment 1:MC 47 10 n.d.
T-enriched 97 0.5 n.d.
T-depleted 2 10 n.d.
Experiment 2:MC 68 13 n.d.
T-enriched 96 1 n.d.
T-depleted 1.5 23 n.d.
Experiment 3:MC 55 10 15
T-enriched 98 0.5 0.5
T-depleted 3 22 45
Experiment 4:MC 52 12 n.d.
T-enriched 93 1 n.d.
T-depleted 5 19 n.d.
n.d. = not done
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TABLE 2.14 COLONY FORMATION BY T-CELL ENRICHED AND DEPLETED
BLOOD MC POPULATIONS ON CM UNDERLAYERS
number of colonies








































In experiment 1 cells were cultured at 2 x 105 cells/well on
standard underlayers (no RBC). In experiments 2 and 3 cells
5




COLONY FORMATION BY T-CELL ENRICHED AND DEPLETED
BLOOD MC POPULATIONS ON ADHERENT CELL UNDERLAYERS
number of colonies
Underlayer: PHA MoCM Adherent cells
Experiment 4
2x10^ cells/well
MC 17 8±5 5 197+11 189+35
T-enriched 40±4 335+12 305+34
T-depleted 15±3 2 7±8 17 + 4
1x10^ cells/well
MC 62 + 22 63 + 5 63+12
T-enriched 17+7 111 + 4 100+11
T-depleted 0 0 0
Figures are the mean values ± 1 S.D. of triplicate cultures.
Cells were cultured on standard underlayers (no RBC)
supplemented either with MoCM (15%v/v) or with adherent cells.
Underlayers were prepared as described in materials and
methods.
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Colony formation by blood MC treated with monoclonal
antibodies
Blood MC were treated with the anti T-cell antibodies
0KT3,0KT4 and 0KT8 and complement in order to deplete MC
suspensions of the respective T- cell subset (TABLE 2.16).
TABLE 2.16
DEPLETION OF T-CELL SUBSETS FROM BLOOD MC BY TREATMENT WITH
MONOCLONAL ANTIBODIES AND COMPLEMENT
% positive cells (expt2)
OKT 3 0KT4 0KT8
untreated 67 43 21
OKT3+complement 15 11 4
0KT4+complement 35 4 28
0KT8+complement 48 39 3
When these subset depleted cell suspensions were cultured
in agar, colony formation was greatly reduced in 0KT3, 0KT4
and OKT8 depleted suspensions. Subset depleted cultures
supplemented with LyCM showed increased numbers of colonies,
although still less than control cultures. Cultures treated
with complement alone grew normally. Treatment with the anti-
thymocyte antibody 0KT6 had no effect on colony formation in
respose to PHA but did reduce the number of colonies produced
on underlayers supplemented with LyCM (TABLE 2.17).
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TABLE 2.17
INHIBITION OF COLONY FORMATION BY TREATMENT OF BLOOD MC WITH
MONOCLONAL ANTIBODIES AND COMPLEMENT
Colonies
expt. 1 expt. 2
Underlayer: PHA LyCM PHA LyCM
OKT3+complement 29 128 36 146
OKT4+complement 107 119 37 141
OKT8+complement 145 134 80 177
OKT6+complement 215 219 185 200
untreated MC 218 281 175 285
tcomplement 226 304 175 283
Figures are the mean values of duplicate cultures in two
experiments using MC from two different donors.
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Treatment of blood MC with the anti-monocyte antibody
OKMl reduced colony formation by around 50%. This inhibition
was completely reversed by the addition of MoCM to cultures
(TABLE 2.18).
TABLE 2.18
INHIBITION OF COLONY FORMATION BY TREATMENT OF BLOOD MC
WITH OKM-1 AND COMPLEMENT
colonies
expt 1. expt 2. expt 3.
underlayer PHA MoCM PHA MoCM PHA MoCM
untreated MC 218 261 175 248 130 218
+complement 226 243 175 263 122 220
OKM-l+complement 107 224 45 271 74 208
Figures are the mean values of duplicate cultures.
In an attempt to determine whether the reduction in
colony formation, following treatment of MC with anti T-cell
antibodies, was solely due to removal of colony forming
precursors or secondary to a loss or reduction of growth
factor production by accessory cells, the release of IL-2
activity by OKT3, OKT4 and OKT8 treated cells was measured.
These experiments showed that depletion of OKT3+ and to a
lesser extent of OKT4+ cells reduced IL-2 production but
depletion of OKT8+ cells moderately increased it (TABLE 2.19).
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TABLE 2.19
INHIBITION OF IL-2 PRODUCTION BY BLOOD MC TREATED
WITH MONOCLONAL ANTIBODIES AND COMPLEMENT
IL-2 activity (c.p.m.)














Culture supernatants were produced by culturing cells at 1 x
10^/ml in RPMI 1640, containing 1% PHA and 1% serum, for 48
hours. Supernatants from these cultures were assayed for IL-2
activity by culturing with T-CFCs as described in materials
and methods. Supernatants were tested at 50% v/v concentration.
Figures are the mean value ± 1S.D. of triplicate cultures.
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Colony formation by thymocytes
Thymocytes showed little or no colony formation with PHA
alone but could be induced to form colonies when cultured on
underlayers containing either MoCM or LyCM. With MoCM colony
formation was poor except at high cell concentrations (TABLE
2.21). Thymocyte colonies and colony cells were
morphologically identical to blood MC derived colonies and
consisted of mature 0KT3+ T cells, and not immature, 0KT6+
thymic precursors. (TABLE 2.20).
TABLE 2.20
PHENOTYPE OF THYMIC COLONY CELLS
%positive cells
E+ OKT3 + OKT6 +
Thymocytes 89 21 86
Thymic colony cells 94 98 1.0
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TABLE 2.21 COLONY FORMATION BY THYMOCYTES
number of colonies
Underlayer: PHA LyCM MoCM LyCM+MoCM
Experiment 1 (freshly isolated thymocytes)
eel1s/wel1 4 4 + 3 207+12 22+16 228+8
xl 0 5 2 1 + 1 112 + 6 5+2 105+27
1 0 46 + 7 0 19+11
0.5 0 1 + 1 0 0
Experiment 2 (cryopreserved thymocytes)
eel1s/wel1 4 41 + 18 154+14 129+13 229+20 ( 23 + 5 )
xlO5 2 13+4 95+10 38+10 141+15 ( 5+2 )
1 0 21 + 10 2 + 2 100+21 ( 0 )
0.5 0 0 0 34+7 ( 0 )
Experiment 3 (cryopreserved thymocytes)
cells/well 4 0 159+15 18 + 5 177+6
xlO5 2 0 55+14 3 + 1 63+27
1 0 27 + 4 0 29+4
0.5 0 12 + 7 0 18+11
In experiment 1 cells were cultured on standard underlayers
(no RBC). In experiments 2 and 3 cells were cultured on RBC
containing underlayers. In experiments 2 and 3 no colonies
were obtained on standard underlayers except in cultures
supplemented with both LyCM and MoCM (figures in parentheses
for experiment 2).
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Colony formation by T-colony forming cells in secondary
culture
T-colony forming cells (T-CFCs) harvested from primary
culture and replated as a single cell suspension in agar
showed no growth in the absence of PHA or conditioned media.
With PHA alone or with MoCM some of the seeded cells
proliferated within the first 1-2 days to form small clusters,
up to 10 cells in size. In most cultures these failed to
enlarge further and after the second day of culture, cells in
the clusters began to degenerate. In contrast cultures
supplemented with LyCM showed rapid proliferation of cells
with colonies (>40 cells) developing within 4-5 days of the
initiation of cultures (TABLE 2.22).
Colony formation in response to LyCM, in secondary
cultures, was dose dependent, but unlike primary cultures was
not increased by adding PHA to cultures (TABLE 2.23).
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TABLE 2.22
A) COLONY FORMATION IN SECONDARY CULTURE
expt.1
colonies
2 3 4 5
medium alone 0 0 11±15 0 0
+PHA 0 0 14 7±13 7 + 6 0
MoCM 0 0 0 0 0
+PHA 0 0 5 + 6 12 + 4 0
LyCM 292±19 5 6 + 1 5 71±2 3 138±11 9 3+.11
+PHA 3 96±18 130 + 5 7 284 + 6 10 8±12 190±17
LyCM+MoCM - not tested - 127±31 97 + 15
+PHA 13 9±2 7 184+21
B) COLONY FORMATION IN SECONDARY CULTURE ON RBC UNDERLAYERS
colonies
6 7 8

















All cultures at 1 x lO^cells /well. Figures are the mean
values + 1 S.D. of triplicate cultures.
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TABLE 2.23
RESPONSE OF T-CFCs TO LYCM IN SECONDARY CULTURE
Concentration (%) of Colonies
LyCM in the underlayer -PHA +PHA (1%)
0 0 0
6 23±11 18±9
12 61 ±16 7 2±8
25 132±25 158+18
50 141±15 151±19
Figures are the mean colony count +1 S.D. of triplicate
cultures.
- 94 -
2. KINETIC ANALYSIS OF COLONY FORMATION
The requirement for cell interactions in colony formation
by blood MC in primary culture and T-CFCs in secondary
culture was investigated by mathematical analysis of the
relationship between colony numbers and plating cell
concentration, as detailed in materials and methods. Briefly,
the number of interacting cells was determined by calculating
the slope (b) of regression lines obtained from a plot of
log.colonies/log.cells per well. By performing experiments in
which CM were added to cultures and comparing regression
coefficients (b) on CM underl'ayers with standard underlayers
(PHA alone) it is possible to determine whether CM reduce the
requirement for cell interactions (i.e. reduce b ) and
substitute for accessory cells.
Kinetic analysis of blood MC colony formation in primary
culture
The results of a typical experiment are shown in TABLE
2.24. On standard underlayers (PHA alone) the slope of the
regression line (log.colonies/log.eel1s per well) was 3.1,
suggesting a requirement for three interacting cells. With
underlayers containing both MoCM and LyCM the slope of the
regression line was 1.0, i.e. the fall in plating efficiency
with falling cell concentration seen in cultures with PHA
alone was abolished and a simple arithmetic relationship
between the number of colonies and the number of cells plated
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existed, suggesting that under these conditions colony
formation was apparently independent of cell interactions.
With underlayers containing either MoCM or LyCM alone slopes
of regression lines were 1.7 for MoCM and 2.3 for LyCM
indicating a partial reduction in the requirement for
interactions from 3, on standard underlayers, to around 2 in
the presence of one CM. No colonies formed with MoCM in the
absence of PHA, but with LyCM (containing residual PHA) and
LyCM+MoCM b-values were similar in cultures without added PHA
to those with PHA although the plating efficiency was reduced
(TABLE 2.24).
In a series of experiments using blood MC from different
donors similar results were obtained to those described
above. Significant differences in b values were found between
cultures on underlayers with PHA alone and underlayers
supplemented with CM. (TABLE 2.25 and FIG 2.5).
The above experiments were all performed on underlayers
without RBCs. Experiments in which kinetic analysis was
applied to colony formation on RBC underlayers showed that
inclusion of RBCs reduced the slopes of regression lines from
3 (PHA, no RBC) to 2 (PHA+1%RBC) (TABLE 2.26). Inclusion of
MoCM or LyCM increased colony formation at lower cell
concentrations and reduced the slope of regression lines to
1.5. However both CM were required, even in the presence of




KINETIC ANALYSIS OF COLONY FORMATION BY BLOOD MC IN
PRIMARY CULTURE
Number of colonies





3 562±75 541+20 4 85±7 0 439+48 223+10 255+8
2 380+84 474+18 399+42 383+48 176+42 194+22
1.5 17 3.+69 232+12 342+15 3 48±4 137il6 173+23
1.0 126±21 169+33 248+18 228+66 148+5 12 6dLl2
0.75 4 5+9 8 2±18 126+29 170+58 7 0i2 2 115+.6
0.5 1 + 1.5 6+2 17+15 65+29 4+6 4 8+.6
b 3.1 2.3 1 . 7 1.0 1 . 9 0.8
r 0.89 0.90 0.88 0.93 o • 00 h-1 0.95
The above table shows results from a typical experiment.
Figures are the mean number of colonies ± 1 S.D. for
triplicate cultures. b=slope of the regression line where logn




KINETIC ANALYSIS OF COLONY FORMATION BY BLOOD MC IN
PRIMARY CULTURE
(Experiments 1-9)
b (regression •> coefficient)
Underlayer PHA PHA+LyCM PHA+MoCM PHA+LyCM+MoCM
experiment:
1 3.8 2.5 n. d n. d
2 3.2 1.5 0.6 n. d
3 4.1 3.1 1.8 0.7
4 3.1 2.3 1.7 1.0
5 2.8 0.8 1 . 0 n. d
6 2.6 1.9 1.7 1.1
7 3.4 1.0 1 . 1 n. d
8 3.5 2.4 1. 8 0 . 8
9 3.8 3.0 1 . 5
>
0.7
mean 3.4 2.1 1 . 4 0.9
Std.Error 0.2 0.3 0.1 0.1
Significant differences for b values were shown between PHA
and LyCM (p<.005) and PHA and MoCM (p<.005) and also between
LyCM or MoCM alone and LyCM+MoCM combined (p<.005). The
difference between LyCM and MoCM was not significant
(0.l>p>0.05). In the above experiments correlation
coefficients (r) varied from 0.85- 0.99. n.d= not done
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FIGURE 2.5 KINETIC ANALYSIS OF COLONY FORMATION
Each point represents the mean value of five to nine cultures
using blood MC from different donors. Calculated slopes of
regression lines gave values of 3.4 with PHA alone (•■ •),
2.1 with LyCM (X - - - -x" ), 1.4 with MoCM (o ©) and 0.9 with
both NfoCM and LyCM ( b » ).
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TABLE 2.26 KINETIC ANALYSIS OF COLONY FORMATION BY BLOOD MC
IN PRIMARY CULTURE WITH RBC CONTAINING UNDERLAYERS
number of colonies WITHOUT RBC
PHA LyCM MoCM LyCM+MoCM
cells/well x 10^
2.0 194+13 2 96±10 305±6 311±14
1.5 147±3 240+49 165+32 280±37
1.0 67 + 22 190+12 122 + 3 260±7
0.75 14±15 3 8 + 10 126±31 114±2 0
If)•o 1 + 1 l'0±l 9 20±2 6 7+4
0.25 not done
b 2.6 1 . 9 1.7 1.1
r 0.94 0.93 0.90 0.92
number of colonies WITH RBC
PHA LyCM MoCM LyCM+MoCM
cells/well x 10^
2 334+15 338+35 353±29 335±38
1.5 2 52±11 2 4 0±2 4 317±92 2 58±2 4
1.0 169±3 0 2303:58 238+61 231+12
0.75 8 0+2 0 9 2±I7 79±15 1213^30
0.5 62 + 17 4 5±21 3 6+6 46 + 21
0.25 3±4 1 3±.l 5 2 6±11 2 7t4
b 2.1 1.4 1.2 1.1
r 0.94 0 . 85 0. 82 0. 82
Figures are the mean values of triplicate cultures ±1 S.D.
This experiment was repeated using blood from a different
donor and similar results were obtained.
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Kinetic anlysis of secondary colony formation
When T-CFCs from primary cultures were recultured in
agar, growth only occured in cultures with LyCM. Kinetic
analysis of secondary colony formation with LyCM gave
regression coefficients close to 1 i.e. the number of colonies
forming was directly proportional to the number of cells
plated and was independent of accesory cells in the presence
of LyCM. The addition of PHA or RBCs to cultures did not
significantly alter b-values, although cultures with RBCs
showed increased plating efficiency (TABLE 2.27).
- 101 -
TABLE 2.27 KINETIC ANALYSIS OF SECONDARY COLONY FORMATION
cells/well Number of colonies
x 105 1.0 0.5 0.25 0.125 0.06 0.03 -b ' r
r
LyCM underlayer
expt. 1 9 3±6 56 + 8 31 + 5 19 + 6 9±3 3 + 2 0.96 0.99
2 163+24 142 + 9 7 5±16 20±3 9±1 0 1 .39 0.99
3 130+23 55 + 12 20±6 13 + 4 1±1 0 1.15 0.99
mean=1 .16 +0.22
LyCM+PHA
expt. 1 91±11 4 8 + 9 30±4 2 0±3 1032 0 0.77 0.99
2 159+26 130317 6839 2438 1132 231 1.25 0.97
3 138±17 7 6±1 2 2 8±4 1 8±4 231 0 1.43 0.86
mean=1.1530.34
LyCM + RBC underlayer
expt. 1 129±17 119+12 7 8±8 5 234 1 9:fc_4 733 1.02 0.98
2 12137 141±5 6 934 2 833 11.34 735 1.15 0.99
3 111±21 7 3+15 3 2±6 1837 16311 332 0.96 0.97
• mean:=1.0430.09
LyCM+PHA+RBC underlayer
expt. 1 11039 10036 5 8t7 3 23.9 2 2±5 1232 0.75 0.99
2 13 4±9 1073:6 583:9 2 439 1 3±3 632 1.05 0.99
3 145321 8 0±9 5 6312 2 83L9 2 033 933 0.78 0.99
mean=0.86+0.16
Figures are the mean values ± 1 s.d of triplicate cultures in
three experiments, using T-CFCs from three different donors.
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DISCUSSION
Demonstration of interleukin activity in CM
In the experiments described in this chapter two types of
CM were prepared and assayed for T-cell stimulatory activity:
MoCM was prepared from acute monocytic leukaemia cells, using
a method described by Lachman et al (1978) for the preparation
of CM with lymphocyte activating factor (IL-1) activity. LyCM
was prepared by PHA stimulation of mononuclear cells from
blood or various tissues (spleen, lymph node, tonsil) using
a method first described by Morgan et al (1976) for the
production of T-cell growth factor (IL-2). At the time of
initiating these studies, specific biochemical or
immunochemical assays (e.g. radioimmunoassay) for the
identification and measurement of the interleukins were not
available and identification and quantitation of interleukin
activity was dependent upon bioassay (Gillis et al 1978b).
Therefore in order to define the CM used in this study
conventional liquid culture bioassays for interleukin activity
were used. Subsequently these CM were tested in T-cell colony
forming experiments to investigate the role of soluble factors
in regulating T colony formation and their ability to
substitute for cellular interactions within the cultures.
MoCM was shown to contain IL-1 by demonstrating a direct
rnitogenic effect on thymocytes and by enhancement of PHA
induced thymocyte and T-cell mi togenesi s (Maize! <->t al 1981,
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Mizel et al 1978, Mizel 1982). The type of assay used and the
results obtained are similar to those used in previous , studie
of IL- 1, showing augmentation by murine or human monocyte
conditioned media of 3H- thymidine incorporation into PHA or
ConA stimulated murine thymocytes (Gery et al 1971, Gery and
Waksman 1972, Calderon et al 1975, Oppenheim et al 1976,
Unanue et al 1976, Lachman et al 1978) and are similar to the
more recent description of enhancement of ConA stimulated
human thymocyte proliferation by monocyte conditioned medium
and purified IL-1 (Maizel et al 1981). Further evidence that
MoCM contained IL-1 was obtained by the demonstration of
enhanced IL-2 production by human T-cells and thymocytes when
stimulated with MoCM in addition to PHA. These findings are
similar to those of Smith et al (1980) who used a murine
system and purified monocyte conditioned media to show that
IL-1 enhanced IL-2 production but was inactive when tested fo
IL-2 activity .
IL-2 activity was demonstrated using PHA activated
cultured T-cells that were unresponsive, or at least poorly
responsive, to further PHA and/or IL-1 stimulation but which
would proliferate in the presence of culture supernatants
(LyCM) from PHA stimulated MC or T-cells . The target cells
for assaying IL-2 activity were either T- CFCs or T- cells
grown in suspension with PHA and LyCM. This assay system is
similar to that described by other groups (Inouye et al 1980,
Gootenberg et al 1981 ) with the exception that in the
majority of experiments T-CFCs rather than conventionally
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cultured T-cells were used. However as no differences could be
found between T-CFCs and T-cells from cultures initiated and
maintained in liquid phase, either in the cell phenotype or in
their proliferative responses to PHA or CM, these assays can
be considered directly comparable with those of other groups
(Gillis et al 1978b, Inouye et al 1980).
Using the above assay systems, LyCM was shown to
stimulate proliferation of cultured T-cells in a dose
r
dependent manner similar to that previously described for
murine IL-2 dependent T-cell lines (Gillis et al 1978b) or
cultured human T-cells (Inouye et al 1980). Different batches
of LyCM, especially those prepared from blood MC, varied
considerably in their IL-2 activity. Spleen LyCM, prepared
from spleen MC of a patient with spherocytosis, showed high
levels of activity and gave near maximal stimulation at 25%
concentration. In subsequent experiments on colony formation
either spleen LyCM, of which approximately 500ml were
prepared, or batches of blood MC CM with comparable high
activity were used in order to obtain optimal and consistent T-
cell stimulation.
In these experiments crude supernatants were used to
supply IL-1 and IL-2 activities and it is possible that the CM
contained other activities than IL-1 or IL-2. For example the
possibility that LyCM contained small amounts of IL-1 in
addition to IL-2 was not formally excluded as the assays for
IL-1 activity, enhancement of thymocyte and T-cell
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mitogenesis, are also sensitive to IL-2 and therefore do not
allow distinction between CM with both IL-1 and IL-2
activity.. Results obtained using LyCM fractionated by G-100
gel filtration sliowed that the major T-cell stimulatory (IL-2)
activity was present in fractions of around 15,000 mol.wt.,
corresponding to the reported mol wt of human IL-2 (Gillis et
al 1980, 1982, Robb 1982), however smaller peaks of activity
could be seen at higher molecular weights. These may represent
high mol wt IL-2 complexes (Oppenheim et al 1980, Robb 1982)
but could possibly represent other interleukins. Nevertheless
in terms of bioassay it was clear that MoCM contained active
IL-1 but no IL-2 and that the major T-cell stimulatory
activity in LyCM both in terms of bioassay and partial
biochemical characterisation corresponded to IL-2.
Enhancement of colony formation by conditioned medium
Both MoCM and LyCM enhanced T-lymphocyte colony formation
as well as demonstrating interleukin activity in liquid
culture. Similar results demonstrating enhanced colony
formation have previously been described by various groups who
have shown production of colony enhancing activity by mitogen
stimulated lymphocytes and adherent cells (Claesson et al
1977b, Rosenszajn et al 1980, 1981).
When CM were assayed for T colony stimulatory activity
the results obtained were found to depend on both the
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composition of the lymphocyte suspension plated (e.g.-blood
MC, enriched T cells, thymocytes in primary culture or T-CFCs
in secondary culture) and on the cell concentration in the
culture wells.
With unfractionated blood MC colony formation was
optimally enhanced by CM at lower cell plating concentrations
(<2xl05 cells/well). This finding is consistent with the
hypothesis that colony formation is dependent upon release of
stimulatory factors from accessory cells which as cell
concentration falls fail to produce adequate amounts of growth
factor(s) to drive T-CFC proliferation (Gerassi and Sachs
1978, Goube deLaForest et al 1978). In order to clarify the
role of such possible cell interactions two experimental
approaches were used: firstly,analysis of conditioned media
requirements for colony formation using purified cell
populations in cultures and secondly kinetic analysis of cell
interactions in colony formation, as described by Goube deLa¬
Forest et al (1979b).
Colony formation by T-cells and thymocytes in primary
culture
In primary culture freshly isolated T-enriched cells
showed poor colony formation in comparison to MC suspensions.
Colony formation was restored to normal levels by adding
either MoCM or LyCM to cultures or by culturing T- cells on
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feeder layers containing adherent cells. These findings are
consistent with previous reports of the macrophage dependency
of colony formation (Claesson et al 1977b, -Rosenszajn et al
1978) and demonstrate the ability of CM with IL-1 activity to
substitute for macrophages in culture. In these experiments
MoCM with IL-1 activity from leukaemic monocytic cells was
used since in preliminary studies I was unable to prepare
active CM from normal blood adherent cells. This was probably
r
due to the release of colony inhibitory factors from normal
adherent cells (Zeevi et al 1977, Bockman and Rothschild
1979). However evidence that normal monocytes do promote T
colony formation was obtained from experiments in which colony
formation was enhanced when enriched T-cells were cultured on
adherent cell underlayers. Further evidence for the
importance of the macrophage in colony formation was provided
by experiments in which blood MC were treated with the
antimonocyte antibody 0KM1 and complement, a procedure which
depletes cell suspensions of at least 50% of the monocytes
present (Poznansky 1983). In these cultures there was a 50%
reduction in the mumber of colonies in response to PHA alone,
but colony numbers were restored to normal in the presence of
MoCM.
Treatment of blood MC with anti T-cell antibodies and
complement reduced colony formation. This was most marked
following treatment with the pan T cell antibody OKT3,
although inhibition was also obtained with anti T-helper
(OKT4) and anti T cytotoxic/suppressor (OKT8) antibodies. In
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these experiments the reduction in colony formation by T-
depleted cells was associated with a reduction in the ability
of 0KT3 and 0KT4 treated cells to produce IL-2, and could be
partially but not completely restored to normal levels by
culturing the treated cells with LyCM. These finding suggest
that the inhibition of colony formation in these experiments
was the result of both removal of T-helper cells (producing IL-
2) and removal of T-CFC precursors. In the case of 0KT3
9
treated cells, although few (<5%) mature T3+ cells remained
after treatment considerable numbers of colonies were formed
in the presence of LyCM suggesting that T-CFC precursors
might include 0KT3-negative as well as 0KT3-positive cells.
Spitzer et al (1982) have also suggested that T-CFC precursors
include not only mature 0KT3-positive cells but also a
population of 0KT3-negative cells. These results should
however probably be treated with some caution since treatment
of cells with OKT3 (and complement) does not fully deplete
0KT3 positive T cells from blood. I have observed that
although immediately following 0KT3 and complement depletion
only small numbers (1-5%) of 0KT3 positive cells can be
detected by immunofluoresence, after overnight incubation up
to 20% OKT3 positive cells can be found in cell suspensions.
This suggests that loss of 0KT3 positive cells may be due to
shedding or endocytosis of membrane antigen as well as due to
lysis of 0KT3 bearing cells by complement.
Thymocytes showed poor colony formation with PHA. Colony
formation was increased by the addition of MoCM to cultures
- 109 -
but was still low in comparison to cultures supplemented with
LyCM which showed similar numbers of colonies to T-enriched
blood MC suspensions. This is in contrast to previous'.studies
of thymocyte colony formation which have shown very poor
colony responses (Gelfand et al 1981). The observation that
thymocyte colony formation approached that of normal T-cells
in cultures containing LyCM suggests that the poor colony
responses to PHA are due to a deficiency of IL-2 production by
thymocytes rather than due to a lack of T-CFC precursors. The
poor response of thymocytes tx> MoCM is consistent with the
observation that thymocytes, even when stimulated with PHA and
IL-1, are poor producers of IL-2 (Smith et al 1980) and with
studies that have shown IL-2 producing cells constitute only a
minority subpopulation of mature thymocytes whereas IL- 2
reponsive cells capable of proliferation include a large
population of both immature cortical as well as mature
medullary thymocytes (Wagner et al 1979).
Colony formation by T-CFCs in secondary culture
T-CFCs, in contrast to freshly isolated T-cells, in
secondary agar culture proliferated to form colonies only in
reponse to LyCM but not in response to PHA or MoCM alone.
Identical findings were reported by Goube deLaForest et al
(1979b) who suggested that the lack of colony formation in
secondary culture, in the absence of LyCM, was the result of
depletion of accessory cells, resposible for the production of
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growth factor (colony promoting activity / CPA), from
harvested T- CFCs. In the present study it was noted that
occasionally a few colonies developed in secondary culture in
response to PHA, although this response was less than with
LyCM. This may be due to the persistence of small numbers of
accessory cells in the cultures. The persistence of
cooperating cells mhy also explain the responsiveness to PHA
and MoCM observed in liquid cultures of TCFCs and the cluster
formation seen in agar occurring during the 2-3 days after
harvesting. The viability or functional capacity of the
cooperating cells is however shortlived as is seen from the
loss of responsiveness to PHA in liquid culture and the
degeneration of clusters in agar after 3 days culture. The
similarity in the responses to CM of T-CFCs in secondary agar
culture and suspension culture with that of conventionally
cultured PHA activated T cells maintained in suspension
culture with LyCM suggests that sustained proliferation of T-
CFCs is dependent upon IL-2. These studies of secondary
colony formation do not exclude the possibility that T-cells
responsive in primary culture (i.e T-CFC precursors rather
than T- CFCs) may require additional or alternative growth
signals to allow them to respond to IL-2.
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Investigation of cell interactions in colony formation by
Kinetic analysis
, f
The role of cellular interactions in colony formation was
further investigated by the application of mathematical
analysis to colony formation at different cell plating
concentrations. This means of analysis suggested that three
independent cells interact in the formation of colonies in
primary culture, in the presence of PHA. This confirms the
previous finding of Goube de Laforest et al (1978, 1979a,
1979b). This analysis further suggested that in the presence
of either LyCM or MoCM the number of interacting cells were
reduced. When both MoCM and LyCM were added, the requirement
for cell interactions appeared to be eliminated. These
findings are consistent with a model of colony formation
involving at least three interacting cells; firstly a colony
forming cell precursor that proliferates in reponse to growth
factors; secondly two growth factor producing accesory cells
that are present in limiting amounts as the cell concentration
in cultures fall but which cah be substituted for by the
addition of conditioned media with IL-1 and IL-2 activity.
Although kinetic analysis has been widely used to
investigate cell interactions in the immune response
(Coppleson and Michie 1966, Mosier et al 1968, Jiminez and
Bloom 1972, Kondracki et al 1977, Kondracki 1979, Goube de
Laforest et al 1979b, Tse et al 1980), the results of this
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type of analysis should be interpreted with some caution. The
kinetic theory, upon which this analysis is based (Tse et al
1980), requires that each cell should act independently and at
random. It is however known that interactions between
monocytes and lymphocytes are complex and involve numerous
stimulatory and inhibitory interactions. For example, IL- 2
production is dependent upon the presence of IL-1 production
by macrophages (Larsson et al 1980, Smith et al 1980), but IL-
1 production itself is dependent on production of macrophage
activating factors by activated lymphocytes (Unanue et al
1976, Unanue 1978, Mizel et al 1978). The situation is further
complicated by the production of inhibitory factors by
macrophages such as prostaglandins which may inhibit IL-2
production and colony formation (Bockman and Rothschild 1979,
Inouye et al 1980, Rosenszajn et al 1980). A further problem
in applying the kinetic theory is that the equation describing
cell interactions (logn = b logN + a) is accurate only if the
concentration of the cell sub-populations and overall cell
concentration remains constant, or if cell interactions
leading to the measured response are, instantaneous. This is
clearly not the case as proliferation of T-CFCs increases one
sub-population and occurs over a period of days.
The problems outlined in the above paragraph may explain
why experimentally derived regression coefficients (b values)
do not correspond exactly to a three cell model of T-colony
formation, involving one colony forming cell precursor and
two accesory cells (i.e. an IL-1 producing macrophage and an
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IL-2 producing T-cell). For example with MoCM experiments gave
a b value of 1.4 rather than 2. A possible explanation for
this is that at high cell plating concentrations MoCM may not
only substitute for the IL-1 producing cell but may also, by
amplification of IL-2 production, substitute partially for a
relative lack of IL-2 producing cells ( giving a b value of 1)
whereas at low cell concentrations, although MoCM may
substitute for the IL-1 producing monocyte, insufficient IL-2
producing cells are present tx> allow optimal IL-2 production
and b values of 2 are obtained.
Growth factors and cellular requirements for colony
formation
Experimental observations of the CM requirements of blood
MC and purified T-cells and thymocytes in primary culture and
T-CFCs in secondary culture together with kinetic analysis of
colony formation clearly shows that T-cell colony formation
is dependent upon cell interactions. As the present work has
demonstrated that MoCM contains IL-1 and LyCM contains IL- 2,
it is therefore possible to construct a model for colony
formation that is analogous to current models for interleukin
action on T-cells in liquid culture (Palacios 1982):
1) In the presence of PHA alone 3 cell populations are
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required to interact for T-cell activation and proliferation
(colony-formation); an IL-1 producing cell (monocyte), an IL-
2 producing cell (T-lymphocyte) and an IL-2 responsive
clonogenic cell (T-CFC precursor).
2) In the presence of PHA and IL-1 (MoCM) two cell
populations are required; an IL-2 producing cell and an IL-2
responsive cell (T-CFC precursor).
r
3) In the presence of PHA and IL-2 (LyCM) two cell
populations are required; a monocyte and an IL-2 responsive T-
cell.
4) In the presence of PHA and both IL-1 and IL-2 there is
a requirement for only the clonogenic IL-2 responsive T-cell.
5) In secondary culture of T-CFCs there is a requirement
for IL-2 and the T-CFC alone.
A suprising finding was that in primary culture LyCM
(which contained IL-2) could not by itself effectively replace
the requirement for cell interactions, although LyCM could
maintain proliferation of T-CFCs in secondary culture and
T-lymphocytes in suspension culture for at least two to three
weeks. A possible explanation for this observation is that T-
CFC precursors, in contrast to cells reponding to PHA in
liquid culture, may include not only mature peripheral T-
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cells responsive to PHA and subsequently IL-2, but also
precursors that require other stimuli to proliferate
(Mossalayi et al.1982, Spitzer et al 1982). The observation
that MoCM and LyCM combined allow colony formation at lower
cell concentrations than with LyCM or MoCM alone suggests that
IL-1 or some other factor present in MoCM may have effects
other than through amplification of IL- 2 production. Possibly
IL-1 present in MoCM may increase the sensitivity of T-cells
to IL-2 through an effect such as induction of IL-2 receptors
although at present there is no direct experimental evidence
for this hypothesis. An alternative explanation for the
synergy of MoCM with LyCM in promoting colony formation is
that some stimulatory factor(s) other than IL-1 is present in
MoCM. A recently defined interleukin, named IL-3, has been
described that induces differentiation of immature T- cells
into mature IL-2 producing or responsive cells (Ihle et al
1982). One source of IL-3 is the myelo- monocytic murine cell
line WEHI-3 (Ihle et al 1982). It would be interesting to
determine whether the MoCM used in this study and derived from
a human monocytic leukaemia produced a factor with similar
activity.
A consistent observation in all experiments was that
below a critical cell concentration no colony formation
occured, even in cultures containing both MoCM and LyCM. This
finding suggests that direct cell-cell interactions in
addition to humoral interactions also play an important role
in the induction of colony formation. Recent studies have
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shown that both production of IL-2 and acquisition of
responsiveness to IL-2 depends upon interaction of T-cells
with HLA-DR determinants expressed on accesory cells, such as
the macrophage (Palacios 1982, Hunig 1983, Larsson and
Couthino 1984). These findings may account for the
observations that LyCM (IL-2) alone is unable to replace cell
interaction requirements in primary culture, and also may
explain the inability to induce colony formation below
critical cell concentrations where the probability of cell-
cell contact is low.
Recently Klein et al (1982) have proposed a 3 cell model
for colony formation similar to that outlined above. They have
however questioned the role of IL-2 in T colony formation and
proposed that the cooperating cells in colony formation
include not only IL2 producing T-cells but also non
adherent non-T cells, that release a colony stimulating
factor (colony promoting activity or CPA) following mitogenic
stimulation. Evidence for this is based upon the observation
that high levels of CPA can be found in the supernatants of
mitogen stimulated B-cells (purified by anti-Ig affinity
chromatography). In subsequent studies this group compared IL-
2 production with CPA production by various MC subsets
(Mossalayi et al 1982). These studies showed no CPA or IL-2
production by purified E+ T cells or adherent cells alone but
did show that a mixture of T cells plus adherent cells
produced both IL-2 and CPA. Suspensions of E negative, non
adherent cells (i.e. B-cells and null cells), still produced
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CPA but did not produce IL-2. CPA production by E negative
cells was not affected by lysis of 0KT3+ cells but was
abolished by treatment with the anti T-cell antibody A50. This
"B-cell factor" may therefore have been produced by that small
numbers of contaminating T-cells (perhaps E-, OKT3-, A50+)
and monocytes present in the suspensions that were used to
prepare CM. Further it is known that B-cells may indirectly
enhance T-cell proliferation by enhancing IL-2 production
(Inouye et al 1980) through T-B cell interactions mediated by
HLA-DR determinants expressed by B-cells that render T-cells
more sensitive to the effects of both IL-1 and IL-2 (Palacios
1982 ). This question of whether B-cells stimulate colony
formation through release of specific B-cell derived growth
factors or indirectly through products such as membrane
associated HLA-DR antigens can be adequately resolved only
through taking stringent precautions to ensure the purity of
the B-cell suspensions or, perhaps best, by using cloned
normal B-cells or B-cell hybridomas to prepare CM.
Conclusions
These studies have shown that the colony formation can be
successfully used to analyse cell interactions in T-
lymphocyte proliferation and have clearly demonstrated that T-
cell colony formation is dependent upon interactions between T-
CFC precursors and accessory cells. Colony formation is
enhanced by MoCM and LyCM. These CM can substitute, at least
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partially, for accesory cell/T-CFC interactions in culture.
As these CM contain IL-1 and IL-2 activity, it is probable
that colony formation is regulated by IL-1 and IL-2, either
singly or in combination, however the possibility that other
less well defined factors also play a role has not been
excluded . It is possible that T-CFC precursors are
heterogeneous and may be regulated by factors other than
IL-1 and IL-2 , with different factors acting on cells at
different stages of differentiation. Further clarification of
r-
the interrelationship of the interleukins and T-cell colony
stimulating factors and the identification of distinct colony
stimulating factors requires further study using biochemically
characterised and purified media.
Despite the limitations imposed by the use of
incompletely defined growth factors in colony forming assays,
this experimental system provides a method for the definition
of abnormalities in T-cell function. Subsequent chapters
describe how colony formation may be used not only to detect
changes in T-cell function occuring in disease but also to
determine whether these changes are the result of
abnormalities in growth factor mediated cell interactions.
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CHAPTER 3
COLONY FORMATION IN LYMPHOPROLIFERATIVE DISEASE
SUMMARY
In this chapter I describe investigations of T-cell
colony formation in two forms of lymphoproliferative disorder:
T-cell chronic lymphocytic leukaemia (T-CLL) and Hodgkin's
disease.
In the first part of this chapter (chapter 3.1) studies
of colony formation by leukaemic T-cells are described. Colony
formation by T-CLL cells was shown to be dependent on growth
factors in a similar manner to colony formation by normal T-
lymphocytes. It was also demonstrated that leukaemic cells
could not only respond to growth factors but were also able to
produce normal or increased amounts of interleukin 2.
In Hodgkin's disease T-lymphocyte proliferation is
frequently depressed. The mechanisms involved in this defect
have however not been clearly defined. In these investigations
of colony formation in Hpdgkin's disease (chapter 3.2) I have
demonstrated that T-cells from these patients show impaired
colony formation. Interleukin 2 production was also shown to
be decreased. Evidence is presented that suggests that the
reduction in colony formation may be the result of alterations
in blood T- cell subsets and in some cases secondary to
impaired IL-2 production.
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CHAPTER 3, part 1
COLONY FORMATION BY LEUKAEMIC HUMAN T-CELLS
SUMMARY
PHA induced*colony formation and interleukin 2 (IL-2)
production were studied in four patients with chronic T-cell
leukaemia. In three of the cases the leukaemic cells showed
an 0KT4+/T- helper phenotype and in one case cells showed an
0KT8+/T- cytotoxic/suppressor phenotype. The cases of T-helper
cell leukaemia showed colony formation that was comparable to
normal blood T cells and was not dependent on the addition of
conditioned medium, containing IL-2 activity, to cultures. In
t
contrast the T-suppressor cell leukaemia formed colonies only
when cultures were supplemented with IL-2 containing medium.
When IL-2 production by PHA stimulated cells was
measured, culture supernatants from the three T-helper cell
leukaemias all showed normal or high levels of activity,when
compared to supernatants from normal blood mononuclear cells,
The T suppressor cell leukaemia showed no evidence of IL-2
production. Culture supernatant from one case of T-helper cell
leukaemia was fractionated by passage through G-100 Sephadex
and was shown to give a similar pattern of elution of IL-2




T-cell lymphocytic leukaemia is a rare form of chronic
lymphocytic leukaemia (CLL) in which the leukaemic cells have
been shown to express differentiation markers characteristic
of mature T-lymphocytes (Pandolfi et al 1982, Catovsky 1984).
The neoplastic cells in these cases usually express the T3
antigen (common to all mature T-lymphocytes) and either the T4
antigen (T- helper/inducer) or T8 antigen (T-cytotoxic/
suppressor) and can therefore be subclassified as T-
helper/inducer or T- cytotoxic/suppressor cell leukaemias
(Reinherz and Schlossman 1981, Foon et al 1982), although less
commonly unusual phenotypes such as T3 with both T4 and T8
have been reported (Foa et al 1982, Vyth et al 1982).
Recently functional studies of T-cell CLL have shown that
in some cases these cells proliferate in response to mitogens
in vitro (Gramatzki et al 1982, Pandolfi et al 1982) and can be
induced to form colonies (Foa et al 1982). It has also been
shown that some cases of T^- cell CLL produce interleukin 2 ( IL-
2) following stimulation by mitogens such as PHA (Friedman et
al 1982) or TPA (Vyth et al 1982), and may also be able to
respond to IL-2 (Devries et al 1981). These findings suggest
that the proliferation of leukaemic T-cells may be regulated,
at least in part, by growth factors, such as the interleukins,
in a similar manner to normal T- lymphocytes.
In this study colony formation and IL-2 production by
- 122 -
neoplastic T-cells, from three patients with T-helper/inducer
CLL and one patient with T-cytotoxic/suppressor CLL, were
investigated in order to determine to what extent thes^
leukaemic cells produce or respond to the growth factors that
modulate normal T-cell proliferation. Responsiveness to
interleukin 1 (IL-1) and interleukin 2 (IL-2) was determined
by measuring colony formation in cultures supplemented with
conditioned media containing IL-1 (MoCM) or IL-2 (LyCM).
Production of IL-2 following PHA stimulation of the leukaemic




Isolation of blood mononuclear cells (MC:) Blood MC from
normal individuals and patients with T-cell leukaemia were
isolated from venous blood by centrifugation over Ficoll-
Hypaque as previously described (chapter 1). MC from the
plasma-Ficol1 interface were washed twice in RPMI 1640 and
resuspended at the required cell concentration for subsequent
cell phenotyping or culture.
Cell phenotyping: Rosetting with sheep red blood cells (E-
rosettes) and mouse red blood cells (MRBC-rosettes) was
carried out as previously described (see chapter 1. Stockdill
et al 1983).Lymphocyte subsets were identified using the
monoclonal anti T-cell antibodies; 0KT3, OKT4 , OKT8 (Ortho
Diagnostics Ltd), and the anti HLA-DR antibody DA6.231 (Guy et
al 1983). Positive cells were detected using an indirect
immunofluorescence assay (chapter 1).Cytochemical staining for
acid phosphatase and non specific esterase was performed on
blood films and cytospin preparations.
Colony Formation: Colony formation was assesed as
previously described. Cells were suspended at 5x10® cells/ml
in 0.33% agar in RPMI 1640 containing 15% heat inactivated
human serum (HIHS). Forty microlitres of this suspension
(2x10^ cells) was pipetted onto underlayers of 0.2ml of 0.5%
agar containing 15% HIHS, 1% PHA and 0.5% autologous red blood
cells. Cultures were also carried out on underlayers
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supplemented with 25%v/v spleen lymphocyte conditioned medium
(LyCM) or 15%v/v monocyte conditioned medium (MoCM). Cultures
were carried out in 17mm diameter wells in Linbro 24 well
dishes. Colonies (aggregates of more than 40 cells) were
counted after 5-6 days incubation at 37°C in a fully
humidified atmosphere of 5% C02 in air.
Colony cells were harvested from cultures for
immunophenotyping as previously described (chapter 1).
IL-2 production: MC from normal individuals and
leukaemic patients were cultured at lxlO^cells/ml in RPMI
1640, with 1% PHA, 1% HIHS and lmicrogram/ml indomethacin
(Sigma laboratories) (Inouye et al 1980). Supernatants were
harvested after 48 hours incubation and stored at -20°C until
assayed for IL-2 activity.Assays for IL-2 activity in
supernatants were carried out as previously described in
chapter 2. Target cells for IL- 2 assays were T- colony cells
harvested from primary cultures after 6-7 days incubation
(chapter2).
Biochemical characterisation* of IL-2 by gel filtration:
The T-cell stimulatory factor(s) in normal and leukaemic cell
culture supernatants were partially characterised and compared
using Sephadex G-100 gel filtration. Gel filtration was
carried out as described by Gillis et al (1980) with minor
modifications. One hundred ml volumes of supernatant were
precipitated using 85% saturated (NH4)2S04. The precipitate
was•col 1ected, dialysed against phophate buffered saline (PBS)
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(pH 7.2), and reconstituted in 2.0ml of PBS. This was then
passed through a 90x5cm column containing Sephadex G-100 that
had previously been equilibrated with PBS and calibrated using
blue dextran, bovine serum albumin, ovalbumin,
chymotrypsinogen A, and cytochrome C as molecular weight
markers. Fractions were collected in 8.0ml aliquots and stored
at 4°C. IL-2 activity in fractions was measured by culturing T-





Patients studied: Four patients with chronic T cell
leukaemia were studied. In cases 1-3 blood MC showed a T-
helper phenotype (0KT3+,0KT4+) and in case 4 a T-
cytotoxic/suppressor phenotype (0KT3+,0KT8+). The leukaemic
cells also showed cytochemical staining typical of T-cells
with focal acid phosphatase and non specific esterase staining
of cells. All cases were negative for Tdt and did not express
B-cell markers (HLA-DR, mouse red blood cell receptor, surface
Ig). Morphologically cases 2 and 3 were classified as
r-
lymphocytic leukaemias and cases 1 and 4 as prolymphocytic
leukaemias (table 3.1).
'Colony formation: Colony formation was measured on
underlayers containing either PHA alone or supplemented with
MoCM or LyCM. The three cases of T- helper (0KT4+) cell
leukaemia showed colony formation that was comparable to that
of normal blood T-cells. Colony formation in these cases was
enhanced by both MoCM and LyCM. In contrast the T-
cytotoxic/suppressor (0KT8+) cell leukaemia (case 4) showed
colony formation only in cultures supplemented with LyCM
(table 3.2). In this case colonies were small (40-50 cells)
and showed early degeneration (5 days), whereas colonies in
cases 1-3 were large (>100 cells) and continued to grow
without evidence of degeneration until day 6-7 of cultures.
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TABLE3.1CELPHENOTYPIFOURCASESOFHR NICLLEUK EMIA %positivem nonuclearcells




0.5T-helperlymphocytic leukaemia 1.0T-helperlymphocytic leukaemia 6.5T-suppressor/cytotoxic prolymphocytic leukaemia
Normalrange
46-7033 641 3215-4 80 5
*(weakreaction) AllcaseswereTdtnegative.Cytoch m calst ininghowedtronfo lacidphosphatasn non-specificesteraseactivityica1-3ds rongphosph tasebuw knon-s esteraseactivityincas4.
Colony cells harvested from cultures were morphologically
large transformed cells similar in appearance to normal T-
CFCs. Leukaemic T-CFCs showed a marked predominance of either
0KT4+ or OKT8+ cells in contrast to normal T-CFCs which
contaioned a mixture of 0KT4+ and 0KT8+ cells (table 3.3).





Patient 1 (OKT4+) 32±4 225+15 252±13
2 12 + 7 85±14 128127
3 122±18 253116 253110
4 (OKT8+) 0 0 7618
Normal MC (4 ) 154+33 171135 175128
/ .. T eelIs (4) 2 0±16 198198 216182
Figures for patients 1-4 are the mean values + 1 S.D. of
triplicate cultures in single, experiments.
Figures for normal MC and T cells are mean values ±1 S.D.
of four experiments. Blood MC contained 47-68% T cells
(E-rosetting) and 10-13% monocytes (non specific esterase
positive cells). T cells purified by rosetting with sheep
RBC contained 93-98% T cells and less than 1% monocytes.
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TABLE 3.3 PHENOTYPE OF COLONY CELLS
% positive cells
Patient OKT3 OKT4 OKT8 E-rosettes
1 97 93 0 99.5
2 93 92 0 99.5
3 72 85 3 93
4 not tested 10 43 not tested
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IL-2 production: Supernatants from PHA stimulated cultures
of leukaemic cells were tested for IL-2 activity by assessing
their ability to stimulate proliferation of normal T-CFCs.
Supernatants from the three cases of OKT4+ leukaemia all
showed normal or high levels of IL-2 activity, when compared
with supernatan.ts from normal blood MC. The 0KT8+ leukaemia
showed no evidence of IL-2 production (table 3.4).
Gel-filtration of normal and leukaemic cell culture
supernatants: The IL-2 activity in both normal (spleen MC
r-
LyCM) and leukaemic (case 3) cell culture supernatants showed
an almost identical pattern of elution from G-100 sephadex.
The major peak of activity was present in fractions of about
15,000 mol.wt, with a smaller peak of activity in a high
mol.wt fraction eluting after blue dextran (fig 3.1).
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50$ 25$ 12$ 6$
Case 1: Ex 1 11,200 6,856 4,150 1 ,755
Ex 2 11,385 4,516 4,916 2,042
Ex 3 - 8,854 6,999 3,098
Ex 4 10,673 8,652 4,299 2,451
Case 2: Ex 1 12,508 13,407 11 ,492 9,353
Ex 3 12,837 11,634 9,250 8,107
Case 3: Ex 2 13,240 4,803 13,555 10,538
Ex 4 18,843 16,821 15,103 9,522
Case 4: Ex 2 1 ,027 1,645 984 286
Ex 4 735 445 496 286
Normal: Ex 1 9,192 7,123 4,771 2,240
blood MC + + + +
2,887 4,108 3,057 1 ,184
Spleen MC: Ex 1 11,573 5,965 3,821 3,120
(LyCM)
PHA control: Ex 1 1 ,400 482 906 1 ,105
Ex 2 1 ,035 1 ,830 582 705
Ex 3 1 ,547 748 682 837
Ex 4 115
Conditioned media from PHA stimulated MC were prepared and tested for
IL-2 activity as described in materials and methods. Figures for
normal MC are the mean value i 1 SD of IL-2 activity in conditioned
medium from eight different normal individuals. In each experiment a
PHA control solution (1$ PHA in RPMI 1640) was tested at the given
dilutions. Responses to RPMI 1640 alone were 330 cpm (Expt 1), 687
cpm (Expt 2), 637 cpm (Expt 3) and 225 cpm (Expt 4).
— I 3 2_ -
DextranBSAOvChymaG tc _i|203AO56 Fractionn
FIGURE3.1SEPHADEX-lOOFRACTIONATIONOFCON ITIONED MEDIUMFROAPATIENTWITHT-CLL Fractionswereassay dforIL-2activitybculturingT-CFCs with50%v/vtestmediumasd scr bedinmetho s. T-CLLconditionedmedium= NormalMCconditionedmedium= ResponsesofT-CFCsi controlculturesw re;m diumalon lf236c.p.m.,PHA0.5%v/v,496c.p.m.,unfractionated T-CLLconditionedmedium25,532c.p. .,unfractionatednor al MCconditionedmedium9,654c.p. ..
DISCUSSION
This study shows that colony formation can be induced in
leukaemic T- cells by PHA and shows a similar growth factor
dependency to that of normal T- cells. T- helper (0KT4+) cell
leukaemias formed similar numbers of colonies to normal T-
cells and showed similar enhancement of colony formation in
the presence of MoCM (IL-1) and LyCM (IL-2) . In contrast
0KT8+ leukaemic cells formed fewer colonies than normal T
cells or OKT4+ leukaemic cells and were completely dependent
e
upon the addition of IL-2 containing CM to cultures. In an
earlier investigation of T- cell colony formation in T-cell
leukaemia, similar results were obtained by Foa et al (1982)
who demonstrated near normal colony formation by 0KT4+
leukaemias, but markedly subnormal colony formation in 0KT8+
leukaemias, although in this study (Foa et al 1982) growth
factor requirements for colony formation were not investigated.
The differences in the culture requirements of 0KT4 + and
OKT8+ leukaemic cells can be explained by differences in the
ability of leukaemic cells to produce IL-2, since 0KT4+ cells
produced IL-2 in response to PHA whereas 0KT8+ cells did not.
Claesson et al (1983) have reported similar findings using
FACS purified T-helper (Leu3+/T4+) and T-cytotoxic/suppressor
(Leu2+/T8+) normal lymphocy.tes. In this study they showed that
whereas T-helper cells formed colonies in response to PHA
alone, T-cytotoxic/suppressor cells required the addition of
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IL-2 to cultures to allow colony formation (Claesson et al
i.983 ). These findings are consistent with the observation that
IL-2 production by normal T-cells is a function of the 0KT4+
T-cell subset (Reinherz et al -1980b, Palacios 1982), and with
I previous observations that OKT4+ T-cell leukaemias can be
i
I
induced to produce IL-2 following mitogenic stimulation
(Friedman et al 1982, Gramatzki et al 1982, Vyth et al 1982).






The role of growth factors such as IL-1 and IL-2 in
maintaining proliferation of leukaemic T-cells in vivo is
unknown. In this study no IL-2 production was detected
\ without PHA stimulation, further the freshly isolated
leukaemic cells did not respond to purified, mitogen free IL-2
. - !
(obtained from R.C.Gallo), although they could be maintained
y'' in proliferation in liquid culture for 3-6 weeks by purified
IL-2 following initial PHA or TPA stimulation (D.Onions,
I personal communication). It has however been shown that
i
neoplastic T-cells from some human T-cell tumours can not only
be maintained by culture in IL-2 but may, in some cases, also
spontaneously produce IL-2 (Gootenberg et al 1981). There is
therefore a possibility that autostimulation, by IL-2
producing/resposive cells may play a role in neoplastic T-cell
proliferation in vivo.
At present the clinical significance of differences in
function of phenotypical1y mature T-cell neoplasms is unknown.
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However it is possible that once these differences have been
fully defined they may be exploited as either prognostic
indicators or targets for the control of cell proliferation-
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CHAPTER 3 part 2
COLONY FORMATION IN HODGKIN"S DISEASE
' »
SUMMARY
T-cell colony formation and interleukin 2 (IL-2)
production were studied in thirty eight patients with
Hodgkin's disease.' Both colony formation and IL-2 production
were found to be significantly lower than normal. Studies of T
lymphocyte subsets in these patients showed abnormal T-
helper:T-suppressor (OKT4:OKT8) cell ratios in some patients.
A positive correlation was observed between T-helper cell
numbers and colony formation and a negative correlation was
i
observed between T-suppresor cell numbers and colony
formation, suggesting that abnormal colony formation may
result from alterations in blood T-cell subsets. Although no
statistically significant correlation could be made between
colony formation and IL-2 production, preliminary studies have
shown that subnormal colony formation may in some cases be
restored to normal by the addition of IL-2 containing
conditioned medium to cultures.
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INTRODUCTION
Hodgkin's disease (HD) is a common form of malignant
• ♦
lymphoma in which there is frequently marked depression of
cell mediated immunity both in vivo and in vitro (Winke"lstein
et al 1974, Twomey et al 1975, Case et al 1975, Goodwin et al
1977, Hillinger and Herzig 1978). At present the precise
mechanisms underlying this impairment of cellular immunity are
not clearly defined, although a number of explanations have
been proposed. These include a reduction in blood T-cell
numbers (Bobrove et al 1975, Case et al 1976) or increased
suppressor cell activity (Hillinger and Herzig 1978). However
although some investigators have found a reduction in blood T
»
cell numbers (Bobrove et al 1975, Case et al 1976, Posner et
al 1981) other groups have found no abnormality in T cells
(Schulhof et al 1981, Dorreen et al 1983). There is also no
agreement as to whether the proportion of T suppressor cells
are increased (Romagni et al 1978) or normal (Posner et al
1981, Dorreen et al 1983), at least when rosetting techniques
(Tg, Tm rosettes) or monoclonal antibodies (anti T4- helper
and anti T8- suppressor) are used to define suppressor T-
cells. Functional studies have however shown that there is
suppression of mixed leucocyte culture responses by both
lymphocytes and monocytes (Twomey et al 1975, Hillinger and
Herzig 1978) and increased T cell suppressor activity is
demonstrable following mitogenic stimulation of blood
lymphocytes (Schulhof et al 1981). Evidence has also been
presented showing that impaired PHA responsiveness may be
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attributable to increased secretion of prostaglandins (PGE) by
blood monocytes (Goodwin et al 1977).
Several groups have studied T-cell colony formation in
Hodgkin's disease and shown that colony formation is reduced
(Dao et al 1978, Bockman 1980, Schulhof et al 1981). Bockman
(1980) has suggested that the reduction in colony formation
results from suppression of T-cell proliferation by increased
monocyte prostaglandin production. However the possibility
that other mechanisms may be involved, such as a reduction of
r-
colony forming precursors or an increase in T-suppressor
cells, have not been excluded (Douer and Sachs 1979).
*
The aim of the present investigation was to determine
whether the reduction in colony formation, reported in
Hodgkin's disease, was associated with abnormalities in blood
T-cell numbers or secondary to abnormalities of growth factor
production by accesory cells that modulate proliferation of
colony forming cells (Rosenszajn et al 1981, Klein et al 1982,
this thesis chapter 2). In order to do this colony formation
and interleukin 2 (IL2) production by blood mononuclear cells
were measured in patients with Hodgkin's disease.
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MATERIALS AND METHODS
Patients: Thirty eight patients with histologically
confirmed diagnoses of Hodgkin's disease and thirty norm'a'l
individuals were studied. Patients studied were either newly
diagnosed, untreated cases or cases that were in remission and
had not received chemotherapy or radiotherapy in the previous
6 weeks. Details of histological type, stage, and individual
results of experimental studies are given in table 3.5.
Blood MC: MC were isolated from anticoagulated (containing
0.2% EDTA) venous blood samples by centrifugation over Ficoll-
Hypaque. T cell percentages and subsets in MC suspensions
wer£ determined by rosetting and indirect immunofluorescent
staining with monoclonal antibodies as desribed in chapter 1.
Colony formation: Colony forming assays were carried out
in cultures containing PHA and autologous RBC underlayers, as
described in chapter 1. Colony formation was also measured in
cultures supplemented with indomethacin (Sigma) at 1
microgram/ml in the underlayer. Blood MC were plated in the
culture overlayer at lxlO^cells/well and in some cases also at
2xl0^cells/well.
Interleukin 2 production by blood MC: Blood MC were
suspended at 1xl0®eel1s/ml in RPMI 1640 containing 1% PHA and
1% pooled normal heat inactivated human serum (with and
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without indomethacin at 1 microgram/ml). Cells were cultured
in 10ml plastic centrifuge tubes at 37°C in 5% C02 in air for
48 hours. Culture supernatants were harvested following
* ?
centrifugation (500g for 15 minutes) and were stored at -20°C
until assayed.
Measurement of IL-2 activity: Supernatants were assayed
for IL-2 activity as described in chapters 2 and 3. In
preliminary experiments culture supernatants from both normal
individuals and HD patients were found to give maximum
stimulation of target T-cells at 50% v/v with progressive
reduction in activity at lower concentrations (see
FIG 3.3). All supernatants were therefore subsequently tested
%
at 50% v/v and IL2 activity was expressed as a function of
the response (3H-thymidine incorporation in counts per minute
- cpm ) to a standard batch of IL-2 containing medium prepared
from blood MC of a patient with T-CLL:
activity of test supernatant 50% v/v (cpm)
IL-2 units = 100 x
activity of T-CLL supernatant 50%v/v (cpm)
In all experiments responses of target cultured T-cells
to T-CLL supernatants were between 10-20 times that of
responses to medium alone or PHA (0.5%) in control cultures.
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RESULTS
Blood T-cells;- MC isolated from the blood of patients
with HD showed novoverall difference from normals in the
percentage of E-rosetting cells although there was wide
variation in individual results (TABLE 3.5, TABLE 3.6).
However when total T-cells were enumerated using 0KT3 there
was found to be a small but significant reduction in the
percentage of 0KT3 positive blood MC. This appeared to be
e
mainly the result of a decrease in the percentage of 0KT4
positive cells with a resulting significant reduction in the T
helper:suppressor (OKT4:OKT8) cell ratio (table 3.6), although
«
again there was wide variation between individual patients
(Appendix l).No correlation was found between total T- cells
or T-cell subsets and disease stage, histological type or
prior treatment.
Colony formation in Hodgkin's disease Colony formation
by blood MC from HD patients was variable. More than half the
patients studied showed subnormal colony formation and
overall colony formation was significantly depressed when
compared to normal individuals (TABLE 3.7, FIG 3.2 ). In a
small number of patients colony formation, that was subnormal
with PHA, was within normal limits when cells were cultured
with indomethacin (FIG 3.2 ).
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TABLE 3.5A EXPERIMENTAL DATA IN HODGKIN'S DISEASE PATIENTS
1A. CLINICAL DATA AND BLOOD T-CELLS
Case Diag Stage Treatment % positive blood MC
status E-rosette OKT3 OKT4 OKT£
1 LP 2A R 27
2 LP 3 A R 30
3 LP 2 A D 26 22 10 11
4 LP 2A R 83
5 LP 2B D 50
6 LP 3 A R 68 20 18
7 , LP not known D 47 13 24
8 LP 2 D 82 21 60
9 MC 1A R 41
10 MC 1A D 64 25 7 13
11 MC 3 A R 68
12 MC 4B R 17
13 MC 2B D 53
14 MC 2A D 55 45 19 24
15 MC 2 A D 40 60 42 16
16 MC 3B R 34
17 MC 1A R 80
18 MC 4 D 55 31 27
19 MC 3B R 42
20 MC 3 D 41
21 MC 2 D 36 11 7 6
continued on next page
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TABLE 3.5A continued
22 MC 3B D 62 14, . 42
23 NS 1A R 30 26 11 15
24 NS 3 R 40
25 NS 2A R 81
26 NS 4 A R 81
27 NS 3 A D 62 34 16 16
28 NS 2A D 50 58 32 22
29 . NS 3A R r 51 51 35 9
30 NS 3B R 58
31 NS 3B D 70
32 NS 3 A R 72 74 34 43
33 NS 1A R 75
34 NS 3B R 56
35 NS 2A D 44 41 21 8
36 NS 3 A D 55 35 15
37 LD 4B D 80
38 LD 4B D 58 25 41
Diagnoses were made by histological examination of lymph
nodes and classified using the Rye classification (Lukes et
al 1967). Patients were staged according to the Ann-Arbor
staging system (Carbone et al 1971). Patients were either




TABLE 3.5B COLONY FORMATION AND INTERLEUKIN 2 PRODUCTION
Colony formation IL-2
Case Diag Stage lxlO5 eel1s/wel1 2x1O^cel1s/wel1 activity
PHA PHA+ind PHA PHA+ind PHA PHA+ind
1 LP 2A 2 0 63 62 4 22
2 LP 3A 7 69 66 230
3 LP 2A 66 107 79 186
4 LP 2 A 0 6 99 131
5 LP 2B 73
e-
76 131 147
6 LP 3A 0 0 6 9
7 LP not known 5 6.5
8 ' LP 2 18 14.5
9 MC 1A 3 3 5 6
10 MC 1A 9 67 32 139 8 15
11 MC 3 A 0 0 34 84
12 MC 4B 15 30 38 124
13 MC 2B 3 25 44 104 3 3
14 MC 2A 2 2 79 117
15 MC 2 A 52 81 82 157
16 MC 3B 10 105 170 232
17 MC 1A 0 0
18 MC 4 11 15 5 6.5
19 MC 3B 20 55
20 MC 3 3.5 5
21 MC 2 6.5
2 2 MC 3 B 9 10
23 NS 1 A 1 1 62 36 121 2 8
continued on next page
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TABLE 3.5B continued
24 NS 3 48 74 69 147
25 NS 2A 50 150 81 241
26 NS 4 A 0 0 53.5 127.
27 NS 3A 7 7 26. 5 172
28 NS 2A 43 63 11 49
29 NS 3A 46 78 4 4
30 NS 3B 31 94
31 NS 3B 79 105 87 133
32 NS 3A 59 106 152 88
33 NS 1A 99 142
34 NS 3B 83 208
35 NS 2A 4.5 3
36 NS 3 A 6.5 6
37 LD 4B 17 23
38 LD 4B 17 28
Figures for colony formation and interleukin 2 avtivity are
mean values of triplicate cultures. Colony formation and
production of supernatants from blood MC were carried out as
described in materials and methods.
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TABLE 3.6 BLOOD T CELLS IN HODGKIN'S DISEASE
% Positive cells ± SEM
normals Hodgkin's disease P
E-rosettes 55.0±2.4 52.8+3.4 (31) NS
0KT3 57.3+2.7 48.7+4.4 =.05
OKT4 40.9+2.5 22.6±2.6 <.001
OKT8 22.2+1.3 22.7+3.4 NS
T4:T8 ratio 1.99+0.19 1.29+0.22 <.01
*
Figures are the results of studies on 17 normal individuals
and 18 patients with HD, except for E-rosetting which was
measured in 31 patients. Significance testing was by the Mann
Whitney U test.
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TABLE 3.7 COLONY FORMATION IN HODGKIN'S DISEASE
colonies + SEM
normals Hodgkin's disease P
MC cultured at 1x10^ cells/well
+PHA 91.7+9.8 (19) 29.7±5.4 (30) <.001
+PHA + Indomethacin 126.8±12.1 58.4+9.8 <.025
MC cultured at 2x10^ cells/well
+PHA 130.6+15.1 (19) 69.2±10.2 (16) <.001
*
+PHA + Indomethacin 177.3+15.9 139.2+15.7 <.01
Figures in parentheses show the number of cases studied. P
























*• •• & ;* *
cells/well ' 1 x 10s 2x10* 1x10s" 2x10s"
PHA PHA+ indomethacin
FIGURE 3.2 COLONY FORMATION IN HQDGKIN'S DISEASE
Each point represents the mean value of triplicate cultures.
Normal X Hodgkins Disease •
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There was no correlation between colony formation and the
percentage of T-cells (E-rosette or 0KT3 positive cells)
(P= -0.5 Kendall rank correlation) present in cell
suspensions. There was however a weak positive correlation
between the percentage of 0KT4 positive cells and the number
of colonies (P= .06 ) and a negative correlation with the
percentage of OKT8 positive cells (P=-.07 ). There was no
correlation between stage or treatment history but patients
with nodular sclerosing type HD formed significantly more
colonies than patients with mixed cellularity type disease
(PC.01, Mann Whitney U test). Statistically significant
^differences between lymphocyte predominant and mixed
cellularity or nodular sclerosing could not be demonstrated
(TABLE 3.8).
TABLE 3.8 COLONY FORMATION IN HODGKIN'S DISEASE AND
HISTOLOGICAL TYPE.
Histological type Colonies at 1 x 10s cells/well
PHA PHA+indomethacin
Lymphocyte predominant (6) 24.7+34.9 43.0+46.7
Nodular sclerosis (12) 46.3+30.9 90.7+58.5"
PC.01
Mixed cellularity (11) L 11 . 4 ± 14 . 9 34 . 8+36. 8_
Lymphocyte depleted (1) 17.0 23.0
Figures for colonies are the mean values + 1S.D.. The
number of cases studied are shown in parentheses. P values
were calculated using the Mann Whitney U test.
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IL-2 production in Hodgkin's disease;- IL-2 activity in
supernatants from HD blood MC was significantly less-than
that in normal blood MC culture supernatants (TABLE 3.9).
Addition of indomethacin to cell cultures during stimulation
with PHA increased IL-2 activity of culture supernatants of
both normals and HD patients (TABLE 3.9, FIG 3.3, FIG 3.4),
but only increased IL-2 activity to within the normal range in
one patient that showed subnormal activity with PHA
stimulation alone .
TABLE 3.9 IL-2 PRODUCTION IN HODGKIN'S DISEASE
/
IL-2 units+SEM
, normals HD P
supernatants from MC stimulated with:
PHA 35.3±4.0 (17) 18.1+5.8 (20) <.001
PHA+indomethacin 59.2±6.4 (17) 37.1±18.6 (19) <.01
Figures in parentheses are the number of samples tested. IL-2
activity was determined as described in methods. P values were
calculated by the Mann "Whitney U test.
No correlation could be made between IL-2 production and
T-cell numbers or subsets. There was no significant
correlation between colony formation and IL-2 production. As
with colony formation there was no correlation with disease
stage or prior treatment but again patients with nodular
sclerosing HD showed significantly higher levels of IL-2
(P<.001) than patients with mixed cellularity disease.
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FIGURE 3.3 IL-2 ACTIVITY IN NORMAL AND HODGKIN'S
DISEASE CELL CULTURE SUPERNATANTS
IL-2 activities in supernatants from 5 normal
individuals (meant 1 S.D.) and two Hodgkin's disease
patients are shown. In fig 3.3a IL-2 activities in
supernatants from PHA stimulated cells are shown and in
fig 3.3b IL-2 activities in supernatants from PHA
stimulated cells cultured with indomethacin are shown.
IL-2 activity was measured as described in methods, by
culturing T-CPCs with culture supernatants at various
concentrations. In this experiment control cultures gave
the following responses: medium alone 540 c.p.m., PHA




















FIGURE 3.4 IL-2 ACTIVITY IN HODGKIN'S DISEASE CELL
CULTURE SUPERNATANTS
Normal X Hodgkin's Disease
t 5"3 -
Colony formation in MC cultures supplemented with
conditioned media:- The results presented above demonstrated
a reduction in both colony formation and IL-2 production.
Although no statistically significant correlation could be
made between these two parameters the findings suggested that
subnormal colony formatio'n might in individual cases be
consequent upon a defect in growth factor production. In order
to further investigate this possibility colony formation was
studied in cultures of HD patients MC supplemented with LyCM
(as a source of IL-2) and MoCM (as a source of IL-1). Two
cases have been studied (cases 18 and 28). Blood MC from
patient 18 showed subnormal colony formation and low IL-2
production in response to PHA (with or without indomethacin).
*The addition of LyCM to cultures of this patient's MC
increased colony formation to normal levels. MoCM also
increased colony formation but to a lesser degree (table
3.10). Blood MC from patient 28 showed low IL-2 production
following stimulation with PHA that was increased to normal by
indomethacin. In this case colony formation was at the lower
limit of the normal range in cultures containing PHA (with or
without indomethacin) and was only moderately increased by the
addition of LyCM or MoCM (table 3.10).
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TABLE 3.10 THE EFFECTS OF CONDITIONED MEDIA ON COLONY
FORMATION IN TWO PATIENTS WITH HODGKIN'S DISEASE
number of colonies/10fcelIs
culture PHA PHA+indomethacin
underlayer:nil LyCM MoCM Ly+MoCM nil LyCM MoCM Ly+MoCM
case 18 11 91 30 232 15 163 99 230
case 28 43 87 72 82 63 84 97 80
normals 60-98 78-127 80-126 94-197 79-125 85-164 80-157 126-
(4) 208
Blood MC were cultured at lxl0scel1s/wel1. Figures are
the mean values of triplicate cultures. Figures for. normals
give the range of values obtained from four normal blood




The reduction in oc..-lor y formation i n Hodgkin's disease
shown .in this study is consistent with previous reports (Douer
and Sachs- 1979, Schulhof et al 1 981 , Mukhopadhyaya et al 1 983 ) . A
reduction in IL-2 production by blood MC has also been
demonstrated for the first time. This reduction in IL-2
production, in Hodgkin's disease, has recently been confirmed
in a study by Ford et al (1984). Reductions in colony
formation and IL-2 production were present in newly diagnosed
and treated patients at all disease stages and in all
histological types.
*
The reduction in colony formation could not be
attributed to a reduction in the percentage of T cells (%E
rosette positive or %0KT3 positive cells) in blood mononuclear
cell suspensions. Although there was wide variation in %T-
i
cell counts, no correlation was found between %T cells and
colony formation, with some patients with low T cells showing
normal colony formation and some with normal T cells showing
reduced numbers of colonies. In order to explain the reduction
in colony formation it is therefore necessary to postulate
either a specific reduction in the subset of T cells that have
colony forming potential (i.e. T colony precursors) or a
reduction in the ability of accesory cells to promote colony
formation.
In previous studies it has been shown that colony
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precursors include both T-helper (0KT4 or Leu3a positive) and
T-cytotoxic/suppressor (0KT8 or Leu2 positive) cells (Claesson
et al 1983), however whereas T-helper cells, which include
the cells responsible for IL-2 production, may form colonies
in response to PHA alone, T-suppressor/cytotoxic cells require
IL-2 to be added to cultures. Thus it might be expected that
colony formation in Hodgkin's disease would be related to
changes in T-cell subsets and possibly through changes in IL-2
production. There was a positive correlation between colony
formation and the percentage of T-helper (0KT4 positive) cells
and a negative correlation between colony formation and the
percentage of T-cytotoxic/suppressor (0KT8 positive) cells.
»
The observation that IL-2 production was reduced in
Hodgkin's disease suggested that defective IL-2 production
might be responsible for the subnormal colony formation. More
direct evidence for this was obtained in an experiment in
which blood MC, from a patient with markedly subnormal colony
formation and IL-2 production, were shown to produce normal
numbers of colonies when cultures were supplemented with IL-2
containing conditioned medium. In one other patient however IL-
2 containing medium had only a small enhancing effect on
colony formation. Further studies of colony formation in
cultures supplemented with IL-2 are in progress in order to
determine the extent to which lack of IL-2 production is
responsible for the defect in colony formation in individual
patients.
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In patients with Hodgkin's disease, no direct correlation
could be made between colony formation and IL-2 production, or
between IL-2 production and T-cell subsets. The lack of
correlation between T-cell subsets and IL-2 production may be
explained by the observation that the monoclonal antibodies
0KT4 and 0KT8 do not fully define functional T-cell subsets
(0KT4 positive cells include cytotoxic and suppressor cells
(Reinherz et al 1983), and 0KT8 positive cells may include IL-
2 producing cells (Luger et al 1982)). The lack of correlation
between IL-2 production and colonies does however suggest that
mechanisms other than reduced IL-2 production may be
responsible for the failure of colony formation in some cases.
It has been suggested that defective colony formation is
related to increased prostaglandin synthesis by blood MC in
Hodgkin's disease (Bockman 1980). In this study the
prostaglandin inhibitor indomethacin was found to increase
both colony formation and IL-2 production by most patients
although even in the presence of indomethacin these both
remained subnormal in the great majority of cases. Thus
although prostaglandins may play a role, probably through
reducing IL-2 production CEnouye etal'1980 ) , it seems unlikely that
this alone accounts for subnormal colony formation.
Mukhopadhyaya et al (1983) have shown that blood MC culture
supernatants from Hodgkin's disease patients produce a factor
that inhibits colony formation by normal blood MC. This factor
has however not been characterised. Further studies are
clearly needed to confirm that Hodgkin's disease blood MC
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produce colony inhibitory factors and to biochemically
characterise these factors.
Conclusions
This study has confirmed previous observations of a
reduction in T cell colony formation in Hodgkin's disease. The
mechanism of this reduction remains uncertain although
evidence has been presented that suggests a reduction in IL-2
production is of major importance. It is possible that
defects other than reduced IL-2 production, including
alterations in the number of colony precursors and the
production of inhibitory factors, may also contribute to
subnormal colony formation in some patients. Further studies
are in progress to determine the extent to which defects in
colony formation can be corrected by the addition of IL-2 to
cultures. If in vitro abnormalities of T-cell function, such
as reduced colony formation, are a consequence of reduced IL-2
production and can be corrected by the addition of IL-2 then
it is probable that impaired cellular immunity in vivo will
also respond to IL-2 administration.
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CHAPTER 4
INHIBITION OF T-LYMPHOCYTE COLONY FORMATION BY '
METHYLPREDNISOLONE
SUMMARY
Methylprednisolone was found to inhibit primary T cell
colony formation at very low concentrations. This inhibition
was shown to be a consequence of inhibition of growth factor
production by accessory cells.
INTRODUCTION
Glucocorticoid hormones are known to inhibit lymphocyte
functions both in vitro and in vivo. In some species, such as
the mouse, glucocorticoids exert a direct lympholytic effect.
In others , including man, lytic effects are not observed
although steroids induce marked immunosuppression (Claman
1972, Cupps and Fauci 1982). In vitro studies of steroid
action on human lymphocytes have shown that steroids can
inhibit lectin induced lymphocyte transformation and
proliferation ( Nowell 1961, Smith et al 1977). These
inhibitory effects have however been found to be highly
dependent on culture conditions and to require concentrations
of hormone greater than those usually obtained in vivo
following glucocorticoid therapy ( Webel and Ritts 1 977, Kraft
et al 1979 , Segel et al 1980 ).
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Early studies of steroid action on lymphocyte
mitogenesis attributed steroid action to a direct effect on
lymphocytes through inhibition of metabolic functions, such as
nutrient uptake, protein and nucleic acid synthesis, with
consequent failure of the stimulated cells to enter or
progress through the cell cycle ( Mendelsohn et al 1977). More
recently however it has been proposed that glucocorticoids
inhibit lymphocyte proliferation not only through direct
inhibitory effects on the metabolism of proliferating cells
but also through inhibition^of growth factor production by
accesory cells (Gillis et al 1979a,b,, Larsson 1980, Palacios
1982).
The aim of the studies presented in this chapter was to
determine whether T-cell colony formation was inhibited by the
glucocorticoid, methylprednisolone, and to establish whether
this effect was mediated by direct effects on colony forming
cells or indirectly through inhibition of growth factor
production by accesory cells.
-161-
METHODS
Blood mononuclear cells (MC) were isolated from
heparinised venous blood by centrifugation over Ficoll-Hypaque
as described in chapter 1.
Colony formation was carried out as described in
chapter 1: For primary colony formation blood MC were
suspended in RPMI 1640 containing 10% autologous plasma with
agar added to 0.3%. Forty microlitres of this suspension (2 x
10'cells) was plated onto an underlayer of 0.2ml of 0.5% agar
in 1640 with 10% autologous plasma and 1% v/v PHA. All
cultures were in 17mm diameter wells in multiwell dishes.
For secondary colony formation 2 x lO^colony cells,
harvested from 6-7 day primary cultures, were plated onto
underlayers containing 50% conditioned medium (see below).
All cultures were incubated at 37°C in a fully
humidified atmosphere of 5% C02 in air.
Methylprednisolone sodium succinate (MPS) (Upjohn) was
added to culture underlayers to give final concentrations
between 10'^ind 101(^M.
Colonies, defined as aggregates of more than 40 cells,
were counted after incubation for 6 days. In some experiments
both clusters (aggregates of 4-40 cells) and colonies were
counted and the number of cells in each cluster and colony
were determined by examination of 50-100 cell aggregates at x
100 magnification.
- 162 -
Conditioned Medium (CM): CM was prepared by incubating
2 x 10®freshly isolated MC in 2ml of RPMI 1640 containing 10%
autologous plasma and l%v/v PHA for 48 hours. Culture
supernatants were harvested following centrifugation at lOOg
for 20 minutes and stored at -20°C. This conditioned medium is
referred to as PHA-CM. CM was also prepared as described above
but with the addition of MPS to cultures, at various
concentrations, throughout the 48 hour incubation period. This
CM is referred to as MPS/PHA-CM. In some experiments
conditioned medium was prepared as described above but with
Monocyte CM (MoCM, 15% v/v) added to cultures of MC in
addition to PHA.
Assays for interleukin 2 (IL-2) activity in CM were
carried out as described in chapter 2: Colony cells harvested
from primary cultures were suspended at 2 x lO^cells/ml in
RPMI 1640 with 20% heat inactivated human serum and 0.2ml of
this suspension was aliquoted into a 17mm diameter flat
bottomed well. A further 0.2ml of either RPMI 1640 (with or
without 1% v/v PHA) or CM was added to the well. Cultures were
incubated for 4 days and then pulsed for 4 hours with 0.4
microcurie of 3H-thymidine. Cells were then harvested onto
25mm Whatman GF/C filters, washed twice with phosphate
buffered saline followed by one wash with 5% TCA and two
washes with absolute ethanol. The filters were then placed in




1) INHIBITION OF PRIMARY COLONY FORMATION BY MPS
MPS inhibited primary colony formation, in a dose dependent
manner, at concentrations between 10% and 10^M (table 4.1).
Inhibition of colony formation was maximal when MPS was added
at the beginning of culture; delay of as little as one hour in




TABLE 4.1 INHIBITION OF PRIMARY T LYMPHOCYTE COLONY
FORMATION BY MPS
Concentration of Colony number (mean±lS.D.)
; [M] expt.1 expt.2 expt.3 expt.4 expt.
0 188+26 124+19 116+15 165+36 15 5+9
10"10 84±31 71 + 7 not tested
10"8 81 + 12 49+6 80+12 88+18 4 0+2
10"6 42 + 11 29+12 48+17 21+8 3 + 3
I—1 o
1
3+2 19+12 11+3 3+2 0
10"2 0 6+3 0 0 0
Figures are the mean value ± 1 S.D. of colony counts from
quadruplicate cultures from 5 different donors.
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TABLE 4.2 THE EFFECT OF THE TIME OF ADDITION OF MPS TO CULTURES









No MPS 115±2 3 73±11 115±5 110±13
MPS added after
0 hours 0 6±4 0 3 + 5
1 hour 124±30 2 6 + 8 4 5±11 39±12
24 hours 113±17
*
5 8±6 51±4 7 3±13
48 hours not tested 52+13 67 + 11
Figures are the mean values ± 1 S.D. of quadruplicate cultures
from 4 different donors. MPS (10 microlitres 10"SM ) were added
by pipetting onto the culture overlayers, either at the
beginning of culture (0 hours), or after various periods of
incubation.
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Evidence that inhibition was the result of specific
glucocorticoid interaction with high affinity cellular
receptors was given by experiments in which cultures were
• »
incubated with the competetive glucocorticoid antagonist
cortexolone. Cortexolone binds specifically to cytoplasmic
glucocorticoid receptor blocking binding by MPS but has little
pharmacological activity itself. The addition of cortexolone
alone had only a small inhibitory effect, but when present in
cultures containing MPS substantially reduced the inhibitory
effects of MPS on colony formation (table 4.3).
TABLE 4.3 THE EFFECT OF CORTEXOLONE ON COLONY FORMATION
IN MPS TREATED CULTURES.
Culture conditions Number of colonies (mean ± 1S.D.)
expt.1 expt.2
No MPS 127±7 6 8±1 3
MPS 10"% 2 5+15 0
Cortexolone 10% 95 + 13 3 5 + 15
MPS 10% + Cortexolone 10"4M 77 + 2 34 + 15
Figures are the mean colony counts ± 1 S.D. of quadruplicate
cultures from 2 different donors.
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In primary cultures MPS reduced not only the number of
colonies but also reduced colony size. When cultures were
scored counting both the number of colonies ( cell aggregates
>40cells) and clusters (cell aggregates 4-40 cells ), there
was found to be no change in the total number of aggregates
developing but a marked diminution in mean aggregate size.
Thus in the absence of MPS most aggregates that developed were
of greater than 40 cell size and scored as colonies whereas in
the the presence of MPS the majority of aggregates were less
r-
than than 40 cells in size and were scored as clusters (plates
4.1,4.2, tables 4.4,4.5).
TABLE 4.4 THE EFFECT OF MPS ON THE TOTAL NUMBER OF COLONIES
AND CLUSTERS AND COLONY SIZE.
Culture total colonies no. cells/
conditions colonies clusters + clusters aggregate
No MPS 116 +20 40±4 156±22 190 + 29
10_8M MPS 4 7+9 86±12 131 + 20 86±5
10"6M MPS 28 + 9 125 + 31 151 + 38 50 + 9
Figures are the mean values + 1 S.E. of 4 experiments using
MC from different donors. In each experiment triplicate or
quadruplicate cultures were examined and colonies (>40 cells)
and clusters (4-40 cells) were counted. Colony and cluster size
(number of cells/aggregate) was determined by examining between
40 and 100 colonies and clusters, in steroid treated and
untreated cultures, in each experiment, at x 100 magnification.
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PLATE 4.1 T-LYMPHOCYTE COLONIES IN PRIMARY CULTURE
Colonies grown in the absence of MPS (original xlOO)
PLATE 4.2 T-LYMPHOCYTE COLONIES IN PRIMARY CULTURE
Colonies grown in the presence of 10 ^M MPS (original xlOO)
- 168
TABLE 4.5 THE EFFECT OF MONOCYTE CONDITIONED MEDIUM (MoCM)
AND LYMPHOCYTE CONDITIONED MEDIUM (PHA-CM) ON
MPS TREATED PRIMARY COLONY FORMATION
Colony number (mean + 1S.D.)




























Figures are mean colony counts ± 1 S.D. of triplicate
cultures using blood MC from 3 different donors.
PHA-CM was included in culture underlayers at 50% v/v
and MoCM at 15% v/v.
In order to determine whether the reduction in the siz
of colonies was due to a direct effect of the hormone on
colony forming cells or secondary to inhibition of growth
factor production by accesory cells, experiments were
performed in which colony formation was measured with
conditioned medium (CM) added to cultures . Both MoCM
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(containing IL1) and PB4-CM(containing IL2) were found to
reduce MPS induced inhibition of colony formation. The
addition of PHArCMcompletely reversed the inhibition due'to
MPS; MoCM partially reversed inhibition (table 4.5). In a
further experiment, in which both colony and cluster formation
and colony size were measured, the addition of PHA-CMto MPS
treated cultures was found to restore colony formation to
normal and to prevent the reduction in colony and cluster size
(table 4.6).
9-
TABLE 4.6 THE EFFECT OF PHA-CM ON COLONY NUMBER AND SIZE
IN MPS TREATED PRIMARY CULTURES
number of cells/colony-cluster Number of
Colony count (% of total counted) aggregates
5-20 21-40 >40 examined
No MPS 2 32±16 15 23 62 56
10_8M MPS 8 3±7 34 38 28 64
PHA-CM - 2 32±11 20 27 53 84
PHA-CM+MPS 243±18 25 30 45 92
Colony counts are the mean value ± 1 S.D. of triplicate cultures.
Colonies were scored by examining three fields per well at x40
magnification. Colony and cluster (aggregate) size was evaluated
by examining cultures at xlOO magnification; the figures for
number of aggregates examined are the number of colonies and
clusters seen in three high power (xlOO) fields.
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2) INHIBITION OF SECONDARY COLONY FORMATION BY MPS
, t
Further evidence that MPS mediated inhibition of colony
formation was due to inhibition of growth factor production
was provided by studies of secondary colony formation. In
order to determine whether proliferation of colony cells in
secondary culture was inhibited by MPS,experiments were
performed in which T-CFCs were cultured with conditioned
medium (PHA-CM) prepared by PHArstimulation of autologous
freshly isolated blood MC . Parallel cultures were also
carried out using CM from the same autologous MC stimulated
with PHA in the presence of MPS (MPS/PHA-CM).
Secondary colony formation occured only in cultures
containing conditioned medium. In the presence of PHA-CM, MPS
was inhibitory but only at high concentrations of MPS (>10~®M);
the inhibitory effect even at these high concentrations was
much less marked than the inhibition found in primary cultures
using the same concentration of MPS. However when cultures
were performed using CM prepared from MPS treated cells
(MPS/PHA-CM) colony formation was reduced even when blood MC
used to prepare CM had been treated with as little as 1MPS
(table4.7). In these secondary cultures the addition of MPS,
even when PHA-CM was present, did however reduce colony size
(table 4.8). This finding suggested that MPS may exert a
direct inhibitory effect on colony cells in addition to
inhibiting the production of growth factors.
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TABLE 4.7 INHIBITION OF SECONDARY T-LYMPHOCYTE COLONY
FORMATION BY MPS.
number of colonies (mean + 1 S.D)
-
expt.1 expt.2 expt.3 expt.4
Culture conditions
PHA-CM, No MPS 113±32 84±8 187124 11517
PHA-CM + 10~10 M MPS not done 9718 201+23 121+15
+ 10"8 M MPS 8 3±2 2 8719 181±11 114+23
+ 10"6 M MPS 7 4±9 79 + 11 120±16 81112
+ 10"4 M MPS not done 6819 81±15 5 8+11
MPS/PHA-CM
1 0~10M not done 91 + 15 142117 103110
10"8 M 6 0115 21 + 9 72116 69120
i—1 o
i CD 3 16 + 11 2 + 1 2319 4716
10"4 M 5+3 0 0 9±6
Figures are the mean colony counts 1 1 S.D. of triplicate
or quadruplicate cultures in each experiment. CM were included
in culture underlayers at 50% v/v concentration. PHA-CM was
the culture supernatant from PHA stimulated blood MC.
MPS/PHA-CM was the culture supernatant of blood MC stimulated
with PHA in the presence of various concentrations of MPS.
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TABLE 4.8 THE EFFECT OF MPS ON COLONY SIZE IN SECONDARY
, t
CULTURE.
Number of Size of
colonies clusters aggregates
Culture conditions
PHA-CM, No MPS 104+9 32±5 79
PHA-CM + 10"8M MPS 102±19
9-
41±11 44
PHA-CM + 10"6M MPS 83 + 10 49+15 35
Figures are the mean colony (aggregates >40cells) and cluster
(aggregates 4-40 cells) counts + 1 S.D. of triplicate cultures.
The mean size of cell aggregates was measured by direct
examination of cultures at xlOO magnification and counting the
number of cells in 50- 100 colonies and clusters.
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When colony cells were incubated in secondary culture
in suspension and proliferation measured by thymidine
incorporation a vigorous proliferative response was seen with
PHA-CM, however MPS/PHA-CM showed no T-cell stimulatory (IL-2)
activity (table 4.9). In suspension culture the addition of
MPS to cultures containing PHA-CM had no measurable inhibitory
effect on proliferation measured by thymidine incorporation
(table 4.9). In these experiments the IL-2 activity of culture
supernatants from blood MC stimulated with PHA and MoCM, with
or without MPS, was also measured. This was done in order to
determine whether the inhibitory effects of MPS on T cell
growth factor production could be blocked by adding exogenous
IL-1 (present in MoCM). The results of these experiments showed
that MPS substantially reduced IL-2 production even when MoCM
was added to cultures. In cultures from MPS treated, PHA and
MoCM stimulated, cells detectable amounts of IL-2 were however
still measurable (table 4.9) . This finding demonstrates that
while MPS probably directly inhibits the IL-2 producing cell,
it is also possible that indirect effects through inhibition
of monocyte IL-1 production may also be involved .
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TABLE 4.8 INHIBITION OF IL-2 PRODUCTION BY MPS.
Source of CM Additive to IL-2 activity
assay system (c.p.m.)
MC + PHA (PHA-CM) nil 8,769+635
MPS 7 ,965 +422
MC + PHA + MPS (MPS/PHA-CM)
9
nil 885+122
MC + PHA + MoCM nil 12,6 50±107 6
MPS 10,894±756
MC + PHA + MOCM + MPS ni 1 3,065+593
Figures are the mean values ± 1 S.D. of triplicate cultures
in a single experiment. These findings were confirmed in two
further identical experiments. Responses of T cells in
control cultures were : medium alone (RPMI 1640 no CM)
1068+322 c.p.m., PHA 0.5% 1465+345 c.p.m., MoCM 15% v/v
965+256, PHA + MoCM 2450+240.
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DISCUSSION
These studies demonstrate that MPS inhibits T lymphocyte
—10 —Q
colony formation at very low concentrations (10 M-1,0 M) that
correspond to concentrations of endogenous glucocorticoid such
as Cortisol of around 2 x 10~8 to 2 x 1(T6M (Claman 1972).
These concentrations overlap the physiological range and fall
well within the range required to saturate the high affinity
cytoplasmic glucocorticoid receptors (Lippman et al 1973,
Smith et al 1977). The observation that inhibitory effects
were blocked by cortexolone* which competes with active
glucocorticoids for these receptors, confirms that inhibition
is due to specific binding to cytoplasmic receptors. In a
recent study, using hydrocortisone, Claesson and Ropke (1983)
have confirmed the sensitivity of T colony formation to
extremely low concentrations of glucocorticoids.
In primary cultures conditioned medium from PHA
stimulated MC (PHA-CM) almost completely abrogated the
inhibitory effects of MPS. This finding suggested that
inhibitory effects of MPS were largely due to inhibition of
growth factor production by accessory cells. This possibility
was confirmed by studies of secondary colony formation, which
is dependent upon the addition of exogenous growth factor
(most probably IL-2) to cultures. In secondary culture it was
found that colony formation in cultures containing PHA-CM
showed little or no inhibition in the presence of MPS.
- 176 -
However, cultures supplemented with conditioned medium from
MPS treated, PHA stimulated MC (MPS/PHA-CM) showed either
reduced or no colony formation. Measurement of IL-2 activity
in culture supernatants confirmed a marked reduction.or
absence of IL-2 activity in MPS/PHA-CM. Similar findings have
been demonstrated by Gillis et al ( 1979a,b) who demonstrated
that dexamethasone inhibits lymphocyte proliferation by
reducing IL- 2 activity in culture supernatants of lectin
stimulated mouse and human lymphocytes.
MoCM (containing IL-1 cTctivity) was less effective than
PHA-CM (containing IL-2) in preventing inhibition of primary
colony formation and was found to only slightly increase IL-2
activity in culture supernatants from MPS treated PHA
stimulated MC. These findings, together with the observations
discussed in the preceding paragraph, suggested that the major
inhibitory action of MPS in colony formation was to inhibit IL-
2 production (Krajewski and Wyllie 1981). However it has
recently been shown that inhibition of IL-2 production by
steroids is in part a consequence of inhibition of IL-1
production by monocytes (Smith 1980, Snyder and Unanue 1982),
as well as a consequence of direct inhibition of IL-2
synthesis by IL-2 producing T-helper cells (Palacios and
Sugawara 1982, Palacios 1982). It is therefore probable that
both IL-1 and IL-2 production are targets for inhibition by
glucocorticoids.
Experiments in which MPS was added to cultures at varying
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times showed that early addition of MPS was necessary to
inhibit colony formation. These findings are similar to those
of Webel and Ritts (1977) and Robertson et al (1981) who found
• »
that early addition, or preincubation of cultures with MPS
was necessary to inhibit thymidine incorporation into lectin
stimulated cells. This is consistent with the hypothesis that
MPS acts mainly through inhibition of growth factor production
since it is known that both monocyte derived colony
stimulatory factors, such as IL-1 (Claesson et al 1977b,
Rosenszajn et al 1981), and lymphocyte derived factors, such as
IL-2 (Gillis et al 1978b), are produced predominantly in the
early stages of culture.
The possibility that MPS may directly inhibit
proliferation of growth factor responsive colony cells has not
been completely excluded in these studies. It is however
unlikely that this is a major effect since the inhibitory
effects of MPS were largely blocked by the addition of PHA-CM
(containing IL- 2) to cultures and it has been reported by
others that glucocorticoids have no effect on the ability of
lectin activated T cells to respond to IL-2 (Gillis et al
1979a,b, Larsson 1980, Palacios 1982). Claesson and Ropke
(1983) have however shown that the proliferation of a
subpopulation of colony cells (Leu2 positive T cells) may be
directly inhibited by hydrocortisone even in the presence of
IL-2. This observation may explain the reduction ir> size of
colonies I have observed in secondary cultures containing MPS
(table 4.8).
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The question arises as to the relevance of these in vitro
findings on the effect of glucocorticoids on proliferating
T cells in vivo. The lymphopenia which follows systemic
administration"of steroid in man is more readily attributable
to sequestration of circulating lymphocytes than to any effect
on their proliferation (Fauci and Dale 1974, Cupps and Fauci
1982). However the proliferation of T cells to form colonies
in agar, observed here, may be considered analogous to the
proliferation of T cells in lymphoid tissue and inflammatory
foci in vivo where proliferation occurs in a cell rich milieu
that includes accessory cells such as macrophages. In such
circumstances it is propsed that the major site of action of
glucocorticoid hormones is to inhibit production of soluble
growth factors by accessory cells rather than due to direct
effects on the proliferating T cells themselves.
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Inhibition of human T lymphocyte colony formation
by methylprednisolone
A. S. KRAJEWSKI & A. H. WYLLIE Department ofPathology, Edinburgh University Medical
School, Edinburgh, Scotland
(Acceptedfor publication 17 April 1981)
SUMMARY
Methylprednisolone, at very low concentrations, inhibits colony formation by PHA-
stimulated human blood lymphocytes in vitro. The inhibition is exerted at an early stage in
transformation. It results not from direct effects on colony-forming cells but from
inhibition of production of a soluble factor produced by accessory cells.
INTRODUCTION
Glucocorticoid hormones are well known to inhibit the function of lymphoid cells in vivo (see review
by Claman, 1972), but attempts to analyse their mode of action in vitro have generated conflicting
results. Direct lethal effects of low concentrations of steroid on lymphocytes in vitro are observed
only in some species, yet the resistant species, which include man, show prominent immunosuppres¬
sion on treatment with steroid. Lymphocyte transformation and proliferation, induced in vitro by
exposure to lectins, has also been investigated as a potential target for steroid action. Whilst some
groups have demonstrated inhibition of transformation (Nowell, 1961; Smith et al., 1977;
Robertson et al., 1981), others have found little effect (Kraft, Thomson & Atkins, 1979; Segel etal.,
1980).
In order to investigate further the effect of glucocorticoids on lymphocyte transformation we
have studied the effect of methylprednisolone (MPS) on phytohaemagglutinin (PHA) induced
human T lymphocyte colony formation in agar gels (Rozenszajn, Kalechman & Shoham, 1975;
Riou et al., 1976). Colony formation was chosen as an assay for proliferation in preference to
conventional techniques for measuring lymphocyte responses, such as tritiated thymidine
incorporation or blast transformation in liquid culture, as there is evidence that colony-forming
assays may more accurately reflect inhibitory drug effects in vivo than other in vitro techniques
(Roper & Drewinko, 1976).
In this paper we show that colony formation by human peripheral blood lymphocytes is
sensitive to low concentrations ofMPS. Moreover, colony formation is shown to provide an assay
system capable of dissecting the point of action of glucocorticoids with considerable precision,
despite the use of culture conditions which were incompletely defined chemically.
MATERIALS AND METHODS
Mononuclear cells. Mononuclear cells were isolated from heparinized venous blood from
healthy volunteers by centrifugation over Ficoll-Hypaque (Boyum, 1968). Freshly isolated
mononuclear cells were washed twice in RPMI 1640.
Correspondence: Dr A. S. Krajewski, Department of Pathology, University Medical School, Teviot Place,
Edinburgh EH8 9AG, Scotland.
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One-step culture procedure (modified from Goube de la Forest et at., 1979). Mononuclear cells
were suspended in RPMI 1640 supplemented with 10% autologous plasma ('growth medium') with
agar added to 0-3%. Forty microlitres of this suspension (2 x10s cells) were plated onto an
underlayer of 0-2 ml of 0-5% agar in growth medium and 20 pg phytohaemagglutinin M (PF1A)
(Difco). All cultures were in 17-mm-diameter wells in Multiwell dishes (Linbro 76-033-05).
Two-step culture procedure (modified from Rozenszajn et al., 1975). Five million mononuclear
cells were incubated for 18 hr in 5 ml RPMI 1640, 10% autologous plasma and 500 pg PHA. The
cells were then harvested by centrifugation, washed three times, disaggregated by repeated passage
through a fine Pasteur pipette, and resuspended in 0-3% agar in growth medium. One millilitre of
this suspension (5 x 105 cells) was plated on to an underlayer of 1 ml of 0- 5% agar in growth medium
and 100 pg PFIA. Cultures were carried out in 35-mm plastic Falcon petri dishes.
Secondary cultures (Goube de la Forest et al., 1979). Cells growing in colonies in primary
(one-step) cultures were harvested after 7 days, washed three times in RPMI 1640, disaggregated by
repeated passage through a fine Pasteur pipette and resuspended in 0-3% agar in growth medium.
Forty microlitres (2 x 105 cells) were pipetted on to a 0-2 ml underlayer of0-5% agar growth medium
with 20 pg PHA. For secondary cultures underlayers contained either 50% PHA-conditioned
medium (CM) or 2 x 105 freshly isolated allogeneic mononuclear cells.
All cultures were incubated at 37°C in a fully humidified atmosphere of 5% CO2 in air.
Methylprednisolone sodium succinate (MPS) (Upjohn) was added in RPMI 1640 to under¬
layers to give a final concentration of between 10 -10 and 10~4 m.
Colonies, defined as aggregates ofmore than 40 cells, were scored after incubation for 6 days. In
some experiments both clusters (4-40 cells) and colonies (more than 40 cells) were scored. Colony
and cluster size was determined by examination at x 100 magnification.
Conditioned medium (CM). CM was prepared by incubating 2x 106 freshly isolated mono¬
nuclear cells in 2 ml growth medium and 200 /rgPHA for 48 hr. Following centrifugation at 100# for
20 min, culture supernatants were harvested, sterilized by millipore filtration and stored at — 20°C
for up to 2 weeks before use. In some experiments conditioned medium was prepared as above but
from cultures to which MPS had been added at various concentrations throughout the 48-hr
incubation period (MPS-CM).
Identification of lymphocyte subclasses. T and B lymphocytes were identified by rosetting with
sheep red blood cells and immunofluorescence respectively. Monocytes were identified by
phagocytosis and staining with non-specific esterase and acid phosphatase (Dewar, Krajewski &
Murray, 1980; Krajewski & Dewar, 1981).
3H-thymidine uptake by T cell blasts. Cells harvested from primary agar cultures (T cell blasts)
were suspended at 105 cells/ml in RPMI 1640 with 20% human serum and 0-2 ml of this suspension
was aliquoted into flat-bottomed wells in multiwell plates (Linbro 76-033-05). A further 0-2 ml of
either RPMI 1640 containing 1% PHA or conditioned medium was added to individual wells.
Cultures were incubated for 4 days and then pulsed for 4 hr with 1 pC\ of 3H-thymidine
([methyl-3H]thymidine, 40-60 Ci/mmol, Radiochemical Centre, Amersham). Cells were collected
on 25-mm Whatman GF/C filters, washed twice with phosphate-buffered saline followed by one
wash with 5% TCA and two washes with absolute alcohol. The filters were then placed in scintillant
for measurement of acid-precipitable 3H-thymidine incorporation (c.p.m.)
RESULTS
Inhibition ofprimary colony formation by MPS
In one-step cultures, MPS was found to inhibit colony formation at concentrations ranging from
10~10 to 10~4 m (Fig. 1). Maximum inhibition was obtained only if MPS was present from the onset
of PHA stimulation; delay of only 1 hr resulted in substantially less inhibition (Table 1).
In two-step cultures, MPS at the same concentrations inhibited colony formation only if the cells
were incubated with MPS during the first step before plating out in agar; incorporation ofMPS into
agar after preincubation without MPS did not reduce colony formation. Similarly, addition ofMPS
to agar did not affect further the number of colonies obtained from cells treated in the preceding 48
hr with MPS.
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Fig. 1. Inhibition of colony formation by MPS in one-step cultures. Mean + s.d. of eight lymphocyte cultures in
each experiment.
Evidence that inhibition ofcolony formation was the result ofspecific glucocorticoid interaction
with high-affinity cellular receptors was given by experiments in which cultures were incubated with
10~6 m MPS together with the glucocorticoid antagonist cortexolone at 10~4 m. By themselves these
high concentrations of cortexolone led to a small reduction in the number of colonies, but the
inhibitory effects of MPS were substantially reversed.
Table 1. Effect of time ofaddition ofMPS to cultures on colony formation
Number of colonies + s.d.
Experiment Experiment Experiment Experiment
12 3 4
No MPS added 115 + 23 73+11 115 + 5 110+13
Time MPS added*
0 hr 0 6 + 4 0 3 + 5
1 hr 124 + 30 26 + 8 45+11 39+12
24 hr 113+17 58 + 6 51+4 73 + 13
48 hr n.d. n.d. 52+13 67+11
* Ten microlitres of 10-5 M MPS were added to cultures either at the
beginning of culture (0 hr) or after varying periods of incubation, by
pipetting MPS onto the cell layer. In each experiment results are the
mean + s.d. of four cultures,
n.d. =Not done.
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Fig. 2. Effect of MPS on secondary cultures, (o) Culture with active CM and freshly added MPS, (0) culture
with CM made in the presence of MPS (MPS-CM). Mean ± s.d. of 10 lymphocyte cultures in each experiment.
Effect of MPS on secondary colony formation
Cells harvested from primary cultures constituted a relatively homogeneous population of large
cells, with prominent nucleoli, frequent mitotic figures and T cell surface characteristics. Thus in
these experiments over 70% ofcells formed rosettes with sheep red blood cells; no phagocytic cells or
cells with surface immunoglobulin were detectable; and the cells were esterase- and acid
phosphatase-negative. Accordingly, we refer to them as T cell blasts.
Such T cell blasts, harvested and reseeded into agar proved incapable of producing secondary
colonies without addition of other factors. This has been shown to be the result of depletion of
accessory cells originally present in the primary cultures (Goube de la Forest et al., 1979).
Table 2. Effect of CM on proliferation of T cell blasts* in agar and liquid culture
Agar culturet Colonies (± s.d.)
Underlay with:
PHA 0
CM 292 + 24
CM+1CT8MMPS 331+60
Liquid culture! c.p.m. x 103 (±s.d.)
Underlay with:
PHA 0-4 + 0-1
CM 63-0 + 6-4
CM+10~8MMPS 58-9 + 2-8
* T cell blasts were harvested from
primary cultures.
t Standard secondary cultures. Results
are mean ± s.d. of three cultures.
J 3H-thymidine uptake was assessed as
described under Materials and Methods.
Results are mean + s.d. of three cultures.
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Proliferation of reseeded T cell blasts was observed, however, when either allogeneic freshly isolated
blood mononuclear cells or conditioned medium (CM) from blood mononuclear cell cultures were
incorporated in culture underlayers. This system thus allowed us to separate direct effects of MPS
on proliferation of T cell blasts from indirect effects on accessory cells responsible for the
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Fig. 3. (a) Human T lymphocyte colonies in primary culture, grown in the absence ofMPS. (Original x 100.) (b)
Human T lymphocyte colonies in primary culture, grown in the presence of 10-6 M MPS. (Original x 100.)
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It was found that MPS added to secondary cultures containing active CM had little effect on
colony formation, except at high concentrations, whereas conditioned medium prepared from
MPS-treated cells (MPS-CM) showed markedly decreased ability to support secondary colony
formation. The activity of conditioned medium was decreased by about 50% by culturing
mononuclear cells used in its preparation with 10~8 m MPS, whereas secondary colony formation,
in the presence of active CM, was not inhibited by the addition of the same concentration ofMPS to
culture underlayers (Fig. 2, Table 2).
Similarly, 3H-thymidine incorporation by T cell blasts harvested from primary culture and
incubated in suspension into CM was not inhibited (Table 2).
In an analogous manner, experiments using allogeneic mononuclear cell feeder layers showed
that MPS incorporated into the culture underlayers inhibited in situ production of colony-
stimulating activity at concentrations as low as 10~10 m.
Effect ofMPS on T cell colony size
In primary cultures MPS consistently reduced the numbers of colonies. This effect appeared to be
mainly the result of a reduction in the size of cell aggregates rather than an overall reduction in the
number of colony-forming cells initially stimulated to proliferation; i.e. in the presence of MPS,
clonogenic cells showed a reduced rate of proliferation resulting in cell aggregates of less than 40
cells (clusters) developing, whereas in the absence ofMPS the majority of cell aggregates contained
more than 40 cells (colonies) (Fig. 3a, b).
In order to determine whether this reduction in the size ofcell aggregates was the result ofdirect
inhibition of clonogenic cell proliferation or inhibition of growth factor production by accessory
cells within the primary culture, CM was incorporated into culture underlayers in primary cultures.
The results of a typical experiment are shown in Table 3. In this experiment, 10~8 m MPS
substantially reduced the number of colonies (aggregates >40 cells). In the presence of CM no
reduction in the number ofcolonies was seen (Table 3a). In the same experiment the total number of
clusters and colonies developing in the presence ofMPS and in control cultures was also determined
(Table 3b). In the presence of MPS the total number of cell aggregates was similar to control
cultures; however, in MPS-treated cultures only 28% of aggregates were of colony size (>40 cells)
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* Figures are mean±s.d. of three cultures.
t The total number of colonies and clusters and their size was
evaluated by examining cultures at x 100 magnification. Figures are
numbers seen in three fields.
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whereas in control cultures 62% of aggregates were of colony size. The addition of CM to cultures
increased the total number of cell aggregates developing in both control and MPS-treated cultures
and increased the number of colony-size aggregates to near control levels in MPS-treated cultures
(Table 3b).
These experiments demonstrate, as expected from previous data, that inhibition of primary
colony formation by MPS is reversible by CM and probably results from inhibition ofaccessory cell
function rather than direct effects on colony-forming cells.
DISCUSSION
The results reported here show that MPS inhibits human T lymphocyte colony formation in vitro.
This inhibition is demonstrable at extremely low concentrations (10~'°-10~8 m), corresponding to
concentrations of endogenous glucocorticoid such as Cortisol of around 2x 10~8 to 2 x 10-6 m
(Claman, 1972) which overlap with the physiological range. Since the growth-supporting medium
included autologous plasma, which would be expected to contain some Cortisol, it is clear that
demonstration of glucocorticoid effects at concentrations lower than those tested would not be
possible without the use of sera from which the physiological concentrations ofglucocorticoid had
been previously removed. The low concentrations to which T lymphocyte colony formation is
sensitive fall well within the range required to saturate the high-affinity cytoplasmic receptors for
glucocorticoids (Lippman et al., 1973), and the inhibition of colony production is antagonized by
cortexolone, which competes with active glucocorticoids for these receptors.
In both primary and secondary cultures conditioned medium from PHA-stimulated lympho¬
cytes (CM) completely abrogated the inhibitory effects of MPS both in terms of colony numbers
and colony size. The active factor in CM is almost certainly T cell growth factor (TCGF, interleukin
II) as we have observed that the CM used was able to maintain T cell blasts in proliferation for
several weeks after cells had lost their responsiveness to PHA (Table 3) (Lotze, Strausser &
Rosenberg, 1980; Zeevi, Chiu & Duquesnoy, 1980; Smith et al., 1980). However, conditioned
medium from MPS-treated cultures (MPS-CM) showed a markedly reduced capacity to support
secondary colony formation. Similarly, the number of secondary colonies developing on
MPS-treated cell feeder layers was also reduced, presumably as a result of inhibition of TCGF
production. These findings show that the major site ofaction of MPS on human T cell growth is the
inhibition of release of growth factors from accessory cells rather than a direct effect on
proliferation of colony cells.
Similar findings have been reported by Gillis, Crabtree & Smith (1979) who demonstrated that
dexamethasone inhibits lymphocyte proliferation by reducing TCGF activity in culture superna-
tants of lectin-stimulated mouse and human lymphocytes.
Experiments in which MPS was added to cultures at varying times showed that early addition of
MPS was necessary to inhibit colony formation. These findings are similar to those ofWebel & Ritts
(1977) and Robertson et al. (1981) who found that early addition or preincubation of cultures with
MPS was necessary to inhibit thymidine incorporation in lectin-stimulated cells. This finding is
consistent with the hypothesis that MPS acts mainly by inhibiting TCGF production as it is known
that TCGF production occurs predominantly during the early stages ofculture (Gillis et al., 1978).
The alternative possibility, that MPS acts by preventing initial activation of colony cells or their
subsequent proliferation in response to TCGF is unlikely since the effects ofMPS were reversed by
addition of CM (and presumably TCGF) to cultures and it has been reported by others that
treatment with the glucocorticoid dexamethasone has no effect on the ability of lectin-treated T cells
to respond to TCGF (Larsson, 1980).
The question arises as to the relevance in vivo of these in vitro effects of glucocorticoid hormone
on proliferating human T cells. The lymphopenia which rapidly follows systemic administration of
steroid is more readily attributable to sequestration ofcirculating lymphocytes than to any effect on
their proliferation (Fauci & Dale, 1974). However, T cells, derived from the peripheral blood,
proliferate in the vicinity of accessory cells such as macrophages in inflammatory foci in vivo. The
phenomena observed here in vitro bear a strong analogy to this situation. On the basis of the results
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presented here, we propose that the major action of glucocorticoid hormones on lymphocytes
within reactive and inflammatory foci is to inhibit production of soluble growth factors by
accessory cells; we have been unable to detect any direct effect on the proliferating T cells
themselves.
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SUMMARY
The potent adenosine deaminase inhibitor, deoxycoformycin (dCF), is currently under
evaluation in the treatment of lymphoid malignancy. We show that dCF inhibits the
growth in soft agar of T cell colonies from PHA stimulated human peripheral blood
lymphocytes. In contrast to previous attempts to develop an in vitro model for analysis of
the drug's action, concentrations lower than 10~"9m are effective, and no 'priming' by
pharmacological concentrations of adenosine is required. Maximum inhibition is
obtained when dCF is present over the first 4 hr of cellular exposure to PHA. T cells
already proliferating in response to PHA are less sensitive to dCF, implying that S-phase
events are not primary targets of the drug's action. Colony inhibition does not appear to
be due to alteration in the production of, or sensitivity to, soluble T cell growth factors. In
suspension cultures, dCF at concentrations up to 10~5m fails to inhibit early
PHA-induced volume changes, or later mitosis, in peripheral blood lymphocytes. The
results show that there is a critical dCF sensitive step early in PHA stimulation. It involves
those T cells capable of forming colonies and may be conditioned by the cellular
microenvironment.
INTRODUCTION
The essential role of adenosine deaminase (ADA) in lymphocyte function was first identified by the
description of severe combined immunodeficiency disease resulting from the congenital absence of
the enzyme (Giblett et al., 1972; Dissing & Knudsen, 1972). Deoxycoformycin (dCF) is a potent
inhibitor ofADA (Woo et al., 1974) that has been shown experimentally to mimic ADA deficiency
by causing a selective lymphopenia in mice (Smyth, Young & Young, 1978). Early clinical trials
have shown that dCF inhibits human lymphocyte ADA, is cytotoxic to malignant lymphocytes
particularly of T cell lineage—cells known to have elevated ADA activity—and has therapeutic
activity in T cell neoplasms (Smyth et al., 1980; Poplack et al., 1981; Prentice et al., 1981). The
lymphopenia produced by inhibition of ADA suggests that dCF might be useful as an
immunosuppressant.
Despite a number of hypotheses, the precise metabolic role of ADA in normal lymphocyte
function is uncertain. At the cellular level we do not know whether ADA inhibitors such as dCF
produce pharmacological immunodeficiency as a result of a general suppression of all T cells or of
some critical subpopulation. Nor is it clear whether the drug acts directly on proliferating T cells, on
accessory cells involved in T cell activation, or through inhibition of the action of humoral factors
such as the interleukins.
Correspondence: A. H. Wyllie, Department of Pathology, University of Edinburgh Medical School, Teviot
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This paper describes a cell culture system in which the cellular mode of action of dCF can be
studied in some detail. The system, which involves growth ofhuman T cells in soft agar (Riou et al.,
1976), provides a more sensitive assay of the drug's cellular actions than any whole cell in vitro
method reported so far and allows analysis of the effects of cell interactions and differentiation on
sensitivity to dCF.
MATERIALS AND METHODS
Mononuclear cells. These were obtained by sedimentation in Ficoll-Hypaque (Boyum, 1968) of
heparinized venous blood from healthy young adult volunteers ofeither sex. Before culture, the cells
were washed twice in RPMI 1640 medium (Gibco), counted by Coulter counter, and assessed for
'viability' by nigrosine exclusion. In all experiments more than 95% cells excluded nigrosine. The
plasma was retained and used to supplement the culture medium.
Primary lymphocyte cultures. Cultures in soft agar were established by a modification of the
method of Riou et al. (1976) as already described (Krajewski & Wyllie, 1981). In brief, the
mononuclear cells were suspended at concentrations between 5 and 20 x 106/ml in 0-33% agar
(Difco) in RPMI 1640 supplemented with 7-5% autologous plasma. This cell suspension was
pipetted on to the surface of an underlay of 0-5% agar in RPMI 1640 supplemented with 1%
phytohaemagglutinin M (Difco) (PHA) and 15% autologous plasma. In both underlay and cell
suspension, the RPMI 1640 included 80 ;Ug/ml streptomycin and 80 iu/ml penicillin G (crystamycin,
Glaxo). Cultures were set up in 16 mm wells of 'Linbro' multiwell plates (Flow Laboratories), using
220 p\ underlay and 40 p\ cell suspension. After incubation for 5 days at 37°C in a humidified
atmosphere of95% air/5% CO2, colonies were counted in transmitted light using a microscope with
a x 10 objective. Colonies were defined as aggregates ofmore than about 40 cells. In each well the
total colony count from 10 fields was recorded. Three or more wells were counted for each culture
condition in each experiment.
Secondary soft agar cultures. These were established by a modification of the method of Goube
de la Forest et al. (1979). T cell 'blasts' were obtained from primary cultures in 90 mm petri dishes,
each ofwhich contained 6-8 ml underlay and 1 -2 ml cell suspension as above. After 6 days' primary
culture the cells were harvested, washed in RPMI 1640 and suspended at 7-5 x 106 cells/ml in 0-33%
agar as above. Forty microlitre aliquots of this suspension were pipetted on to the surface of
underlays in Linbro plate wells. The underlay in these secondary cultures differed from that in the
primary cultures in that PHA was omitted, and conditioned medium (as described below) was
added at a final concentration of 25-50%.
Conditioned media. These were prepared from suspensions of peripheral blood mononuclear
cells (106 cells/ml) in RPMI 1640 supplemented with 1% autologous plasma and 1% PHA. Three
millilitre aliquots of these suspensions were incubated in 25 ml Falcon flasks for 48 hr. Cells and
cellular debris were removed by centrifugation at 700 # for 20 min. The supernatants were stored at
— 20°C and used within 1 month. Ability of conditioned media to support DNA synthesis in T cell
'blasts' was measured as follows. Cells harvested from primary agar cultures were suspended at
105/ml in RPMI 1640 supplemented with 10% newborn calf serum. One fifth of a millilitre of this
suspension was incubated with 0-2 ml of a test solution in Linbro plate wells. Test solutions
comprised RPMI 1640 alone, RPMI 1640 containing 1 % PHA, or conditioned media. After 4 days'
incubation at 37°C the wells were pulsed with 1 pCi 3H-thymidine (Amersham) for 4 hr. Cells were
collected on Whatman GF/c filters, washed twice with ice cold phosphate-buffered saline (PBS),
precipitated by three washes of 5% trichloroacetic acid, and rinsed with absolute ethanol. The filters
were then dried and counted in scintillant, with an efficiency for tritium of around 50%. All
conditioned media prepared from untreated cells stimulated thymidine incorporation 4-10-fold
more than could be attributed to the residual presence of PHA alone.
Deoxycoformycin. Freeze dried 2' deoxycoformycin ('Pentostatin', Division of Cancer Treat¬
ment, National Cancer Institute, Bethesda, Maryland, USA) was reconstituted with PBS,
resterilized by filtration and added to cultures by pipetting on to the surface of the agar. Control
cultures received the same volume of saline. Pilot experiments showed that dCF was much less
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effective when incorporated into the agar underlay than when pipetted on to the surface.
Application of dCF to the agar surface had the further advantage that it could be done at any time
after setting up the culture. It is however difficult to be precise about drug concentrations reaching
cells by diffusion through soft agar. Cited concentrations are those pipetted on to the agar surface
and are therefore all over-estimates by up to 10-fold of the concentrations surrounding the cells,
since the volume of saline in which the dCF was applied was one tenth that of the agar in each well.
Methodsfor cell identification. These included sheep RBC rosetting and indirect immunofluores¬
cence for surface immunoglobulins (Habeshaw & Young, 1975), in cell suspensions. Cytoplasmic
immunoglobulin and non-specific esterase activity (Yam, Li & Crosby, 1971) were detected in
ethanol fixed cytospin preparations.
Assessment ofPHA transformation in suspension cultures. In some experiments, the effect ofdCF
was studied on peripheral blood lymphocytes undergoing PHA transformation in suspension
culture. As it is theoretically possible that 3H-thymidine uptake measurement would be misleading
following dCF treatment, because of alterations in the deoxyribonucleoside pool (Smyth & Harrap,
1977), PHA-induced transformation was assessed by cell volume spectroscopy (to monitor early
changes) and by scoring mitotic indices (to monitor late changes).
Volume spectroscopy. This was conducted by the method of Gibbs et al. (1979) after 22 hrs
exposure of lymphocytes at a concentration of 2 x 106/ml to PHA. This method quantifies the well
known increase in size ofPHA stimulated lymphocytes in the first 24 hr of transformation, prior to
entry to S-phase. Size distributions of stimulated and control cell populations are obtained by
Coulter counter analysis and permit derivation of two scores: the percentage of cells showing a cell
size increase (% growing cells) and the rate at which this size increase takes place (incremental
growth rate). dCF was present in the treated cultures throughout the incubation, at concentrations
between 10~9 and 10~5m.
Cellsfor morphological assessment ofmitotic index. These were cultured for up to 72 hr at 106/ml
in sterile Wasserman tubes, in the presence of PHA and, in treated cultures, dCF at a final
concentration of 10-7 m. Cells were collected by centrifugation (110# for 10 min), smeared on glass
slides, fixed in Bouin's fluid for 15 min and stained by the Feulgen reaction. The proportion of
mitotic cells was assessed from examination of 500 consecutive cells on each smear.
RESULTS
dCF inhibits colony formation at low concentrations
Within 3-4 days of incubation, the untreated cultures included many small aggregates ofcells on or
immediately below the agar surface. By 5-6 days, these had grown into large groups of closely
packed cells. The great majority of these cells displayed T cell characteristics: 80-90% formed
rosettes with sheep red blood cells, whereas only 5% possessed surface immunoglobulin, 3%
cytoplasmic immunoglobulin and 0-01% non-specific esterase. When dCF was added at 10~9 m at
the onset of the incubation, fewer colonies grew than in untreated controls. The reduction in colony
numbers was dose related up to about 10~6 m (Fig. 1). In the colonies which did develop, however,
the proportion of cells showing T, B, plasma cell and monocyte markers were exactly as above.
By contrast dCF had little effect on PHA-induced changes in peripheral blood lymphocytes
incubated in free suspension. Thus in concentrations up to 10~5m dCF had no effect on the
PHA-induced increase in % 'growing cells' or on the incremental growth rate, and there was no
difference in the mitotic indices in smears of suspension cultures incubated without dCF or with
dCFat 10"7m (Table 1).
dCF is maximally effective early after PFIA stimulation
The inhibition of colony formation by dCF might be due to an action of the drug on T cell
proliferation in general, or to a more restricted action on the cellular events responsible for the
initiation ofcolonies. To distinguish between these possibilities, dCF was added to primary cultures
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at various times after their initiation or was incubated briefly with the peripheral blood lymphocytes
before culture was initiated (Table 2). dCF was most effective in inhibiting colony formation when
present during the first 4 hrs of culture. If added thereafter, despite its presence in the cultures over
the next 5 days, colony inhibition was much less. Only slight inhibition of colony formation was
observed when cells were exposed briefly to dCF prior to incubation in soft agar and PHA (Table 2).
Further, cells from previously untreated colonies were harvested and tested for responsiveness
to dCF in secondary culture. Such cells proliferate to form new colonies provided they are supplied
with humoral factors present in conditioned media. dCF did not significantly inhibit the number of
these new colonies developing in medium, supplemented with 50% conditioned medium, prepared
as described in Methods. When the conditioned medium supplement was halved, colony numbers in




































Fig. 1. Effect of dCF on T cell colony growth in vitro. Results are the means + 1 s.e. of between six and eight
replicate cultures. Colony numbers are significantly less than control in cultures treated with dCF applied at
concentrations of 10~9 M (P<005, t-test), 10~8 M (PcO-005), 10~6 M and 10~4 M (PcO-0005).
dCF does not affect interleukin production by PHA stimulated lymphocytes
It is possible that dCF might inhibit T cell colony formation indirectly, through inhibition of
production of humoral T cell growth factors. To test this hypothesis, conditioned media derived
from cultures of control or dCF treated, PHA stimulated mononuclear cells, were assayed for their
ability to support the growth of T cell colonies in secondary culture. There were no significant
differences in the number of colonies which developed in the presence of conditioned media from
control or dCF treated cells and similar numbers of colonies developed when dCF was added
directly to the assay culture (Table 3).
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Table 1. Effect of dCF on PHA-induced transformation of peripheral blood lymphocytes in suspension culture
(a) Incremental growth rate and percentage growing cells
over first 18 hr*
Incremental
growth rate % growing
dCF mean (± s.e.) cells mean
(M) x 102 (±s.e.)
0 4-88 (±0-18) 90-42 (±1-16)
10"9 4-63 (±0-16) 87-10 (±3-14)
10"8 4-55 (±0-22) 87-22 (±4-48)
10-7 4-73 (±0-24) 86-56 (±3-77)
10"6 5-00 (±0-15) 90-46 (±1-53)
10"5 5-02 (±0-08) 91-12 (±0-50)
(h) Mitotic indices (mean + s.eJt
Time since addition of PHA
24 hr 48 hr 72 hr
Without dCF 0-00 0-07 + 0-07 3-37 + 0-92
With dCF (10"7 m) 0-13 + 0-13 0-27 + 0-13 5-20+1-37
* Each result is the mean (± 1 s.e.) of at least five
observations. 'Incremental growth rate' and '% growing
cells' were derived from Coulter counter analysis as
described in Methods.
t Each result is the mean (± 1 s.e.) of three experiments
from each of which 500 cells were scored. None of the
differences between dCF treated and control cells is
significant.
Table 2. Effects of dCF on T cell colony formation when added at various stages in T cell response to PHA
Colony number
No. of (mean ± s.e. as % control
Culture conditions experiments scored after 5 days)
dCF incubated with cells for 2 hr prior to PHA 5 81-7 + 4-7
dCF added to primary cultures in PHA after
0 hr 5 63-2+ 3-8
2 hr 5 56-3+ 1-2
4 hr 5 86-0 + 4-4
8 hr 5 82-3 + 4-4
24 hr 3 82-2 + 4-0
48 hr 3 96-8+ 1-4
dCF was added at a concentration of 10~6 m. Colony number is significantly less when
dCF was added at 0 hr and 2 hr than when it was added at 4 hr (P < 0-0025); the depression
in colony number when dCF was added at other times up to 24 hr is also significant,
although less profound (0-005 <P<0-05).
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Table 3. Effect of dCF on growth factor production
Colony number
Culture conditions (mean±s.e.)
CM* from untreated cells 68-6 + 9-4
CM* from dCF treated cells 52-0+11-2
CM* from untreated cells;
dCF added to assay cultures 66-9± 11-2
CM* = cell free conditioned medium, in¬
cluded in assay culture agar to 50% volume.
Results are from four separate experiments.
There are no significant differences in colony
number between these three conditions.
DISCUSSION
We have demonstrated that certain peripheral blood T cells—those which are the progenitors ofT
cell colonies in vitro—are sensitive to dCF at concentrations lower than 10""9 m. This is well within
the concentration achieved in plasma during the treatment of patients, and associated with
profound lymphopenia (Smyth et al., 1980). It is relevant that the dissociation constant of the
reaction of dCF with adenosine deaminase extracted from human erythrocytes is about 10~" m
(Agarwal, Spector & Parks, 1977).
Our method employs lymphocytes cultured in semi-solid agar. The results contrast with
previous studies on the consequences of ADA inhibition in vitro, in which lymphocytes in
suspension culture were exposed to both deoxycoformycin and the ribose equivalent, coformycin.
PHA transformation in suspension culture is inhibited to a variable extent (Hovi et al., 1976) or not
at all (Snyder, Mendelsohn & Seegmiller, 1976; Carson & Kaye, 1979; Uberti, Lightbody &
Johnson, 1979) by concentrations of coformycins many orders of magnitude greater than 10~9 m.
Using methods which detect both early and late phases of PHA transformation, and which are
independent of any dCF related alterations in nucleoside pools, we have confirmed this insensitivity
of lymphocytes in suspension culture. Previous workers have, however, observed inhibition when
the lymphocytes were exposed concurrently to high concentrations of adenosine.
The high sensitivity of human peripheral blood T cells to dCF recorded in this study, in which
adenosine was not added to the culture media, may be attributable to two factors. Firstly, certain
cell derived substances (perhaps including adenosine) may reach higher concentrations in the
immediate microenvironment of cells in soft agar than are attained around cells in free suspension.
Secondly, the soft agar method preferentially studies a numerically very small subpopulation of
peripheral blood T cells, which is maximally sensitive to dCF immediately after PHA stimulation.
The proliferating T cells which are the product of this stimulation are less sensitive to dCF, yet it is
these cells which have usually been studied in attempts to analyse the drug's actions.
The question arises as to the mechanism of this high sensitivity to dCF early after PHA
stimulation. The period of maximum sensitivity recorded here occurs around 20 hr prior to the
onset ofDNA synthesis in PHA stimulated cells observed by several workers (Jasinska, Steffen &
Michalowski, 1970; Soren, 1973; O'Leary et al., 1980), implying that events within S-phase are not
the primary target of the drug. These results concord with those of Uberti et al. (1979) who
demonstrated that lymphocytes in suspension culture, if supplemented with adenosine, are
maximally sensitive to dCF early after PHA stimulation. It is possible that restriction in the
production of DNA synthesis precursors may account for this (Cohen et a!., 1978), but colony
forming T cells in secondary culture appear relatively insensitive to dCF although actively engaged
in DNA synthesis. Moreover adenosine deaminase inhibition has been shown to exert lethal effects
on those cells from the human thymus which do not engage in DNA synthesis (Kefford & Fox,
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1982). Others have suggested that the effects of ADA inhibition are due to intracellular
accumulation of cAMP (Wolberg et at., 1975; Carson & Seegmiller, 1976) or to inhibition of
methylation reactions (Kredich & Martin, 1977). The role—and indeed the existence—of early
changes in cAMP concentration in PHA-induced lymphocyte transformation is still uncertain
(reviewed by Hume & Weidemann, 1980), but histone methylation has been demonstrated within
the first hour of exposure to PHA (Monjardino & MacGillivray, 1970).
A different class of mechanism would be an effect of dCF on accessory cells involved in the
cellular interactions known to be essential in lymphocyte transformation (summarized in O'Brien,
Parker & Dixon, 1978) and to occur within the first few hours of PHA stimulation. Some of these
interactions are mediated by soluble factors such as the interleukins (Smith et al., 1980). We did not
detect inhibition by dCF of the production of such soluble factors, however, using an assay system
sufficiently sensitive to demonstrate low concentrations of a glucocorticoid which does act in this
way (Krajewski & Wyllie, 1981). The secondary colony assay measures T cell growth factor
(interleukin-2) activity. However, release of this into the conditioned medium by cultured
mononuclear cells is dependent upon their production of interleukin-1. The failure of dCF to
diminish the potency of such conditioned medium thus makes it unlikely that dCF exerts its
inhibitory effects through modification of either of these soluble factors. Further, the resistance to
dCF of colonies growing in secondary culture, supported by conditioned media, makes it
improbable that dCF reduces the sensitivity of colony forming cells to such factors. We have not
excluded, however, the possibility that the dCF sensitive event might involve a direct physical
interaction between colony forming T cells and accessory cells.
In conclusion, the simple, in vitro culture system described has made it possible to identify an
effect of dCF on lymphocyte proliferation at concentrations of the drug known to be
pharmacologically effective in vivo, but without additions of nucleoside to the culture medium. The
data show that there is a step in T cell blastogenesis which is highly dCF sensitive, and precedes the
onset of DNA synthesis by many hours. More precise definition of the dCF sensitive event is
desirable, as it will shed light not only on the mode of action of this promising new chemo-
therapeutic agent, but also on the role ofADA in processes critical to the initiation of lymphocyte
proliferation and differentiation.
We are grateful to Professor J. Swanson Beck, Department of Pathology, Dundee University, for his help with
the cell volume spectroscopy work. ASK is supported by a Research Training Fellowship from the Medical
Research Council, AHW by a grant and Career Development Award from the Cancer Research Campaign, and
NC by a scholarship from the Scottish Home and Health Department.
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SUMMARY
PHA-induced colony formation and interleukin 2 (IL-2) production were studied in four
patients with T cell leukaemia (three cases OKT4+/T helper and one case OKT8+/T
cytotoxic suppressor). Cases ofT helper cell leukaemia showed colony formation that was
comparable to normal purified blood T cells and was not dependent on the addition of
conditioned medium, containing IL-2 activity, to cultures. In contrast the T suppressor
cell leukaemia formed colonies only when cultures were supplemented with IL-2
containing medium. When IL-2 production by PHA stimulated cells was measured
culture supernatants from the three T helper cell leukaemias all showed normal or high
levels of activity, when compared to normal blood mononuclear cells, whereas the T
suppressor cell leukaemia showed no activity.
Keywords T cell leukaemia colonies interleukin 2
INTRODUCTION
Recently, leukaemic cells in adult chronic T cell leukaemia have been shown to express
differentiation markers characteristic ofmature T lymphocytes and have been classified as either T
helper or T suppressor-cytotoxic cell tumours on the basis of the cell surface phenotype determined
using monoclonal antibodies such as OKT4 and OKT8 (Reinherz & Schlossman, 1981; Foon,
Schroff& Gale, 1982). Relatively little, however, is known of the function of these cells and to what
extent these leukaemic cells produce or respond to the growth factors (interleukins) that regulate
normal T cell proliferation (Foa & Catovsky, 1979; De Vries, Vyth & Mendelsohn, 1981; Friedman
et al., 1982; Palacios, 1982).
In order to investigate these problems we have studied PHA-induced interleukin-2 (IL-2)
production and T cell proliferation in four patients with chronic T cell leukaemia. T cell
proliferation was measured using an in vitro colony forming assay in soft agar (Krajewski & Wyllie,
1981). By measuring colony formation in cultures supplemented with interleukin l(IL-l) and IL-2
the growth factor responsiveness of normal and leukaemic T cells could be compared.
In this report we show that leukaemic cells with a T helper phenotype produce IL-2 and
proliferate to form colonies in response to PHA. Colony formation by leukaemic T helper cells was
enhanced by both IL-1 and IL-2. In contrast leukaemic cells with a T suppressor-cytotoxic
phenotype failed to produce IL-2 or proliferate in response to PHA and IL-1 but did form colonies
in the presence of IL-2.
Correspondence: Dr A. S. Krajewski, Department of Pathology, Edinburgh University Medical School.
Teviot Place, Edinburgh EH8 9AG, UK.
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MATERIALS AND METHODS
Preparation of cell suspensions. Blood mononuclear cells (MC) from normal individuals and
patients with T cell leukaemia were isolated from heparinized venous blood by centrifugation over
Ficoll-Hypaque. Spleen mononuclear cells were obtained from patients who had undergone
splenectomy for congenital spherocytosis. Spleen cells were obtained by scraping the cut surface of
spleen in heparinized tissue culture medium, followed by sieving through a fine wire mesh and
centrifugation over Ficoll-Hypaque. MC suspensions from the plasma-Ficoll interface were washed
twice in RPMI 1640 and then resuspended at the appropriate cell concentration. In all cases cell
viability, assessed by trypan blue dye exclusion, was greater than 95%.
T cell enriched MC suspensions were prepared by rosetting blood MC with neuraminidase
treated sheep red blood cells followed by centrifugation over Ficoll-Hypaque. Sheep red cells in the
cell pellet were removed by hypotonic lysis and the purified T cells resuspended in culture medium.
Colony formation. Colony formation by blood MC was assessed as previously described
(Krajewski & Wyllie, 1981) with some modifications. Blood MC were suspended at 5 x 106 cells/ml
in 0-33% agar in RPMI 1640 containing 15% heat-inactivated human serum. Forty microlitres of
this suspension (2 x 10s cells) was pipetted on to underlayers of 0-2 ml of 0-5% agar in RPMI 1640
containing 15% human serum, 20 pg PHA-M (Difco) and 0-5% washed human red blood cells.
Cells were also cultured on underlayers supplemented with spleen lymphocyte conditioned medium
(25%) or monocyte conditioned medium (15%). Cultures were carried out in 17 mm diameter wells
in multiwell dishes (Linbro 76-033-05).
Colonies, defined as cell aggregates greater than 40 cells, were scored after 5-6 days culture, at
37°C in a fully humidified atmosphere of 5% CCL in air. Scoring was carried out by counting three
fields per well at x 40 magnification using a ruled eye piece grid. Each grid area represented
approximately 1/20 of total well area. The total number of colonies per well was estimated. Thus
number counted in 3 grids x 20
3
Conditioned media. Monocyte conditioned medium (MoCM) was prepared as described by
Lachman, Moore & Metzgar (1978). Human monocytic leukaemia cells were incubated at 0-5 x 106
cells/ml in RPMI 1640 supplemented with 5% heat-inactivated human serum and 10~5m
2-mercaptoethanol. After 24 h incubation at 37°C in 5% C02 in Roux flasks, the supernatants were
collected, centrifuged at 800# for 20 min, aliquoted, frozen and stored at — 20°C until used. MoCM
was shown to contain IL-1 activity by enhancement of human thymocyte mitogenesis (Maizel et a!.,
1981) with maximum activity when present at 15% concentration. MoCM did not contain IL-2
activity, as assayed below.
Lymphocyte conditioned medium (LyCM) was prepared by incubating human spleen cells at
1 x 106 cells/ml in RPMI 1640, with 1% PHA, 1% human serum and 1 #g/ml indomethacin (Inouye
et al., 1980). Supernatants were harvested after 48 h incubation and stored at — 20°C until used.
These supernatants contained IL-2 activity as assayed below.
IL-2 assay. Culture supernatants from PHA stimulated MC (prepared as described for LyCM)
were tested for IL-2 activity using techniques similar to those described byGillise/ al. (1978). Target
cells for testing IL-2 activity were T colony cells harvested from primary cultures after 6-7 days
(Krajewski & Wyllie, 1981). These cells do not respond to PHA but proliferate if LyCM is present. T
colony cells were suspended at 1 x 105 cells/ml in RPMI 1640 with 20% heat-inactivated human
serum and 0-1 ml aliquots were added to 10 mm diameter flat bottomed wells containing 0-1 ml of
test supernatant. Duplicate cultures of supernatants at concentrations between 50 and 6% were
assayed. After 96 h incubation at 37°C cultures were pulsed for 4 h with 0-2 pC'\ of3H-thymidine per
well and then harvested on to filters using an automatic harvester (Multimash Cell Harvester,
Dynatech Laboratories Ltd.). The cells were washed with 0'85% NaCl and then with 5% TCA, the
filters dried and placed in scintillant for measurement of acid precipitable 'H-thymidine
incorporation.
Cellphenotyping. Rosetting with sheep red blood cells (E rosettes) and mouse red cells (MRBC
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rosettes) and staining for acid phosphatase and non-specific esterase were carried out as previously
described (Dewar, Krajewski & Murray, 1980; Stockdill, Dewar & Harrison, 1983).
Lymphocyte subsets were identified using monoclonal anti-T cell antibodies, OKT3, OKT4,
OKT8 (Ortho Diagnostics Ltd.) and the anti-HLA-DR antibody DA6-231 (Guy et al., 1983).
Aliquots of 0-5-1-0 x 106 cells were pelleted in 12 x 7 mm glass tubes and the supernatants removed.
Ten microlitres ofmonoclonal antibody were added to the appropriate tube and cells resuspended
and incubated on ice for 30 min. Cells were then washed twice in ice cold PBS and the supernatants
drained off. Twenty microlitres of FITC conjugated goat anti-mouse immunoglobulin (FITC-
GAMIg) (Meloy Ltd.) was added and suspensions incubated for 30 min on ice and then washed
twice. A drop ofcell suspension was placed on a slide under a cover slip and 200 cells were examined
for fluorescence. Controls stained with FITC-GAMIg only were also examined. The controls
always showed less than 5% positive (i.e. non-specific staining) cells.
RESULTS
Cases studied
Four patients with chronic T cell leukaemia were studied. In cases 1-3 blood mononuclear cells
showed a T helper phenotype (OKT3 + , OKT4+, OKT8") and in case 4 a T suppressor-cytotoxic
phenotype (OKT3 + , OKT4~, OKT8+). The leukaemic cells also showed cytochemical staining
typical of T cells (focal acid phosphatase and non-specific esterase positivity). All cases were
negative for Tdt, and cells did not express B cell markers (HLA-DR, mouse red blood cell receptor).
Morphologically cases 2 and 3 were classified as lymphocytic leukaemias and cases 1 and 4 as
prolymphocytic leukaemias (Table 1).
Colony formation
Colony formation was measured on underlayers containing either PHA alone or supplemented with
monocyte conditioned medium, as a source of IL-1, or lymphocyte conditioned medium, as a source
of IL-2. The three cases of T helper cell leukaemia (cases 1-3) showed colony formation that was
comparable to that of purified normal blood T cells. Colony formation in these cases was enhanced
by both monocyte and lymphocyte conditioned media. In contrast in the case of the T
suppressor-cytotoxic leukaemia (case 4) colonies developed only when cultures contained
lymphocyte conditioned medium (Table 2).
Table 1. Cell phenotype in four cases of chronic T cell leukaemia
% positive mononuclear cells
Patient Age/sex wcc %lyms OKT3 OKT4 OKT8 HLA-DR E MRBC Diagnosis
1 73 M 213 98 98 97 5 1-5 85 2 T helper prolymphocytic
leukaemia
2 82 F 51-5 97 96-5 100 0-5 — 77-5 0-5 T helper lymphocytic
leukaemia
3 65 F 47 85 81 100 1-0 1-0 17 1-0 T helper lymphocytic
leukaemia
4 49 M 15 95 94 25* 88-5 1-0 79-5 6-5 T suppressor/cytotoxic
prolymphocytic
leukaemia
Normal range 46-70 33-64 16-32 15-30 43-68 0-5
* (weak reaction).
All cases were Tdt negative. Cytochemical staining showed strong focal acid phosphatase and non-specific
esterase activity in cases 1-3 and strong acid phosphatase but weak non-specific esterase activity in case 4.
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Table 2. Colony formation by normal and leukaemic cells
Colonies/2 x 105 cells
Normals (4)* T cell leukaemia
Culture underlayer MC E+ (range) 12 3 4
PHA 1,026 133 (0-267) 80 213 813 0
PHA +monocyte CM (IL-l)t 1,140 1,320 (687-2,233) 567 1,500 1,687 0
PHA + lymphocyte CM (IL-2)} 1,167 1,440 (840-1,913) 853 1,680 1,687 480
* Blood mononuclear cells (MC) contained 47-68% T cells (mean 56% E+) and 10-13%
monocytes (non-specific esterase positive cells). T cells (E+) purified by rosetting with sheep RBC
contained 93-98% T cells (mean 96% E+) and less than 1% monocytes. Figures for normals are mean
values of experiments on four different donors. Figures for leukaemics are mean values of triplicate
cultures in a single experiment.
t Monocyte CM (TTAl) was prepared by culturing human monocytic leukaemia cells at
0-5 x 106/ml in RPM1 1640 with 5% human serum and 10_5m 2-mercaptoethanol for 24 h. The
supernatant from these cultures enhanced thymocyte mitogenesis but was unable to stimulate
proliferation of cultured T cells.
t Lymphocyte CM (IL-2) was prepared by culturing human spleen cells at 1 x 106/ml in RPMI
1640 with 1% PHA, 1% serum and 1 /tg/ml indomethacin for 48 h. The supernatant from these
cultures was able to stimulate proliferation of cultured T cells that were no longer responsive to PHA
alone.
The colonies that developed in case 4 were smaller than in cases 1-3 and showed early
degeneration, whereas colonies in cases 1-3 continued to enlarge without degenerative changes
occurring over the 6-7 day culture period.
Colony cells harvested from agar cultures weremorphologically large, transformed cells some of
which were in mitosis. Monoclonal antibody analyses showed that these expressed a similar
phenotype to the initial T cell population, i.e. colony cells derived from normal blood mononuclear
cells consisted of a mixture of OKT4+ and OKT8+ cells, whereas colony cells from leukaemics
showed a predominance of either OKT4+ cells (cases 1-3) or OKT8+ cells (case 4) (Table 3).
IL-2 production
In parallel with the colony forming assays, experiments were performed to determine whether
leukaemic T cells were able to produce IL-2. Supernatants from PHA stimulated cell cultures were
tested for IL-2 activity by assessing their ability to stimulate proliferation of normal cultured T cells
which were not responsive to PHA. Supernatants from the three cases ofT helper cell leukaemia all
showed normal or high levels of IL-2 activity, when compared to supernatants from normal blood
Table 3. Phenotype of colony cells
% positive cells
Patient OKT3 OKT4 OKT8 E rosettes
1 97 93 0 99-5
2 93 92 0 99-5
3 72 85 3 93
4 — 10 43 —
Normals (4) 93-98-5 42-5-78 34-52 93-99-5
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Normal blood MC Expt 1 9,192 + 2,887 7,123 ±4,108 4,771 + 3,057 2,240 ±1,184



















Conditioned media from PHA stimulated MC were prepared and tested for IL-2
activity as described in Materials and Methods. Figures for normal MC are the mean
value+1 s.d. of IL-2 activity in conditioned medium from eight different normal
individuals. In each experiment a PHA control solution (1% PHA in RPMI 1640) was
tested at the given dilutions. Responses to RPMI 1640 alone were 330 ct/min (Expt 1), 687
ct/min (Expt 2), 637 ct/min (Expt 3) and 225 ct/min (Expt 4).
mononuclear cells. The T suppressor-cytotoxic cell leukaemia showed no evidence of IL-2
production (Table 4).
DISCUSSION
Colony formation by normal T cells is known to depend upon interactions between colony forming
cell precursors and accessory cells that modulate colony formation through the release of T cell
stimulatory or inhibitory factors (Rosenszajn et ah, 1981; Klein et al., 1982). Thus colony formation
depends not only on the presence of growth factor responsive precursors, but also on the amount of
growth factor produced by cultured cells or added to cultures (Krajewski & Wyllie, 1981).
In the present study we have shown that colony formation can be induced in leukaemic T cells by
PHA and shows a similar growth factor dependency to that of normal T cells. T helper (OKT4+)
cell leukaemias formed similar numbers of colonies to normal human T cells and, like normal T
cells, required IL-1 for optimal colony formation (Claesson et al., 1977; Rosenszajn et al., 1981).
Colony formation by the T suppressor-cytotoxic (OKT8+) cell leukaemia however differed from
that of normal T cells in that colony formation could only be induced when IL-2 containing
conditioned medium was added to cultures.
The differences in the culture requirements of OKT4+ and OKT8+ leukaemic T cells could be
explained by differences in the ability of the leukaemic cells to produce IL-2. In the present study we
have shown the OKT4+ leukaemic cells produced IL-2 in response to PHA, but the OKT8 +
leukaemic cells did not. These findings are consistent with the observation that IL-2 production by
normal T cells is a function of the OKT4+ T cell subset (Reinherz et ah, 1980; Palacios, 1982), and
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suggest that leukaemic cells expressing helper T cell phenotypes retain some of the functional
capabilities of their normal counterparts. These findings are consistent with two previous case
studies of chronic T cell leukaemia which have shown that OKT4+ leukaemic cells produce IL-2
(Friedman et al., 1982; Gramatzki et al., 1982). Investigations of IL-2 production by OKT8 +
leukaemic T cells have not been reported; however De Vries et al. (1981) have described a case of
T-CLL that responds to but does not produce IL-2. Although this case was not phenotyped using
monoclonal antibodies this may be similar to our case of OKT8+ leukaemia.
While it is tempting to postulate that autostimulation by IL-2 producing and responsive cells
may, in some cases, play a role in leukaemic cell proliferation in vivo, we agreewith Gootenberg et al.
(1981) that this is unlikely to be a key event in induction ofT cell neoplasia. The clinical significance
of differences in T cell phenotype and function in chronic T cell leukaemia is at present uncertain. It
is possible, however, that these differences, once accurately defined, may allow not only more
precise classification ofclinico-pathological groups but may also be utilized to control proliferation
of the neoplastic cells.
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Summary
1. In order to investigate the cellular
mechanism of glucocorticoid resistance in chronic
asthma, peripheral blood mononuclear cells (MNC)
from asthmatic patients were cultured in soft
agar.
2. Cells from patients known to be clinically
sensitive to glucocorticoid therapy did not differ
significantly from those of clinically resistant
patients in terms of their immunophenotype or
the number of colonies generated by culture in the
presence of phytohaemagglutinin.
3. The glucocorticoid methylprednisolone
(MP) at low concentration (10nmol/l) inhibited
colony growth from cells of glucocorticoid-
sensitive patients, whereas there was much less
inhibition of colony growth from resistant
patients' cells.
4. In a small prospective study inhibition of
colony growth by methylprednisolone in vitro
correlated with the subsequently determined
sensitivity of the patients' asthma to glucocorti¬
coid therapy.
5. Assessment in vitro of glucocorticoid
sensitivity may help to predict which patients may
be spared ineffectual glucocorticoid medication.
The results raise the possibility that peripheral
blood mononuclear cells may respond to gluco¬
corticoid in a similar manner to cells involved in
the pathogenesis of asthma.
Correspondence: Dr A. H. Wyllie, Department
of Pathology, University of Edinburgh Medical
School, Teviot Place, Edinburgh EH8 9AG, U.K.
Key words: asthma, glucocorticoid resistance,
methylprednisolone, mononuclear cells, T-cell
colony.
Abbreviations: MNC, mononuclear cells; MP,
methylprednisolone sodium succinate.
Introduction
Some patients with chronic asthma are resistant to
systemic treatment with glucocorticoids, even in
high dosage. Measurements of forced expiratory
volume in 1 s (FEV10) show striking differences
between the response of resistant and sensitive
patients to the short-term administration of
systemic glucocorticoids, in sharp contrast to the
considerable increases recorded in both groups
after use of a bronchodilator aerosol [1], Detailed
study of a large group of glucocorticoid-resistant
asthmatic patients in Edinburgh has already
identified some differences in the aetiology and
clinical patterns of asthma between the two
groups. It was considered improbable, however,
that these differences were central to the
phenomenon of glucocorticoid resistance. Only
one of a wide range of laboratory investigations
discriminated between resistant and sensitive
asthmatic patients, the measurement ofmonocyte
complement receptors and their enhancement by
casein, a monocyte chemotactic factor [2]. In this
paper we show that peripheral blood mononuclear
cells (MNC) from glucocorticoid-resistant asth¬
matic patients are relatively unresponsive to
glucocorticoids in vitro and we suggest that this
may be used to predict glucocorticoid resistance
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in asthmatic subjects whose clinical response to
these drugs has not yet been assessed.
Patients and methods
Patients
The laboratory studies reported in this paper
were performed on venous blood samples obtained
from 41 patients with chronic asthma and 15
normal subjects (Table 1).
All 41 asthmatic patients had been shown to
respond to the inhalation of an aqueous 62-agonist
aerosol (salbutamol, 5 mg) by an increase in the
FEVj 0 of at least 30% from the baseline value
of less than 60% of the predicted normal value.
This evidence of reversible airflow limitation was
regarded as consistent with the diagnosis of
asthma. The patients were, however, selected in
such a way as to form three separate groups.
Group 1: 15 asthmatic patients who were
'glucocorticoid resistant' in that their FEVj 0 did
not increase by more than 15% after a short course
of prednisolone by mouth, even when the dose
was increased progressively to at least 60 (and in
some cases to 1000) mg/day. Although nine were
on regular treatment with a glucocorticoid aerosol,
the mean FEV1 0 for the whole group was no
higher on the day of blood sampling than on
earlier clinic visits.
Group 2: 15 asthmatic patients who were
'glucocorticoid sensitive', as shown by an increase
in FEVj o of more than 30% after a 7 day course
of prednisolone in a dose of only 20 mg/day. Nine
of these patients had recently started regular
treatment with a glucocorticoid aerosol, and in all
15 the disease was well controlled at the time of
blood sampling. This may explain why the mean
FEVj 0 was significantly higher at that time than
at their initial clinic visit.
Group 3: 11 'new' asthmatic patients whose
response to prednisolone, in terms of FEV10, had
not previously been assessed.
As observed in the original study [1 ], the gluco-
corticoid-resistant patients were on average older,
had a longer history of asthma, and were more
prone to nocturnal wheeze and 'morning dipping'
than the sensitive patients. There was no
difference between the two groups in respect of
atopic status or smoking habits. The more
frequent family history of asthma in the resistant
patients noted in the original study [1] did not
emerge in the smaller numbers included in the
present series (Table 1).
The criteria for inclusion of patients in groups
1 and 2 eliminated all asthmatic patients whose
FEVj q response to glucocorticoid was in the
'grey area' between 15 and 30%, with the result
that only patients who were unequivocally either
'glucocorticoid resistant' or 'glucocorticoid sensi¬
tive' were studied. Although this facilitated
correlation of clinical and laboratory findings, it
left unexplored the possibility that 'glucocorti¬
coid resistance' and 'glucocorticoid sensitivity'
might represent the ends of a continuous
spectrum. It was hoped that the inclusion of
group 3 would elucidate this point. The 11 sub-
TABLE 1. Details of asthmatic patients and controls
Values are means (± SD), or numbers of patients/total studied, unless otherwise indicated. *P< 0.02
(Mann-Whitney U-test).
Group 1 Group 2 Group 3 Controls
(glucocorticoid- (glucocorticoid- (new asthmatic
resistant asthmatic sensitive asthmatic patients)
patients) patients)
Age (years) 55.7 (±17.0) 44.5 (±19.6) 58.2 (±12.9) 49.1 (±15.3)
Duration of asthma (years) 19.3 (±5.3) 11.5 (±5.3) 14.0 (±11.5) —
Atopic 7/15 9/15 5/11 —
Nocturnal wheeze/morning dip 10/15 6/15 6/11 -
Family history of asthma 3/15 3/15 2/11 -
Smokers 3/15 3/15 2/11 -
Total dose of prednisolone in 205 169 - -
previous 12 months (mg) (range 0-1200) (range 0-700)
On regular treatment with steroid 9/15 9/15 - _
aerosol
FEV, 0 (initial clinic attendance)
(litres)
1.24 (±0.54) 1.59 (±0.71) 1.33 (±0.29) -
FEV, 0 (day of study) (litres) 1.21 (±0.58)* 2.48 (±0.79)* 1.33 (±0.29) -
Plasma Cortisol (day of study) 506 (±140) 547 (±290) 535 (±150) 510 (±210)
(nmol/1)
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jects in that group were asthmatic patients who
had presented with moderately severe airflow
obstruction for which a course of oral predni¬
solone was indicated. Their FEVj 0 was measured
before, and immediately after, a 7 day course of
prednisolone (20 mg/day). Laboratory studies
were undertaken in all 11 cases before treatment
commenced and again in nine on its completion.
None of the asthmatic patients or the controls
had coexisting malignant disease, was being treated
with cytotoxic or immunosuppressive drugs, or
was suffering from any form of intercurrent
infection, including oropharyngeal candidiasis.
About half of the patients in groups 1 and 2 had
previously been treated with oral prednisolone but
there was no significant difference between the
groups in terms of total dosage. For at least 4
weeks before this study no subject had received
glucocorticoid therapy other than beclomethasone
dipropionate by inhalation. The dose did not
exceed 400 pg daily, which is known not to
suppress pituitary-adrenal function [3], On the
morning of blood sampling the mean plasma
Cortisol was normal in all groups (Table 1).
Analysis of blood samples
Peripheral venous blood (50 ml) was with¬
drawn at 09.00 hours from each subject into a
sterile bottle containing 2 ml of 2% EDTA in
phosphate-buffered sodium chloride solution (154
nmol/1). All the laboratory studies were carried
out without knowledge of the clinical status of the
subjects. Total leucocyte count, differential
leucocyte cell count and plasma Cortisol were
determined on all samples.
MNC were obtained from the peripheral blood
by centrifugation over Ficoll-Hypaque [4] and
were then washed twice in Hank's balanced salt
solution. Subpopulations of T-lymphocytes,
monocytes and la-positive cells were quantified
by means of monoclonal antibodies with the
following specificities: OKT3 (peripheral blood
T-cells), OKT4 (inducer T-cell subset); OKT8
(cytotoxic/suppressor T-cell subset), OKM1
(peripheral blood monocytes) and Ia231 (MNC
bearing la antigens, including 90% of B-lympho-
cytes and monocytes, 20% of null cells, and
activated T-lymphocytes). Antibodies in the OK
series were obtained from Ortho Diagnostics Ltd.
Cells positive for OKT3, OKT4, OKT8, OKM1
or Ia231 were detected by indirect immuno¬
fluorescence using fluorescein isothiocyanate-
labelled goat anti-mouse immunoglobulin (Meloy
Ltd) as the second antibody. The percentage of
cells with membrane fluorescence was calculated
from study of 200 cells. For each case a negative
control was included: cells to which only second
antibody had been added.
Colony formation from peripheral MNC
MNC from each subject were cultured by using
previously described methods [5, 6]. For each
culture, 2xl05 cells were suspended in 40 pi of
RPM1 1640 supplemented with 10% heterologous
serum and 0.3% agar, and plated on to an under-
layer of 0.2 ml of 0.5% agar containing 20 pg of
phytohaemagglutinin (Difco) and 10% hetero¬
logous AB serum (the same source of serum was
used throughout). Methylprednisolone sodium
succinate (MP; Upjohn) was added to underlayers
to give a final concentration of 10 nmol/1. Control
cultures received no MP. All cultures were in
17 mm diameter wells in Multiwell dishes (Linbro)
and were incubated at 37°C in a fully humidified
atmosphere of 5% C02 in air. After 5 days of
incubation colonies (defined as aggregates of more
than 40 cells) were counted by phase contrast
microscopy at x 100 magnification in three central
fields in each of three replicate wells. This
relatively simple scoring method has been verified
by detailed computer-assisted analysis of the size
distribution of all cell clusters in the cultures.
Detailed immunophenotyping of these colony
cells showed them to consist mainly of OKT4 and
OKT8 lymphocytes, but most colonies also
included a central cell bearing monocyte markers
(M. C. Poznansky, A. C. H. Gordon, 1. W. B. Grant
& A. H. Wyllie, unpublished work).
Results
Analysis of the peripheral blood leucocytes
revealed that there were few differences between
the known 'glucocorticoid-resistant' asthmatic
patients (group 1) and the 'glucocorticoid-sensi¬
tive' asthmatic patients (group 2) or between the
asthmatic patients and normal control subjects. As
expected, the asthmatic patients had an eosino¬
phils not found in controls. The resistant and
sensitive patients did not differ significantly from
each other or from control subjects in terms of the
proportion of T-cells, T-inducer cells, Ia-positive
cells or cells reacting with the OKM1 monocyte
monoclonal antibody. There was a slightly higher
proportion of T-suppressor/cytotoxic cells in the
blood of sensitive asthmatic patients as compared
with controls. The mean proportion of T-sup¬
pressor/cytotoxic cells in resistant asthmatic
patients was less than in sensitive asthmatic
patients, but this difference failed to attain signifi¬
cance at theP< 0.05 level (Table 2).
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Table 2. Immunophenotype of peripheral blood mononuclear cells of asthmatic
patients and controls
Mean results ± SD are shown. *P < 0.01 (f-test).




























table 3. Effect of glucocorticoid on colony formation by peripheral blood mono¬
nuclear cells from asthmatic patients and controls
The reduction in colony number with methylprednisolone is significant for controls
and sensitive asthmatic patients (P< 0.0001) but not for resistant asthmatic patients.
Mean results ± SD are shown.
















In the absence of MP, MNC from both controls
and asthmatic patients in groups 1 and 2 generated
similar numbers of colonies in soft agar after 3-5
days incubation, representing a plating efficiency
of approximately 0.05% (Table 3). Incubation
during growth with MP at 10 nmol/1 significantly
inhibited colony numbers developing from the
MNC of control subjects and sensitive asthmatic
patients. In contrast this concentration of MP
had little effect on colony development from the
MNC of resistant asthmatic patients (Table 3).
To minimize purely technical variations in the
plating efficiency and in order to permit com¬
parison between patients, the number of colonies
developing from each patient's MNC in the
presence of MP at 10 nmol/1 was expressed as a
percentage of the number developing in its absence
(Fig. 1). It was clear that the responses of indi¬
vidual patients, expressed in this way, fell with
very few exceptions into two categories. Colony
growth from MNC of glucocorticoid-sensitive
patients was strongly inhibited by MP in vitro,
whereas growth from MNC of resistant patients
was affected little by MP. In all but one of the
control subjects colony growth was inhibited by
MP to the same extent as that from glucocorti¬
coid-sensitive asthmatic patients.
The clinical sensitivity of the 11 asthmatic
patients in group 3 to glucocorticoid was unknown
at the outset of the study. In these patients,
however, the response to glucocorticoid, as de¬
termined by colony inhibition in vitro, was found
to correlate closely with the extent to which
FEVj 0 increased during subsequent treatment
with oral prednisolone (Fig. 2). This is shown in
Fig. 2, where percentage changes in colony
number, induced in vitro by MP, are plotted
against the percentage change in FEVj 0 resulting
from a 7 day course of oral prednisolone. An
identical relationship was evident when the
responses in vitro were plotted against the absolute
change in FEVj 0 (data not shown).
The percentage change in colony number,
induced by MP in vitro, appeared to be character¬
istic for each subject. Thus, on re-testing six
subjects between 3 weeks and 4 months later, the
divergence from the initial value was in every case
less than 20% (Fig. 3a). In particular, colony
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FIG. 1. Effect of methylprednisolone (MP) on
colony formation from mononuclear cells of
resistant and sensitive asthmatic patients (groups
1 and 2) and of controls. The number of colonies
developing in the presence of methylprednisolone
at 10nmol/l is expressed as a percentage of the
number which developed in the absence of methyl¬
prednisolone, from cells of the same subject. Each
point derives from a different subject. N.S., Not
significant.
numbers from glucocorticoid-sensitive patients and
control subjects were strongly inhibited by MP on
both occasions (i.e. to less than 60% of the un¬
treated value). In glucocorticoid-resistant patients
colony numbers remained in excess of 60% of the
untreated value.
Perhaps surprisingly, glucocorticoid medication
did not appear to affect the extent to which
colony growth was inhibited by MP in vitro. Thus
in the ten subjects tested before and immediately
after the 7 day course of oral prednisolone, colony
growth remained strongly inhibited in eight, and
little affected in two (Fig. 3b).
Discussion
Previous studies of the characteristics of overtly
glucocorticoid-resistant asthmatic patients have
revealed few differences from the majority of
patients with chronic asthma, who respond well to
glucocorticoids [1, 2], In this paper we show
that MNC from such glucocorticoid-resistant
patients were significantly more resistant to the
effects of MP in vitro than the MNC from clini-
Colony number without MP
Fig. 2. Correlation between inhibition of colony
growth by methylprednisolone (MP) in vitro and
relief of bronchospasm by a course of predni¬
solone in vivo, in the 11 unselected patients in







Fig. 3. Repeated estimations of inhibition of
colony growth by methylprednisolone (MP) in
vitro. In (a) the initial values (•) and values
obtained on re-testing under identical conditions
(point of arrow) are shown for six subjects (two
of them glucocorticoid resistant). In (ft) initial
values (•) and values obtained immediately after a
7 day course of oral prednisolone (point of arrow)
are shown for ten subjects, nine of which came
from group 3 (new asthmatic patients).
cally sensitive asthmatic patients or normal
controls. The criterion adopted was the ability of
phytohaemagglutinin-stimulated MNC to grow as
colonies in soft agar. This phenomenon is known
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to depend upon interactions of monocytes and
lymphocytes [6, 7], but as the proportions of
monocytes and T-cells in the peripheral blood of
the two groups of patients were similar, the
observed difference in glucocorticoid responsive¬
ness in vitro cannot be attributed merely to
differences in the relative numbers of cell types
under study.
MNC from individual patients with clearcut
glucocorticoid-resistant or -sensitive asthma (i.e.
groups 1 and 2) responded to MP in vitro in a
consistent manner on repeated testing. The
response bore no relationship to the endogenous
plasma Cortisol at the time of blood sampling (see
Table 1). Further, the response in vitro did not
change after a 7 day course of systemic glucocorti¬
coid therapy. Flence it is probable that the MNC
of each individual have a characteristic response
to glucocorticoid in vitro, uninfluenced by
endogenous Cortisol or by the administration of
exogenous glucocorticoid.
The close correlation between the response to
glucocorticoid in vitro and in vivo suggests that the
cell types involved in generating colonies in vitro
(i.e. monocytes and T-lymphocytes) may be
similar to those contributing to the pathogenesis
of asthma in these patients. A substantial body of
evidence implicates cells of the monocyte lineage
in the pathogenesis of asthma [8-10]. There are
several ways in which improvement in the clinical
condition of asthmatic patients treated with
glucocorticoids may depend upon the effects of
these drugs on such cells. Of particular relevance
to the interpretation of the present results is the
well-documented inhibition of production of inter-
leukin 1 by low concentrations of glucocorticoids
[11-13], Interleukin 1 is a monocyte product
which mediates mitogen-induced T-cell prolifera¬
tion in vitro [14], and is known to support T-cell
colony formation in soft agar [7], It is also a
pyrogen and promotes the synthesis of inflamma¬
tory mediators from arachidonic acid [15, 16].
Other effects of glucocorticoids that may be
implicated in their therapeutic action in asthma
are modulation of complement receptor
expression by monocytes [2] and induction in
leucocytes of the phospholipase A2 inhibitor
lipomodulin [17], which also suppresses reactions
mediated by immunoglobulin E [18]. It thus may
be postulated that cells of monocyte lineage
within the lungs of glucocorticoid-resistant
asthmatic patients might continue to secrete
inflammatory mediators, support lymphocyte
proliferation and exist in a hyperreactive state
with enhanced complement receptor expression,
despite the presence of inhibitory concentrations
of glucocorticoids.
We embarked on this study on the premise that
glucocorticoid resistance in chronic asthma was an
all or none phenomenon, which is what prompted
us to restrict our investigations in vitro initially
to patients whose asthma was readily recognizable
on clinical criteria as sensitive or resistant. It
would seem, however, from the observations on
previously untreated, and thus unselected,
asthmatic patients, that sensitivity and resistance
may form a continuous spectrum. At one end
would be patients whose asthma is overtly
resistant to systemic glucocorticoids, even in high
dosage. It is important to recognize these patients
since they may otherwise be needlessly exposed to
hazardous side effects. This study indicates one
way in which such patients may he identified.
Although the cellular basis <j>f glucocorticoid
resistance remains obscure, our findings suggest
that a defect in MNC, and perhaps monocytes in
particular, may be responsible. We are currently
defining the nature of this cellular defect more
precisely. We are also exploring the potential of
simpler tests in vitro to identify resistant patients
before they are treated with glucocorticoids either
for asthma or for other diseases normally
responsive to these therapeutic agents.
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